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1.1 Drug Discovery 
Krankheiten begleiten die Menschheit seit ihren Anfängen. Aber wie heilt man eine 
Krankheit, wie findet man die richtige Therapie? Am Anfang der Menschheitsgeschichte 
bediente man sich der Natur, indem man ohne jegliche Vorkenntnisse über die Ursache der 
Krankheit verschiedene Pflanzen, Pflanzenteile oder deren Extrakte nicht immer in rationaler 
Weise einsetzte und schaute ob eine Wirkung erzielt werden kann. Dieser Prozess war also 
nicht rational sondern beruhte auf dem Testen vorhandener Substanzen. Insbesondere im 
Laufe des letzten Jahrhunderts gab es schließlich enorme Fortschritte auf dem Gebiet der 
Medizin, wodurch es nun möglich wurde die Ursachen einer Krankheit aufzuklären. Nun 
konnte man auf molekularer Ebene erkennen, was die Krankheit auslöste. Meistens handelt 
es sich hierbei um Proteine, die aus verschiedensten Gründen einen pathogenen 
Mechanismus im Körper einleiten. Die Bandbreite wie diese körpereigenen Moleküle einen 
schädlichen Einfluss ausüben, ist breit gestreut: sie können erblich bedingt nicht richtig 
funktionieren (Morbus Gaucher, Mukoviszidose), sind in zu niedriger (Laktoseintoleranz) 
oder zu hoher Konzentration (Hyperinsulinämie) vorhanden oder die Aktivität wird durch 
körpereigene Substanzen derart falsch reguliert, dass eine schädliche Dauer- oder Inaktivität 
(Depression, Bluthochdruck) die Folge ist. Aber auch körperfremde Proteine aus Bakterien 
oder Viren wurden schnell als Zielscheibe entdeckt um den Fremdorganismus (Gyrase, HIV-
Protease) selbst zu beseitigen.  
Im Vergleich zu den Anfängen der Therapiesuche war es also oft möglich die Ursache einer 
Erkrankung auf ein einzelnes Proteinmolekül zurückzuführen. Die Folge dieser Erkenntnis 
war dann ein bedingungsloser Focus der Arzneistoffentwicklung auf das in irgendeiner Art 
außer Kontrolle geratene Protein. Wurde ein körperfremdes Protein als überlebenswichtig 
für den Fremdorganismus eingestuft, wurde es gehemmt (HIV-Protease-Inhibitoren), oder 
war ein körpereigenes Protein falsch reguliert, fand man entsprechende Substanzen, die 
wieder für eine ausgewogene Regulierung des Proteins sorgten (Selektive-Serotonin-





neuen Therapien im 20. Jahrhundert. Die Chemie war dann auch längst, parallel zu den 
Fortschritten aus der Medizin, in der Lage mithilfe der Parallelsynthese Unmengen von 
Substanzen zu synthetisieren, die alle potentielle Wirkstoffkandidaten darstellen.  
Obwohl nun das Wissen über die Pathophysiologie einer Krankheit vorhanden war, waren 
die Probleme dieselben wie vor Jahrhunderten. Wie findet man die richtige Therapie? Man 
ersetzte zwar die damaligen pflanzlichen und tierischen Substanzgemische durch eine 
einzelne Substanz, aber die Suche nach der Richtigen ist und bleibt eine der größten 
Herausforderung auf dem Gebiet der Arzneistoffentwicklung. Eine der ersten 
vielversprechendsten Ansätze entwickelte sich in den späten Achtzigern und basierte auf 
einer altbekannten Idee: man testete nicht unbedingt nach rationalen Konzepten, sondern 
untersuchte einfach die vorhandenen Substanzen auf deren Wirkung gegen das gewünschte 
Zielmolekül. In diesem als High-throughput screening (HTS) bezeichneten Verfahren werden 
im Schnelldurchlauf ganze Bibliotheken aus Hunderttausenden von Substanzen auf deren 
Aktivität hin geprüft. Die Treffer aus dem HTS bieten schließlich erste Gerüststrukturen 
(Leitstruktur) für die weitere Optimierung. Obwohl diese Strategie einleuchtend erscheint 
und sehr erfolgreich war in den letzten beiden Jahrzehnten, sind Nachteile bei diesem 
Verfahren nicht von der Hand zu weisen. Ein zentrales Problem ist die eingeschränkte Größe 
der Bibliothek, die auch in den größten bekannten Fällen nicht mehr als 106-107 Substanzen 
enthält. Die Anzahl der synthetisierbaren Verbindungen wurde dagegen auf 1060 
geschätzt.(1,2) Dies macht deutlich, dass nur ein Bruchteil an möglichen Verbindungen 
überhaupt getestet werden kann und ein Großteil von potentiell aktiven Substanzen nicht 
berücksichtigt wird. Darüber hinaus ist die Trefferrate oft viel zu niedrig(3) und die 
gefundenen Strukturen sind weit davon entfernt, optimale Arzneistoffkandidaten zu werden, 
da wichtige physikochemische und pharmakokinetische Gesichtspunkte im HTS völlig außer 
Acht gelassen werden. Dieses muss dann im aufwendigen Optimierungsprozess korrigiert 
werden, wo schließlich Löslichkeit, Stabilität, Bioverfügbarkeit, Permeabilität und 
Bindungsaffinität der Leitstruktur verfeinert werden.   
Ein anderer vielversprechender Ansatz ist das fragment-based drug discovery (FBDD), das 
vor über 25 Jahren begründet wurde.(4) Es beruht auf der Idee, dass im ersten Schritt nur 
Substanzen berücksichtigt werden, die nicht größer als 160 Da sind. Durch diese Vorgabe 
wird die Anzahl synthetisierbarer Verbindungen drastisch reduziert. Der gesamte Bereich 





Substanzen einen Großteil des Machbaren abdecken. Auch hier stellen die gefundenen 
Fragmente erste Leitstrukturen dar. Die Vorteile gegenüber dem HTS liegen aber auf der 
Hand: weniger Substanzen werden getestet, die Optimierung der Treffer ist wegen der weit 
weniger komplexen Strukturen leicht möglich und man kann früh im Optimierungsprozess 
auf die physikochemischen Parameter Einfluss nehmen, während dies oft bei Leitstrukturen 
aus dem HTS wegen der Komplexität und Größe der Moleküle schwer gelingt.  
Das computergestützte Drug Design verzichtet dagegen auf experimentelle Verfahren und 
versucht die Aktivität von Strukturen so gut es geht in silico vorherzusagen. Man 
unterscheidet hier ligand- und strukturbasierte Ansätze. Ist keine Kristallstruktur vom 
Zielprotein vorhanden, bedient man sich dem Ligand-basierten Verfahren. Hier wird aus 
bisher entdeckten aktiven Liganden nach gemeinsamen Strukturmerkmalen gesucht und 
daraus ein Pharmakophor-Modell abgeleitet. Man definiert also ein Minimum an 
Merkmalen, die für eine ausreichende Inhibition vorhanden sein müssen. Im 
strukturbasierten Design muss die 3D-Struktur des Proteins dagegen aufgeklärt und die 
Bindetasche eindeutig definiert sein. Mit diesem Wissen ist es nun möglich eine virtuelle, 
theoretisch unbegrenzte Substanzbibliothek mithilfe des Docking zu screenen. Die 
gefundenen Liganden werden schließlich mit einer Scoring-Funktion bewertet, um eine Art 
Ranking aufzustellen. Die Scoring-Funktion ist in diesem Verfahren ein kritischer Punkt, da 
sie darüber entscheidet, welche Liganden beim Docking als sinnvoll betrachtet werden. Hier 
können mehrere Scoring-Funktionen ausgewählt werden, die auf total unterschiedlichen 
Konzepten basieren. Die wissensbasierte Scoring-Funktion bedient sich statistisch ermittelter 
Potentiale, die aus Beobachtungen von großen Strukturdatenbanken (CSD, PDB) abgeleitet 
wurden. Dabei bildet das Vorkommen distanzabhängiger Kontaktgeometrien die Grundlage 
für das Potential. Zu dieser Klasse gehören DrugScore(5) und SuperStar(6). GoldScore dagegen 
verwendet theoretische Kraftfelder um die Pose eines Liganden zu bewerten.(7) Dieser 
Ansatz ermittelt die Stärke jeder Interaktion zwischen dem Liganden und dem Protein. Die 
Summe aller Beiträge im Komplex spiegelt dann die Bindungsaffinität des Liganden wider. 
Hier wird also auf rein theoretischer Basis versucht die unterschiedlichen Bindungsbeiträge 
zu quantifizieren.  
Eine zuverlässige Vorhersage ist nur bedingt mit Scoring-Funktionen möglich, weshalb eine 
experimentelle Evaluation immer notwendig ist. Daher ist die Weiterentwicklung von 





Bindungsstudien über einzelne Bindungsaspekte wie z.B. Wasser-Einfluss, Kooperativität 
oder Enthalpie-Entropie-Kompensation liefern oftmals entscheidende Erkenntnisse, die in 
die Scoring-Funktion einfließen und sie zuverlässiger machen.     
                 
1.2 Bindungsprozess/Binding process 
Wie oben beschrieben ist der Bindungsprozess durch viele komplexe Phänomene 
gekennzeichnet, welche verantwortlich dafür sind, wieso Scoring-Funktionen oftmals 
Defizite aufweisen die Bindungsaffinität richtig abzuschätzen. Trotz dieser Komplexität ist es 
aber möglich, alle beobachteten Vorgänge innerhalb des Bindungsprozesses auf drei 
Bereiche zurückzuführen: die shape complementarity, die Wasserstoffbrücken und die Van-
der-Waals Wechselwirkungen. 
  
1.2.1 Shape complementarity 
Die shape complementarity beschreibt eine der Grundvoraussetzung für die Bindung 
zwischen einem Liganden und einem Zielprotein. Nur zueinander komplementäre Systeme, 
die räumlich zueinander passen, können miteinander interagieren. Diese Beobachtung geht 
auf Emil Fischer zurück, der es hypothetisch am Beispiel der Bindung zwischen Substrat und 
Protein beschrieben hatte. Dieser Vorgang ist wegen der Analogie zu einem Schlüssel, der 
nur für ein Schloss konzipiert wurde, als Schlüssel-Schloss-Prinzip bekannt. Mit der Zeit 
erkannte man, dass weder das Protein noch der Ligand starre Systeme darstellen. Die 
Proteinbindetasche zeigt oftmals adaptive Eigenschaften (Induced fit), um mit dem Liganden 
bestmöglich zu interagieren. Die starre Vorstellung von Emil Fischer wurde daher 
zunehmend von einem Induced-Fit-Konzept abgelöst, das beiden Bindungspartnern einen 
gewissen Grad an Flexibilität erlaubt. 
 
1.2.2 Wasserstoffbrücken/Hydrogen bonds 
Durch nichtkovalente Interaktionen, wie die Wasserstoffbrücken und die Van-der-Waals 
Wechselwirkungen, lassen sich alle Bindungsvorgänge, sei es vor oder nach der 
Komplexierung, beschreiben. Besonders die Rolle der Interaktion im Komplex ist 
allgegenwärtig, während der Einfluss der Interaktion vor der Komplexbildung oftmals 





Eine neue Wasserstoffbrücke im Komplex wird nämlich meistens mit einem positiven Beitrag 
zur Bindungsaffinität assoziiert. Aus thermodynamischer Sicht resultiert aus jeder neuen 
Wasserstoffbrücke ein bestimmter enthalpischer Beitrag (ΔHH-Brücke). Ob dieser Beitrag 
jedoch einen günstigen Effekt auf die Bindungsaffinität (ΔGBindung) hat, kann man leider mit 
großer Sicherheit nicht vorhersagen. Oftmals wird nämlich übersehen, dass der 
resultierende enthalpische Term (ΔHH-Brücke) sich aus der Summe von zwei enthalpischen 
Beiträgen ergibt: ΔHH-Bindung aus der neu gebildeten Interaktion im Komplex (exothermer 
Prozess) und das ΔHH-Desol. aus der Desolvatation der beteiligten Gruppen (endothermer 
Prozess). Nur wenn die Distanz und die Orientierung der neuen Wasserstoffbrücke im 
Komplex optimal sind, überwiegt der exotherme Term, und es wirkt sich günstig auf ΔGBindung 
aus. Im Umkehrschluss bedeutet dies, dass eine nichtoptimale Interaktion sogar einen 
ungünstigen Einfluss auf die Bindungsaffinität ausübt, da der endotherme Term der 
Desolvatation nicht kompensiert wird und somit ΔGBindung erniedrigt wird. Die freie Energie 
einer Wasserstoffbrücke (ΔGH-Brücke) setzt sich jedoch zusätzlich auch aus einem entropischen 
Term zusammen, was die Sache noch komplizierter macht. Die Enthalpie-Entropie-
Kompensation(8,9) zeigt eindrucksvoll, dass auch eine optimal gesetzte Wasserstoffbrücke 
eine Verbesserung der Bindungsaffinität nicht garantiert, da der enthalpische Beitrag nahezu 
vollständig durch einen ungünstigen entropischen Term kompensiert wird. Die Ursache 
dieser Kompensation liegt darin, dass durch eine neue Interaktion die adressierten 
Proteinbereiche stärker fixiert werden. Ein vorher in der Apoform leicht ungeordneter Rest 
wird geordneter und der entsprechende Verlust in der Entropie (- TΔSH-Protein) macht die 
günstige Enthalpie einer Wasserstoffbrücke zunichte. Ein Ansatz dies zu erfassen, ist die 
Berücksichtigung der Flexibilität eines Proteinrestes, der durch eine neue Wasserstoffbrücke 
adressiert wird. Anhand von kristallographischen B-Werten und MD-Simulationen kann man 
diese Flexibilität bewerten und entscheiden, wie aussichtsreich eine neue Wasserstoffbrücke 
im Hinblick auf die Bindungsaffinität ist. Alternativ besteht das Konzept zwei 
Wasserstoffbrücken einzuführen, die denselben Rest adressieren. Die erste würde für den 
entropischen Beitrag zahlen, während aus der zweiten Bindung kein nachteiliger 
entropischer Term resultiert, da eine Interaktion mit einer schon vorfixierten Region 
stattfindet.(10)  
Es ist daher sehr komplex exakt festzulegen, welchen Wert die freie Energie einer einzelnen 





unternommen, diesen Beitrag abzuschätzen. Fersht et al.(11) untersuchten die tyrosyl-t-RNA-
Synthase im Komplex mit ihrem Substrat. Die Reste, die mit dem Substrat in Form einer 
Wasserstoffbrücke interagierten, wurden systematisch mutiert. Die anschließende 
kinetische Untersuchung der Interaktion quantifizierte die Verschlechterung der 
Bindungsaffinität. So konnte der positive Beitrag einer neutralen Wasserstoffbrücke auf 2,1 - 
6,3 kJ/mol abgeschätzt werden. Dieser Wert konnte durch eine Studie von Williams et al.(12) 
nahezu identisch mit einem anderen Verfahren reproduziert werden. Hier untersuchte man 
die Interaktion von Peptiden aus dem D-Ala-D-Ala-Terminus des Peptidoglykans mit 
Vancomycin. Die Bindung von leicht modifizierten Peptiden zu Vancomycin wurde 
anschließend mithilfe der NMR-Spektroskopie untersucht. In dieser Arbeit konnte der Wert 
von Fersht et al.(11) reproduziert werden. 
 
1.2.3 Van-der-Waals-Wechselwirkung/Van-der-Waals interactions 
Eine weitere nichtkovalente Interaktion in Protein-Ligand-Komplexen ist die aus 
enthalpischer Sicht weitaus schwächere Van-der-Waals-Wechselwirkung. Diese Kraft ist 
nicht gerichtet und wird abhängig vom Dipolcharakter der beteiligten Molekülpartner in drei 
Bereiche untergliedert. Sind zwei permanente Dipole vorhanden, wird die anziehende Kraft 
zwischen diesen als Keesom-Wechselwirkung bezeichnet. Ein Beispiel dafür ist das 
Chlorwasserstoff-Molekül. Das partiell negativ geladene Chloratom interagiert mit dem 
partiell positiv geladenen Wasserstoff. Die Interaktion zwischen einem permanenten Dipol 
und einem polarisierbaren Molekül wird dagegen als Debye-Wechselwirkung bezeichnet. 
Das Molekül mit dem Dipolmoment ist hier in der Lage einen Dipol im unpolaren Molekül zu 
induzieren. Ein Beispiel für diese Van-der-Waals-Wechselwirkung ist der Komplex aus 
Chlorwasserstoff und Argon.(13) Das teils negativ geladene Chlor verformt die 
Elektronenhülle des Argons, da sich beide Elektronenhüllen bei ausreichender Annäherung 
abstoßen. Auf diese Weise kommt es zu einer asymmetrischen Elektronenverteilung im 
Argon. Das teils positive Wasserstoff kann analog zum Chlor ebenfalls ein Dipolmoment im 
Argon induzieren, da es die Elektronen nun anzieht. Die weitaus bekannteste Van-der-Waals-
Wechselwirkung ist die London-Kraft. Hier interagieren zwei unpolare Moleküle 
miteinander, die kein permanentes Dipolmoment aufweisen. Während der Interaktion von 
unpolaren Molekülen kommen sich die unpolarisierten Elektronenhüllen näher, was 





Dipolmomenten auf beiden Seiten, um die ungünstige Nähe von Elektronenhüllen zu 
vermeiden. Die Energie dieser Wechselwirkung hängt stark vom Abstand zwischen den 
unpolaren Atomen ab. In Abbildung 1 ist die Abhängigkeit der Energie einer Van-der-Waals-
Wechselwirkung von der Distanz gezeigt. 
  
Abbildung 1: Die Abhängigkeit der Energie der Van-der-Waals-Wechselwirkung von der Distanz. 
 
 
Im Minimum dieser Kurve existiert die größte Anziehung zwischen unpolaren Atomen. Wird 
der Abstand größer, nähert sich die Energie langsam dem Wert 0 an. Wird der Kontakt aber 
näher als die typische Van-der-Waals-Distanz, fällt die Energie sprunghaft ab und schließlich 
überwiegen abstoßende Kräfte. Die Distanz für einen optimalen Van-der-Waals-Kontakt 
zwischen zwei Kohlenstoffen wird in einem Protein-Ligand-Komplex auf 3,6-3.9 Å geschätzt.  
Verglichen mit den beiden anderen ist die London-Kraft am schwächsten, wenn nur die 
Energie der Interaktion betrachtet wird. Die Betrachtungen werden zusätzlich durch das 
Faktum verkompliziert, dass sich alle in einem biologischen System ablaufenden Prozesse in 
Wasser abspielen. Wie bei der Wasserstoffbrücke muss man auch hier berücksichtigen, dass 
vor der eigentlichen Bindung das polare Molekül desolvatisiert werden muss. Der 
energetische Beitrag aus der Debye-Kraft kann jedoch die hohe Desolvatationsenergie nicht 
kompensieren. Die Folge ist, dass es, wie bei einer schlecht platzierten Wasserstoffbrücke, 
wegen Desolvatationseffekten insgesamt zu einer Verschlechterung der Bindungsaffinität 
kommt. Die hydrophobe Optimierung von Arzneistoffkandidaten ist daher auf die London-
Kräfte angewiesen. 
Wenn die enthalpischen Beiträge aus der London-Kraft sehr niedrig ausfallen und gerade mal 
ausreichen für die Desolvatation der hydrophoben Bindungspartner, ist die Frage berechtigt, 
welche treibenden Kräfte hinter dieser Interaktion stecken. Vor Jahrzehnten wurde 




















Wasserstrukturen aus hydrophoben Bereichen der Bindungspartner resultiert.(14) Die 
Wassermoleküle können vor der Bindung mit einem hydrophoben Rest keine 
Wasserstoffbrücken eingehen. Die Folge davon ist, dass sich die Wassermoleküle 
reorganisieren und die Wasserstoffbrücken zu benachbarten Wassermolekülen gestärkt 
werden. Dieses erhöht natürlich den Grad der Ordnung an der Grenzfläche zwischen der 
Wasserphase und dem hydrophoben Bereich. Die beschriebenen Wasserstrukturen um 
hydrophobe Bereiche werden in der Literatur als „Eisberge“ oder „Clathrate“ 
bezeichnet.(15,16) Bei der Bindung werden diese energetisch ungünstigen Wassermoleküle 
wieder in die Wasserphase freigesetzt. Die Konsequenz ist eine Erhöhung der Unordnung 
des gesamten Systems, da die Wassermoleküle wieder ihre Freiheitsgrade gewinnen 
(Abbildung 2). Die hydrophobe Wechselwirkung gilt daher von jeher als getrieben von einer 
Reorganisation der beteiligten Wassermoleküle.  
 
Abbildung. 2: Schematische Darstellung des hydrophoben Effekts. In grün wird der Ligand und in gelb 









1.3 Wasser in Protein-Ligand-Interaktionen/Water in protein-ligand interaction                
Obwohl das Wassermolekül auf den ersten Blick einfach erscheint, ist es in seinen 
chemischen und strukturellen Eigenschaften sehr speziell. Einzigartig ist, dass es als einziges 
Molekül in der Natur bei den für biologische Systeme relevanten Temperaturen in allen drei 
Aggregatzuständen vorkommt. Wasser hat bei 4°C seine größte Dichte und das Volumen 
steigt beim Gefrieren sprunghaft an (Dichteanomalie). Einzig Quecksilber besitzt unter den 
Wassermoleküle gefangen in  
hydrophoben Taschen 
Geordnete Wasserstruktur um  
den hydrophoben Liganden 
Nach der Komplexbildung → Geordnete 
Wasser werden freigesetzt, erhalten mehr 





Flüssigkeiten eine höhere Oberflächenspannung als Wasser. Es besitzt außerdem eine der 
höchsten Wärmekapazitäten aller bekannten Flüssigkeiten (75,4 Jmol-1K-1).  
Strukturell besitzt Wasser zwei Wasserstoffatome, die mit einem Sauerstoffatom verbunden 
sind (Abbildung 3). Auffällig ist, dass der Winkel zwischen den OH-Bindungen (104,5 °) vom 
erwarteten Wert für einen Tetraeder (109,5 °) abweicht. Die freien Elektronenpaare des 
Sauerstoffs nehmen im Molekül einen erhöhten Raumbedarf ein, was den Winkel zwischen 
den OH-Bindungen ein wenig zusammenstaucht.  
 
Abbildung 3: Darstellung der chemischen Struktur des Wassers (Bild erstellt von Patrick Emil-Zörner). 
 
 
Wegen der hohen Elektronegativität des Sauerstoffs ist das Wassermolekül stark polarisiert. 
Der Sauerstoff zieht die Elektronen des Wasserstoffs zu sich und es resultiert ein starkes 
Dipolmoment (1,8 Debye). Wasser kann daher in Protein-Ligand-Komplexen sowohl als 
Akzeptor als auch Donator für Wasserstoffbrücken dienen. Insgesamt kann ein 
Wassermolekül theoretisch vier Wasserstoffbrücken ausbilden. Zusammengenommen muss 
man feststellen, dass Wasser vor allem für biologische Systeme die wichtigste Flüssigkeit auf 
der Erde darstellt, ist aber zugleich auch eine der kompliziertesten.  
Wegen der vielen komplexen Eigenschaften des Wassers wird nun verständlich, warum im 
strukturbasierten Design oftmals die Effekte von Wasser vernachlässigt werden. Fakt ist 
jedoch, dass jeder beobachtete Bindungsprozess im Wasser stattfindet. Eine 
Vernachlässigung der Wassereffekte ist in jeder Hinsicht naiv, da es das gesamte System auf 
den schon gebildeten Komplex reduziert. Wenn man das gesamte System betrachtet, sind 
beide Bindungspartner, Protein und Ligand, auch vor der Bindung komplett von Wasser 
umgeben. Bevor es zur Bindung zwischen Ligand und Protein kommen kann, müssen die 
Wasserhüllen beider Bindungspartner abgestreift werden. Diese Desolvatationsenergien 
müssen berücksichtigt werden, da sie die Bindungsaffinität entscheidend beeinflussen. 





neutrale Liganden.(17) Der Beitrag von polaren Gruppen im Liganden könnte daher nachteilig 
sein, wenn keine vergleichbaren Interaktionen im Komplex stattfinden. Die Abschätzung 
dieser Energien ist mit verschiedenen Solvatationsmodellen möglich. Implizite Modelle 
behandeln das Wasser als ein Kontinuum, das den Liganden umgibt, während explizite 
Modelle einzelne Wassermoleküle betrachten, die mit dem Liganden interagieren. 
COSMO(18) oder SM8(19) sind Beispiele für implizite Modelle und SPC/E(20) für ein explizites 
Modell, das oft in MD-Simulationen benutzt wird. Oftmals unterscheiden sich diese Werte 
jedoch sehr stark, abhängig davon welches Modell benutzt wird. Das zeigt, dass diese 
Energien nicht zuverlässig genug vorhergesagt werden können. Die Desolvatation von 
Proteinseite her spielt natürlich auch eine Rolle, aber die Abschätzung dieser Energien ist 
noch komplexer(21) und experimentelle Ansätze existieren nur für Spezialfälle(22). 
Eine andere entscheidende Rolle spielt Wasser direkt im Komplex. Grundsätzlich gilt die 
Annahme, dass vergrabene Wassermoleküle im Komplex einen negativen Bindungsbeitrag 
liefern, da das Wassermolekül durch die Fixierung Freiheitsgrade verliert. Im 
strukturbasierten Design wird daher versucht gefundene Wasser im Komplex zu verdrängen 
um einen entropischen Vorteil zu erhalten.(23,24) Oft erkennt man jedoch auch keine 
Verbesserung in der Bindungsaffinität wegen einer Enthalpie/Entropie-Kompensation.(25) 
Teils sind die Wassermoleküle so stark am Protein gebunden, dass der entropische Vorteil 
nicht ausreicht um die Energie zu kompensieren, die benötigt wird, um diese 
Wassermoleküle aus der Bindetasche zu entfernen. Eine Abschätzung darüber wie stark ein 
Wassermolekül am Protein gebunden ist, ist ebenfalls schwierig, da stark gebundene Wasser 
in unterschiedlichen Kristallformen oftmals nicht konserviert sind.(26)  
Andererseits existieren Ansätze, die zeigen, dass auch ein Einschluss von Wassermolekülen 
einen günstigen Effekt auf die Bindungsaffinität haben könnte.(27) Die Idee dahinter ist 
simpel und überzeugend. Wenn ein Ligand eine Bindetasche komplett ausfüllt, kann eine 
wasservermittelte Interaktion zu Proteinresten die Bindetasche ausdehnen. So entstehen 
zusätzliche Wasserstoffbrücken, die sich günstig auf den enthalpischen Term auswirken. Ein 
Problem ist jedoch die Unkenntnis darüber,  wie und wo ein Wassermolekül platziert werden 
muss, um zu garantieren, dass die freiwerdende Enthalpie auch ausreicht den entropischen 
Nachteil gewinnbringend wettzumachen. Eine zuverlässige Vorhersage ist hier nicht möglich.  
Auch das mangelnde Verständnis über die Enthalpie/Entropie-Kompensation bei der 





nahezu unmöglich. Aus Gründen der Einfachheit werden im Drug Design derartige Einflüsse 
von Seiten des Wassers her größtenteils vernachlässigt. Andererseits existieren viel zu 
wenige Studien, die auf die Problematik von Wasser vor und nach der Komplexbildung 
eingehen. Wegen der allgemein schwachen Datenlage ist eine umfassende Berücksichtigung 
von Wasser im Drug Design bisher nicht möglich, muss aber in der Zukunft verstärkt 
berücksichtigt werden.       
 
1.4 Zielsetzung/Aims of the thesis 
Die Arbeit ist in fünf Teile untergliedert. Der Focus dieser Arbeit liegt auf der 
thermodynamischen und kristallographischen Untersuchung von Wassereffekten bei der 
Interaktion zwischen Protein und Ligand. Die thermodynamische Charakterisierung der 
Interaktion wurde mittels Isothermaler Titrationskalorimetrie (ITC) durchgeführt. Die erste 
Serie war durch eine schwache Bindungsaffinität im mikromolaren Bereich gekennzeichnet. 
Leider ist dieser Affinitätsbereich schwer zugänglich für eine thermodynamische 
Charakterisierung. Daher besteht das erste Kapitel dieser Arbeit in der Etablierung und 
Validierung einer ITC-Methode, die es erlaubt, thermodynamische Daten mit einer hohen 
Genauigkeit aus einer mikromolaren Inhibitorserie zu gewinnen. Die Methode basiert auf 
einem Verdrängungsansatz, der von Sigurskjold(28) für äußerst starke Liganden im 
pikomolaren Bereich beschrieben wurde. 
Im zweiten Teil wird diese schwach affine Serie dann mit der validierten Verdrängungs-ITC 
thermodynamisch untersucht. Diese Serie wurde entworfen und synthetisiert um die 
Bindungsbeiträge zu erfassen, die sich aus der Desolvatation der polaren S1 Tasche von 
Thrombin ergeben. Anschließend wurden Desolvatationsenergien aller untersuchten 
Liganden mit quantenmechanischen Berechnungen abgeschätzt, um deren Auswirkungen 
auf das thermodynamische Profil zu diskutieren. 
Der dritte Teil handelt über die Rolle von Wasser bei der hydrophoben Wechselwirkung. 
Obwohl als gesichert gilt, dass die treibenden Kräfte hinter dem hydrophoben Effekt durch 
die Verdrängung von Wassermolekülen aus hydrophoben Bereichen resultieren, wurden in 
der Vergangenheit zahlreiche Beispiele(29-31) entdeckt, die nicht in dieses Konzept passen, da 
die Interaktion trotz hydrophoben Bindungspartnern durch einen unerklärlich hohen 
enthalpischen Term dominiert wird. Die letzten beiden Berichte gehen davon aus, dass eine 





Enthalpiesignal darstellt.(32,33) Basierend auf dieser Hypothese wurde eine Serie konzipiert, in 
der systematisch der Rest variiert ist, der die hydrophobe S3/4 Tasche von Thrombin 
adressiert. Diese Tasche gilt zwar als hydrophob, ist aber dafür ausreichend solvatisiert. Ziel 
war es nun zu zeigen, ob die Adressierung einer gut solvatisierten hydrophoben Bindetasche 
mit hydrophoben Liganden den klassischen hydrophoben Effekt zeigt. 
Die vierte Studie beschäftigt sich mit der hydrophoben S2‘ Tasche von Thermolysin. Die 
benachbarte schwach solvatisierte S1‘ Tasche lieferte in einer früheren Arbeit ein 
enthalpisches Signal(33), das ebenfalls mit der schwachen Solvatation der untersuchten 
Proteintasche erklärt wird. Um die Solvatations-Hypothese zur enthalpisch getriebenen 
hydrophoben Wechselwirkung indirekt zu bestätigen, wurde eine hydrophobe Ligandenserie 
für die Interaktion mit der S2‘ Tasche konzipiert und thermodynamisch charakterisiert. Eine 
kristallographische Untersuchung der Thermolysin-Komplexe wurde schließlich durchgeführt 
um die Auswirkung auf die adressierten Wassermolekülen zu dokumentieren. 
Die fünfte Studie befasst sich mit dem kooperativen Effekt, der in einer Arbeit von Baum et 
al.(34) entdeckt wurde. Eine kinetische Untersuchung von zwei Serien zeigte dort, dass eine 
Kooperativität zwischen der hydrophoben Interaktion zur S3/4 Tasche und der Stärke einer 
Wasserstoffbrücke in Thrombin existiert. Basierend auf diesen Ergebnissen wurden fünf 
neue Serien synthetisiert, die alle mit denselben Resten die hydrophobe S3/4 Tasche von 
Thrombin adressieren. Die Serien unterscheiden sich lediglich in dem Bereich, der sich in der 
Nähe der Wasserstoffbrücke im β-Faltblatt befindet. Ziel war es, mit unterschiedlichen 
Substitutionen einen Einfluss auf die Stärke dieser Wasserstoffbrücke auszuüben und zu 
evaluieren, ob die hydrophobe Wechselwirkung tatsächlich mit der Stärke der Wasserstoff-
brücke korreliert. Zusätzlich wurde auf einem reduzierten Ligandgerüst mit 
quantenchemischen Rechnungen überprüft, ob die Stärke der Wasserstoffbrücke tatsächlich 
durch die eingeführten Reste beeinflusst wird.        
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2  Validation of ITC displacement titration and implications to 





Fragment-based lead discovery (FBLD) has matured in recent years into a very propitious 
strategy in drug development giving multiple promising starting points to generate drug 
candidates. Usually, a fragment screening campaign provides an impressive series of 
favorable hits to be considered for hit-to-lead evaluation. It has recently been suggested that 
first hit candidates with largest enthalpic efficiency are the most promising candidates for 
further optimization. Therefore, in particular for fragments the information about the 
enthalpic binding contribution is of utmost importance to take an optimal decision. 
Unfortunately, reliable thermodynamic data are difficult to collect for fragments and they 
are strongly affected by large errors due to the exceptionally weak binding affinities. In 
consequence, the thermodynamic parameter enthalpy can hardly be considered as prime 
selection criterion. We suggest a displacement ITC approach to determine the 
thermodynamic signature of weak binding fragments with high accuracy and reliability. To 
validate the reliability and scope of this new technique Kd values between 132 μM and 12 
pM have been determined for a series of thrombin inhibitors and faced with independent 
kinetically recorded Ki data. As insufficient protein solubility can also hamper determination 
of thermodynamic data we showed that the displacement approach can also be used to 
circumvent poor solubility of the protein. It is shown that significantly reduced protein 
concentrations reveal equally reliable data using the suggested displacement technique 
instead of direct titrations. 
 
2.2 Introduction 
Once a novel protein has been discovered and validated as putative drug target for 
therapeutic intervention, usually high-throughput screening is applied to discover initial hits 
as prospective candidates for further development. Huge compound libraries of small 
molecules are enumerated and provide pharmaceutical industry in prospective cases with 




large numbers of potential hits, mostly with affinities in one- to two-digit micromolar 
range.(1) Considering the molecular weight of these hits rather disappointing ligand binding 
efficiencies (affinity per unit molecular mass) become apparent.(2,3) In consequence, 
screening has been expanded towards increasingly smaller candidates, so-called fragments 
which leave sufficient room for optimization. Also this approach unravels large samples of 
promising hits for further development.(4) At this point, a crucial decision has to be made as 
to which of these fragments should be taken to the next level of development. As this step 
will allocate major resources, it requires reliable and relevant parameters to support this 
decision process. Recently, the use of thermodynamic data collected by isothermal titration 
calorimetry (ITC) was suggested as a promising additional indicator.(5,6) With respect to 
ligand optimization, it appears advisable to start with a hit of pronounced enthalpic binding 
characteristics as strategies to improve the entropic component of binding free energy are 
more obvious to achieve.(7) In consequence, it was proposed to start in particular with a 
fragment hit showing the largest enthalpic efficiency. ITC is the straight-forward-to-use 
biophysical technique to record the required data. However, its general sensitivity ranges 
from low micromolar to one-digit nanomolar binders, thus hardly applicable to weak binding 
fragments.  
Sigurskjold(8) first introduced theoretically the concept of displacement titration to expand 
the above-mentioned dynamic range of ITC. By applying elaborate measurement protocols 
the range of sensitivity could be expanded towards high-affinity binding using this approach. 
In such cases, the protein solution is saturated with a weak-binding ligand followed by the 
titration of a competitive high affine ligand. The latter will successively displace the weak-
binding ligand from the binding site. In this concept the binding affinity of the highly potent 
ligand is artifically lowered to a range where it can be measured by ITC. This displacement 
strategy has been tested experimentally to extremely strong HIV protease inhibitors with 
affinities in picomolar range(9) and a detailed measurement protocol for strong binders is 
available.(10) With respect to drug development, the thermodynamic profile of highly potent 
and fully optimized ligands is interesting for retrospective analysis and to elucidate 
structure-function relations but not applicable in the acute process of selecting the most 
promising fragments for optimization. 
The study of fragment hits proved to be very difficult as these show mostly low binding 
affinities. Especially, the determination of accurate association constants of these low 




affinity systems would mean a huge contribution in order to understand why fragments 
actually bind. Common methods for interaction analysis like surface plasmon resonance or 
kinetic assay are well known to have problems to generate reliable data in the high micro to 
millimolar range. ITC is another technique which can be applied to address this affinity range 
by some modifications in the experimental procedure. Unfortunately, considering the low 
molecular weight of fragments we would expect a scenario where the interaction between 
fragment and protein is, in addition to the weak binding affinity, linked with a low enthalpy 
signal. This makes the ITC experiment even more complex and material-consuming as the 
ITC titration must be carried out at a higher protein concentration to realize sufficient heat 
changes. The high protein concentration in a direct titration is crucial either because the 
amount of available protein material is limited or the insufficient solubility of the 
biomolecule makes ITC experiments at high concentrations impossible. Additionally, the 
titration curves recorded under these conditions are difficult to analyze because they lack 
sigmoidal shape (Figure 1). As the inflection point (stoichiometry) in this mode is poorly 
defined, the enthalpy of binding can only be extracted by fixing the stoichiometry parameter 
during the fitting procedure. Another approach how to deal with low affinity systems is to 
carry out low c-value titrations. Considering the importance of consulting reliable 
thermodynamic signatures of initial weak binding hits with respect to lead optimization, 
more reliable measuring protocols to record accurate microcalorimetric data of two-digit 
micromolar to even millimolar binders are desperately needed. In this respect, the working 
under conditions which lead to the typical sigmoidal shape are always preferred with respect 
to reliability.  
In this contribution we present a measurement strategy to reliably overcome the 
aformentioned problems by expanding the dynamic range of ITC towards micro- to even 
millimolar binding affinities by applying the displacement technique first experimentally 
realized by Zhang and Zhang.(11) The experiment needs two titrations following the same 
protocol. In a first step, a nanomolar ligand is selected and characterized directly by ITC. In a 
second step the nanomolar ligand is titrated into the protein solution saturated with the 
weak-binding ligand of interest. The apparent binding parameters of the nanomolar ligand 
obtained in a displacement titration can be used to calculate the entire thermodynamic 
profile of the weak-binding ligand by applying the displacement model of Sigurskjod, 
originally developed for potent binders. Although the principle of the method is known since 




11 years we could just find a handful of studies dealing with special problems comprising 
peptides binding to Src kinase SH2 domain(12) or 5’CMP binding to ribonuclease.(13) A 
comprehensive thermodynamic analysis of weak-binding fragments is unfortunately missing 
but desperately needed to clarify why fragments show activity and to finally support the 
FBDD with thermodynamic data comparable to the ITC support in lead optimization. 
Moreover, the review by Edink et al.(14) shows impressively that thermodynamic fragment 
characterization is not still applied widely and is in the found cases mainly limited to 
fragments showing already moderate affinities. 
In our opinion, the main reasons for this reluctance is a missing experimental validation of 
the displacement approach and unsolved questions when working with displacement 
titrations. Are measured fragment affinities and enthalpies reliable, do the fragment 
affinities correlate well with kinetically determined inhibition constants, how much fragment 
is needed to saturate the protein and what is an appropriate competitive ligand are aspects 
responsible for the lacking acceptance of this method. In this publication, we give solutions 
to some of these questions in order to make this valuable ITC titration strategy better 
applicable to a larger community.   
 
Figure 1: Titration curve for a weak binder from this study in a direct ITC titration. A weak binding 
ligand (1.5 mM) is directly measured at a thrombin concentration of 20 μM in Hepes buffer. 
Obviously, the sigmoidal shape is not obtained. 
 
 




2.3 Methodology & Titration Protocol 
2.3.1 The procedure of the displacement titration 
Before the displacement titration can be performed a sufficiently potent reporter ligand 
must be selected. This latter ligand must be characterized in a direct ITC titration. The 
resulting titration curve has the typical sigmoidal shape which can be analyzed by the single-
site binding isotherm(15) using Origin 7.0. Once this competitive ligand is characterized we 
prepare a protein solution incubated with the weak-binding ligand under investigation. 
Highest saturation possible of the protein with bound ligand should be attempted. This 
solution is injected to the sample cell. The solution of the competitive ligand is adjusted to 
the desired concentration and then filled in to the syringe. Usually, the concentration of this 
solution should be 15-20 times the applied protein concentration. Due to application of high 
concentrations of the weak-binding ligand in the sample cell, large signals of heat of dilution 
will result during the displacement titration. We, therefore highly recommend to add the 
weak-binding ligand at the same concentration to the solution used for the study of the 
competitive ligand. The subsequent experiment is performed similarly to direct ITC 
titrations. The strong binder will displace step-by-step the weakly bound ligand from the 
macromolecule in the course of the titration. The titration is finished when complete 
displacement of the weak binder is achieved which is indicated once only small peaks of 
dilution are recorded. The resulting titration curve of the displacement titration is analyzed 
using the Origin 7.0 software by fitting a single-site binding isotherm as there is no fitting 
function available for the resulting curves in case of displacement of weak-binding ligands. A 
displacement fitting routine for the ITC model is only available for the analysis of high-
affinity ligands. The derived parameters are used as Ka obs and ΔHobs in equation 1 and 2
(11) to 
calculate the thermodynamic properties Ka WL and ΔHWL of the weak-binding ligand. The 




Ka obs = Observed association constant of the strong binder in presence of the weak binder (displacement) 
Ka WL = Unknown association constant of the weak binder   
Ka SL = Association constant of the strong binder measured in a direct ITC titration   
[Lfree] = Concentration of free weak binder in the saturated protein solution 






ΔHWL = Unknown enthalpy change of weak binder 
ΔHobs = Observed enthaly change of strong binder in presence of the weak binder (displacement) 
ΔHSL = Enthalpy change of strong binder measured in a direct ITC titration 
Ka WL = Association constant of weak binder  
[Lfree] = Concentration of weak binder in the saturated protein solution 
 
The concentration of the free ligand [Lfree] (Equ. 3) is unknown. As the concentration of the 
weak-binding ligand is much larger than that of the protein [Ltot] >> [Ptot], the free ligand 
concentration [Lfree] is practically equal to [Ltot]. Thus [Ltot] was used in the further analysis.   
 (3) 
2.3.2 The accuracy of the association constant determination of the competitive ligand 
The ligand used for competitive displacement has to be selected carefully with respect to its 
thermodynamic profile. The accuracy of the affinity determination of the weak-binding 
ligand (Kd WL) strongly depends on the correct determination of the affinity of the strong-
binding ligand (Kd SL) as indicated in equation 1. In order to estimate this influence of the 
strong-binding ligand we calculated the anticipated error for Kd WL as a function of the 
uncertainty in measurement of Kd SL. The uncertainty in Kd WL is in the beginning of the error 
estimation (cf. Figure 2) nearly directly proportional to the error in Kd SL of the strong binder. 
The larger the measured Kd of the strong-binding ligand deviates from the actual dissociation 
constant the larger will be the uncertainty in the Kd determination of the weak binder. 
Competitive ligands with a potency of 1-50 nM should not be used as their determined 
association constants are mostly accompanied with large errors in ITC. If there is no choice, 
displacement titrations in turn must be done for these potent ligands to confirm the direct 
Kd SL estimation. To estimate the anticipated error, an Excel file is found in the 
supplementary material. A strong ligand with Kd in the range of 100-1000 nM is usually 








Figure 2: Error estimation. The plot illustrates the deviation of the Kd of the weak binder as a function 
of the deviation of Kd of the strong binder. The exact calculation of this error estimation can be found 
in the method section. 
 
 
2.3.3 The required strength of the competitive ligand 
Aside accuracy of the predetermined binding constant of the strong binder, the affinity 
difference with respect to the ligand to be displaced has to be considered. The competitive 
ligand must be strong enough to virtually displace the weak-binding ligand completely. The 
higher the affinity of the weak-binding ligand the higher the affinity for the competitive 
ligand must be. On the other hand the strong-binding ligand must not exhibit a too high 
affinity or, more precisely, a too strong enthalpic signal (s. below) as then the recorded 
signal of the strong-binding ligand alone and in the competition experiment with the weak 
binder will be nearly identical. It is thus recommended to apply first as competitive ligand 
the one with the highest affinity and then to examine whether the competition experiment 
shows data at least five times the standard deviation of the data of the strong-binding ligand 
measured in a direct ITC titration. If this is not the case, an alternative strong-binding ligand 









2.3.4 The resulting enphalpy signal 
As for any ITC experiment, prerequisite to perform such measurements a sufficiently large 
heat signal must occur. The special situation might be given where the competition titration 
cannot be recorded because no heat signal is produced upon displacing of the weak binder.  
If both the strong and weak binder exhibit the same enthalpy value the resulting ΔHobs will 
be close to zero according to equation 4 which results from equation 2 by rearrangement.  
 
(4) 
For most displacement titrations, the product of Ka WL and [Ltot] will be significantly larger 
than 100. The term in brackets in the denominator will thus tend to be 1 and the equation is 
therefore dominated by (ΔHSL - ΔHWL). In consequence, proper selection of the strong-
binding ligand with respect to the expected enthalpy of the weak-binding ligand is crucial. 
Opposing thermodynamic signatures (e.g. endothermic for the strong and exothermic for 
the weak ligand or vice versa) will guarantee sufficiently changed heat signal in the 
displacement titration. On the other hand prior to actually performing the experiment no 
information is available about the thermodynamic signature of the ligands under 
investigation and the number of fully characterized strong-binding ligands with opposite 
thermodynamic signature is most likely limited. Fortunately, the described situation is not 
that problematic because mostly the difference in enthalpies with equal sign is high enough 
to record measureable heat signals. In our examples we used strong exothermic ligands to 
characterize weak exothermic ligands because we lacked an endothermic binder. 
Nevertheless, the differences in enthalpies were at least 5 kJ/mol. 
 
2.3.5 Estimation of the required concentration of weak binder for sufficient saturation 
The crucial factor in this section is to estimate what concentration should be applied to 
guarantee a sufficient saturation of the protein solution. We can precisely predict how much 
ligand is needed to ensure a desired degree of saturation at a given protein concentration if 
the binding constant of the weak-binding ligand is known from an independent experiment, 
such as a biochemical assay. If there is no information given about the binding affinity of the 




weak binder, a very weak binding affinity must be assumed, for instance 10 mM, to calculate 
the required concentration of the weak binder. 
The equilibrium for the binding of protein P and weak-binding ligand L is described in 
equation 5 and 6.  [L] is the concentration of unbound ligand with respect to the total 
concentration of [Lt] at the beginning of the experiment and [P] the free protein with respect 
to the likewise total concentration [Pt]. [PL] is the concentration of the formed complex. 








x is assumed as the degree of saturation which is defined in equation 10. x can adopt values 
between 0 (no inhibition) and 1 (full inhibition). Rearranging equation 11 and substituting 





















We provide in the supporting information an Excel file integrating equation 17 in a sheet 
called saturation. By inserting the protein concentration [Pt] and the approximate binding 
constant of the weak-binding ligand from an independent experiment we can estimate the 
required concentration [Lt] to achieve a desired degree of saturation. In case of limited 
ligand availability or solubility problems it is possible to calculate for a given ligand 
concentration the achieved degree of saturation (x≠1). In case the titration started from 
incomplete saturation of the weak-binding ligand, the titration curve indicates double 
sigmoidal shape where two distinct processes are taking place (Figure 4). In the first step, the 
competitive ligand binds first to unoccupied sites of the protein. When all sites are occupied, 
in the second step the strong binder starts to displace the weak-binding ligand from the 
protein. 
 
Figure 4: Titration curve in case of incomplete saturation in an ITC displacement titration. The 
experiment includes a titration of a mix of ligands into a protein solution to illustrate what happens if 









2.4.1 Displacement titration for weak and strong thrombin binder with MW ≥ 250 Da 
As an application of the above-described displacement titrations we selected thrombin as a 
model system. Fragments could not be used in this context as the assay experiment is not 
sensitive enough to provide accurate affinity data in this low affinity range. Thus we selected 
small molecules for the validation procedure. Seventeen thrombin ligands, investgated in 
other studies(16,17) were selected for validation of the scope and reliability of the suggested 
displacement protocol. We considered not only weak ligands (Series A composed of nine 
ligands 1-9) but also high affinity ligands (Series B composed of seven ligands 10-16). The 
displacement theory was originally developed for potent ligands and thus it was also 
reasonable to include a high affine series in order to cover the whole affinity range of the 
displacement approach. The weak binding series was analyzed by a photometric assay and 
the strong binding series by a fluorogenic assay prior to the performence of displacement 
ITC in order to compare kinetically determined inhibition constants (Ki) and ITC recorded 
dissociation constants (Kd). The weak-binding ligands feature low affinities between 2 and 
132 μM while the high affinity series exhibits an affinity range between 12 pM and 4.8 nM in 
this biochemical assay.  
Two competitive ligands with different thermodynamic profiles were selected to 
characterize the series regarding the low-affinity ligands (Table 1). Depending on the 
resulting titration curves either competitve ligand 17 or 18 were applied in series A. In case 
of the high-affinity series (Series B) also two binders (18 and 19) were selected with different 
thermodynamic profiles as competitive ligands (Table 1 and Table 2 for chemical structures). 
If no remarkable enthalpy signal had been observed the other competitve ligand was tested 
to reveal a detectable heat signal in both series. The measured affinities are plotted as ΔG 
values in Figure 5 and a correlation coefficient of R2=0.98 indicates good correlation of the 
two binding constants Kd and Ki resulting from two completely different methods. The 
enthalpies (Figure 6) of weak binders are associated with a low standard deviation and 










Table 1: Thermodynamic data of the competitve reporter ligands used for thrombin displacement 
titrations. 
 ΔG0 (kJ/mol) ΔH0 (kJ/mol) -TΔS0 (kJ/mol) 
17a) - 47.3 ± 0.9 - 40.2 ± 0.9 - 7.1 ± 1.9 
18a) - 37.4 ± 0.3 - 34.5 ± 1.1 - 3.0 ± 1.4 
18b) - 37.9 ± 0.5 - 17.1 ± 1.1 - 20.8 ± 1.7 
19b) - 37.6 ± 0.2 - 37.5 ± 0.1 - 0.1 ± 0.2 
a)The thermodynamic profiles of the competitive ligands used for testing the weak-affinity series in a 
displacement titration in Hepes buffer. These data were derived in a direct ITC titration. 
b)
The binding parameters for the competitive ligands applied to study high-affinity ligands by the displacement 
technique in Tris buffer. These data were measured in a direct ITC titration. 
 
Figure 5: The affinities Kd (displacement ITC) and Ki (biochemical assay) are plotted as ΔG values 
according the equation ΔG = RTln(Kd or Ki). The high correlation coefficient of R
2=0.98 indicates a 
good correlation of the different methods and underline the reliability of our displacement titrations. 
 
 
Figure 6: The estimated enthalpies of the studied weak ligands 1-9 (Series A) show apart of two cases 








2.4.2 Fragments (MW ≤ 250 Da) measured by displacement titration  
In order to demonstrate that fragments can be measured by the displacement titration we 
selected the aspartylprotease endothiapepsin as a model system. Four fragments (Table 2) 
discovered in a previous study(18) were incubated at 20 mmol/L with the protein solution 
(42.3 μmol/L). The HIV protease inhibitor saquinavir (named as 20) also known to block 
endothiapepsin was used as competitive reporter ligand (625 μmol/L). Prior to the 
displacement experiment the thermodynamic profile of saquinavir was determined by direct 
ITC titration in acetate buffer (Figure 7a). The titration curve in displacement mode does not 
exhibit a double sigmoidal shape (Figure 7b) indicating sufficient saturation of the protein 
with the fragment. The results in Table 3 indicate a huge enthalpic contribution to binding 
despite the low molecular weight of the fragments which are partly compensated by 
unfavorable entropic contribution. The experiments were done at single buffer condition 
(acetate). The binding event could be superimposed by a change in protonation states which 
usually takes influence on the heat signal. To distinguish heat contributions caused by 
protonation changes from the actual binding event, the titrations would have to be 
conducted in three different buffers. Since, however, the ionization enthalpy of an acetate 
buffer amounts only to 0.49 kJ/mol(19) the obtained enthalpies can be considered as net 
binding enthalpies with a negligible contribution of the enthalpy of protonation from the 
buffer.  
Considering the validation study with seventeen thrombin ligands we are keen to suggest 
this method as very reliable and robust also to very weak fragments despite the more 
elaborate experimental procedure. 
 
2.4.3 Overcoming poor solubility of the protein 
Poor solubility of proteins often limits the application of the ITC. In case of nanomolar 
ligands with sufficient enthalphic contributions this fact is usually not important as the 
required protein concentration can be obtained because only a low amount of protein is 
needed. In contrast, the characterization of moderate binders (1-10 μM, normally falling into 
the scope of direct ITC titration) with commonly small enthalpic contributions are often not 
accessible by direct ITC titrations simply because the high protein concentration required 
cannot be obtained due to solubility issues.  
 




Figure 7: a) The titration curve for the competitive ligand saquinavir (625 μM) in a direct ITC titration 
at 49 μM endothiapepsin. b) Titration curve for a fragment in an ITC displacement titration. The 
titration of saquinavir (625 μM) used as competitive ligand into a solution of endothiapepsin (49 μM) 
in the presence of fragment 21 (20 mM). 




Table 2: Chemical structures of the ligands are shown with naming used in the text. 




























Table 3: Thermodynamic data of fragment binding to endothiapepsin. 
 ΔG (kJ/mol) ΔH (kJ/mol) -TΔS (kJ/mol) 
20 (Saquinavir)a) - 35.6 ± 1.0 - 11.6 ± 1.3 - 24.0 ± 2.3 
21b) - 12.0 ± 2.2 - 28.7 ± 0.5 16.7 ± 1.8 
22b) - 18.1 ± 0.8 - 35.4 ± 0.8 17.3 ± 0.1 
23b) - 17.7 ± 0.1 - 28.9 ± 0.3 11.9 ± 0.4 
24b) - 19.1 ± 0.6 - 33.5 ± 1.9 14.3 ± 2.6 
a)Direct ITC determination of the competitive ligand saquinavir to endothiapepsin in acetate buffer.  
b)The binding profiles of the fragments studied by competitive ITC titration using saquinavir as displacing ligand. 
 
We have chosen a thrombin ligand with a dissociation constant of Kd = 1.4 μM to 
demonstrate that also the low micromolar range can be addressed by the displacement 
titration when solubility or availability of protein material are crucial factors.  
Prior to the displacement experiments the test ligand 25 was directly titrated to a 20 μmol/L 
thrombin solution to determine its binding parameters (Kd = 1.4 ± 0.3 μM and ΔH = - 25.3 ± 
0.6 kJ/mol). In a comparable displacement titration protein concentration was lowered 
threefold (6 μmol/L). The competitive reporter ligand 17 at a concentration of 250 μmol/L 
was titrated into the protein solution saturated with 25 (1.25 mmol/L). The comparison of 
the affinity and enthalpy between direct and displacement approach (Kd = 7.4 ± 1.0 μM and 









Despite its potential, thermodynamic analysis of fragments is not yet applied widely in 
fragment-based lead discovery (FBLD). This fact does not result from limited relevance of 
such data but from drawbacks that are faced once working with low affinity systems. A 
recent review by Edink et al.(14) summarizes some successful examples for the application of 
thermodynamic data to support the optimization process in fragment-based drug discovery. 
Interestingly, most of the binding signatures for fragments in FBLD described in literature 
were collected for fragments showing already high binding affinities.(20) In contrast it is well 
known that fragments identified in early stages of FBLD exhibit very low affinities. Especially 
the use of direct ITC titrations to profile the first discovered hits is restrictive either due to 
huge protein consumption or insufficiently accurate binding parameter determination. 
Binding parameters obtained from van’t Hoff analysis of, e.g. SPR biosensor data at different 
temperatures often show poor correlation with ITC binding signatures.(21,22,23) Clearly both 
techniques evaluate different aspects of binding under different conditions. However, the 
evaluation of thermodynamic phenomena with restricted number of data points and at a 
narrow temperature interval makes the data analysis and interpretation by far more 
complicated in case of SPR measurements. In contrast ITC directly determines enthalpy 
under thermodynamic equilibrium conditions at one temperature which rules out all 
temperature-dependent effects superimposed by changes of the complex protein-ligand-
water system. Therefore, we believe van’t Hoff data are less appropriate for a 
comprehensive thermodynamic analysis of fragments.  
As presented here, ITC displacement titrations are a promising alternative in this context to 
characterize low-affinity systems without applying unreasonable high protein concentration 
or immobilizing the binding partner as it is done for SPR measurements. If the described 
strategy is followed highly reliable binding parameters can be obtained. Once a competitive 
ligand is found the whole characterization requires approximately 1.5 h including all sample 
preparations and the amount of protein can be lowered at least fourfold compared to a 
direct titration.  
Especially the accurate factorization into enthalpic and entropic contributions to fragment 
binding by ITC provides valuable information to understand and improve binding of 
fragments to their target molecule. Once a series of fragments has been characterized by the 
ITC displacement approach, the obtained thermodynamic profiles will help to decide at very 




early stages of drug discovery which fragments to carry on to further lead optimization. 
Choosing enthalpic binders as most promising candidates was suggested as a propitious 
strategy. Starting with initial enthalpic hits appears advisable as most medchem-
optimization protocols more easily optimize the entropy contribution to binding. This fact is 
already apparent for the four fragments characterized here for endothiapepsin binding. Even 
though the much larger and better active-site complementary saquinavir is more potent, its 
enthalpic binding contribution is significantly smaller than for the four fragment hits. 
Saquinavir wins entropically whereas the four fragments show entropic contributions still 
rather detrimental to binding. Thermodynamic profiling planned in parallel to fragment-to-
lead optimization of the discovered hits will help us in the future to better define the most 
appropriate optimization strategies.  
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2.7 Materials & Methods 
2.7.1 Materials 
ITC experiments were performed using an ITC200™ system from Microcal (now part of GE 
Healthcare), Northhampton, MA, USA. Thrombin was used from Beriplast® (CSL Behring, 
Marburg, Germany). Endothiapepsin was purified from Suparen® (provided by DSM food 
specialities) by exchanging the buffer to 0.1 M acetate buffer pH 4.6 using a Vivaspin 20 with 
a molecular weight cut off at 10 kDa. The protein concentration was measured by 
absorbance at 280 nm assuming an extinction coefficient of 1.15 for 1 mg/ml solutions.(24) 
Thrombin ligands from series A were synthesized in the group of Prof. Hangauer 
(Department of Chemistry, University of Buffalo, USA). Thrombin ligands from series B were 
synthesized in the group of Prof. Steinmetzer (Department of Pharmaceutical Chemistry, 




Philipps-University Marburg, Germany). Saquinavir mesylate is purchased from Roche (Basel, 
Switzerland) 
 
2.7.2 Bioassay  
Kinetic inhibition of human thrombin (from Beriplast®, CSL Behring, Marburg, Germany) was 
determined photometrically for ligands with Ki ≥ 1nM at 405 nm using the chromogenic 
substrate Pefachrom tPa (LoxoGmbH, Dossenheim, Germany) as described(25) under the 
following conditions: 50 mM Tris–HCl, pH 7.4, 154 mM NaCl, 5 % DMSO, 0.1 % polyethylene 
glycol 8000 at 25°C using different concentrations of substrate and inhibitor. Ki (n ≥ 3) were 
determined as described.(26) 
Thrombin inhibitors with a Ki ≤ 1nM were characterized by a fluorogenic assay. Kinetic data 
were obtained using Tos-Gly-Pro-Arg-AMC(27) (tosyl-Gly-Pro-Arg-aminomethylcoumarin) as 
the fluorogenic substrate with a Safire II platereader (Tecan, Schweiz, ex = 380 nm, em = 460 
nm). This substrate allows us to work at a protein concentration of 0.050 nM which is 
sufficiently lower than the lowest applied ligand concentration (0.780 nM). The experimental 
buffer contained 50 mM Tris-HCL, 154 mM NaCl, 0.1 % polyethylene glycol 8000 and 5 % 
DMSO at pH 7.4. The Km of the substrate (1.1 ± 0.4 μM) was measured at ten different 
substrate concentrations and the resulting curve was analyzed using GraFit 4 software.(28) 
Cleavage of the substrate was measured by monitoring the change in fluorescence over a 
dilution series of at least ten inhibitor concentrations (500 nM – 0.780 nM) at 5 μM 
substrate (S) over 600 sec. The fluoroscence signal was plotted against time and after linear 
regression the reaction rates (ν) were calculated. The latter values (ν) were plotted against 
the respective inhibitor concentration (I) and the resulting curve was fitted with ORIGIN 
software using equation 18. All measurements were performed at least in triplicate.  
 Equation 18 
2.7.3 Experimental conditions for ITC titrations 
Thrombin was freshly prepared for each experiment by dialysis of a thrombin sample in the 
buffer used for titration experiments (50 mM Hepes (Series A) or Tris (Series B), 100 mM 
NaCl, 1 % PEG8000, pH 7.8). After the dialysis the weak-binding ligand (Series A) was added 




from a stock solution (50 mM, 100% DMSO) to the solution of thrombin (27 μM) in order to 
obtain the required ligand concentration for complete saturation (1.25 - 1.5 mM). The final 
DMSO concentration was subsequently adjusted to 3 %. Either 17 or 18 (500 – 625 μM) was 
filled in the syringe and then titrated into the stirred sample cell (200 μL) containing the 
thrombin solution (27 μM) saturated with the weak-binding ligand under investigation. The 
following analysis of the displacement titration curve is described in the results section. 
The binding parameters of the strong binders (Series B) were determined performing two 
titrations in tris buffer (50 mM tris, 100 mM NaCl, 1% PEG8000, pH 7.8). First either 18 or 19 
(500 μM) was directly titrated into a protein solution at 27 μM. As small peaks of dilution 
indicate complete inhibition of the protein, the titration was stopped and the resulting 
titration curve was analyzed by fitting a single-site-binding isotherm that yields ΔH0 
(enthalpy of binding) and KD (dissociation constant). Afterwards the syringe was thoroughly 
cleaned and filled with a solution containing the strong binder (500 μM). This syringe was 
placed into the sample cell now filled with the protein-ligand complex from the first 
titration. In the following second titration the strong binder displaced step-by-step the weak-
binding ligand. The analysis of the displacement titration was performed using a binding 
competition model. This fitting function is integrated in Origin 7.0 and is called Competitive 
Binding. 
Endothiapepsin was diluted from a stock solution (147 μM) to the final concentration (49 
μM) with the experimental buffer composed of 20 mM acetate, 6 % DMSO, pH 4.6 and the 
fragment at 6 - 20 mM to ensure sufficient saturation of the protein. Saquinavir was 
prepared as a stock solution in 100 % DMSO at 25 mM. Final concentration of saquinavir 
(625 μM) was achieved by diluting the stock in the experimental buffer containing the weak 
binder at 6 - 20 mM to avoid large peaks of dilutions during the titration. Prior to the 
displacement titration saquinavir (625 μM) was characterized by a direct titration at 49 μM 
Endothiapepsin.      
All ITC experiments were started at 25 °C after a stable baseline had been achieved. The 
experimental design comprises an initial ligand injection of 0.3 μL followed by 15 injections 
of 1.1 - 1.4 μl with a 300 s interval between each injection. 
All measurements were performed in duplicate. Raw data were collected and the area under 
each peak was integrated, followed by correction for heats of dilution and mixing by 
subtracting the final baseline consisting of small peaks of the same size to zero. The initial 




data point was deleted from the integrated data because this injection usually reflects an 
erroneous amount of heat due to the possible exchange of liquids between syringe and cell 
when inserting the syringe into the calorimetric cell and the backlash error in the motorized 
screw mechanism in the injector.(29) 
 
2.7.4 Excel file 
The excel file contains two sheets covering the calculation of the required ligand 
concentration for complete inhibition of the protein and the estimated error in Kd.  
The sheet for estimation of the required ligand concentration for a certain degree of 
inhibition is called saturation. The derivation of the applied equation can be found in the 
results section.  
Concerning the error estimates of Kd WL we calculated the observed Kd of the strong-binding 
ligand in a displacement mode if the titration would have been conducted with a strong 
binder showing 100 nM affinity to characterize a weak-binding ligand with a actual affinity of 
500 μM in presence of 10 mmol/L of the weak binder. The observed KD of the strong binder 
would be 2.1 μM in this displacement titration. Then we calculated the affinity for the weak 
binder with affinities for the strong-binding ligand which deviate systematically from the 
actual 100 nM affinity (101, 102, 103 nM). So we artificially introduced an error in the 
determination of Kd of the strong binder. Subsequently, the deviation is calculated between 
the actual Kd of the weak-binding ligand (500 μM) and the Kd’s of the weak-binding ligand 
derived from the calculation of false affinities for the strong binder.   
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3 Impact of ligand and protein desolvation on ligand binding to 




3.1 Introductory remarks 
This study was done in cooperation with the group of Prof. Dr. Hangauer (University of 
Buffalo). The following text is submitted to the scientific journal Journal of Molecular 
Biology. Maan Khyat from the Hangauer group is included as second author.  
 
3.2 Abstract 
In the present study we investigate the impact of a tightly bound water molecule on ligand 
binding in the S1 pocket of thrombin. The S1 pocket contains a deeply buried deprotonated 
aspartate residue (Asp189) which is, due to its charged state, well hydrated in the 
uncomplexed state. We systematically studied the importance of this water molecule by 
evaluating a series of ligands that contains a pyridine-type P1 side chains that could 
potentially alter the binding properties of this water molecule. All of the pyridine derivatives 
retain the original hydration state albeit sometimes with a slight perturbance. In order to 
prevent a direct H-bond formation with Asp189, and to create a permanent positive charge 
on the P1 side chain that is positioned adjacent to the Asp189 carboxylate anion, the 
pyridine nitrogen was methylated. This methylation resulted in displacement of water but 
was accompanied by a loss in binding affinity. Quantum chemical calculations of the ligand 
solvation free energy showed that the positively charged methylpyridinium derivatives suffer 
a large penalty of desolvation upon binding. Consequently, they have a substantially less 
favorable enthalpy of binding. In addition to the ligand desolvation penalty the hydration 
shell around Asp189 has to be overcome which is achieved in nearly all pyridinium 
derivatives. Only for the ortho derivative is a partial population of a water next to Asp189 
found. Possibly the gain of electrostatic interactions between the charged P1 side chain and 
Asp189 helps to compensate for the desolvation penalty. In all uncharged pyridine 
derivatives the solvation shell remains next to Asp189 partly mediating interactions between 
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ligand and protein. In the case of the para pyridine derivative a strongly disordered cluster of 
water sites is observed between ligand and Asp189.   
 
3.3 Introduction 
Water molecules play a crucial role in the mutual recognition of proteins and ligands during 
the binding process. For better understanding, the effects produced by water can be split 
into two parts: first the impact of water on the formed complex and second the influence of 
water on ligand and protein prior to complex formation, commonly summarized as 
solvation/desolvation properties. The first part is mainly characterized by the ability of water 
molecules to mediate interactions between target protein and ligand in the formed complex. 
The water incorporation is thought to be a promising concept to enhance binding affinity, as 
mediated through water molecules, the binding site can be extended and additional 
hydrogen bonds can be formed.(1) Unfortunately, up to now there are only very few cases 
reported in literature that clearly demonstrate under which conditions the incorporation of a 
water molecule into the protein-ligand interface results in a gain of Gibbs free energy of 
binding. In the case of binding of L-arabinose to L-arabinose binding protein (ABP) the 
incorporation of a water molecule is associated with an increase in binding affinity.(2,3,4) The 
picked-up water molecule clearly determines the specificity of the latter sugar over D-
galactose wherein an additional -CH2OH group fills the space occupied by the water 
molecule in the other complex and therefore explains the gain in binding affinity. Indeed, 
most of the reported water-mediated interactions seem to be formed to stabilize the 
protein-ligand complex by establishing bridges to the protein site.(5,6,7) However, usually no 
conclusions can be drawn about the real benefit of these water interactions as the studies 
lack the comparison with the corresponding water-free reference states. Moreover, it is 
generally believed that the displacement of the bound water molecules leads to an 
improved binding affinity(8), but on the other hand impressive cases have been reported 
where no gain in binding affinity could be observed upon water displacement.(9) This 
puzzling situation results from our currently rather rudimentary understanding of the 
influence of water molecules on ligand binding. It is widely assumed that trapping a water 
molecule in a binding pocket is entropically unfavorable and enthalpically favorable as water 
can form multiple interactions with either protein and bound ligand, thereby losing many 
degrees of freedom. The desired overall increase in binding affinity will only be achieved if 
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the entropic penalty is overcompensated by a large enthalpic benefit resulting from the 
formation of strong additional hydrogen bonds. Accordingly, it appears difficult to predict 
whether the incorporation of a water molecule at a given interface will enhance the 
enthalpic term enough to attain an improvement in free energy of binding. The ability of the 
water molecule to act simultaneously as a hydrogen-bond donor and acceptor at the 
interface of a protein-ligand complex, its strong tendency to form ordered structures, and its 
substantial contribution to heat capacity changes, are some characteristics that account for 
the complexity of the water problem. Aside from water’s impact on the ligand bound state, 
one should also consider the situation of the binding partners in their solvated state prior to 
complex formation. Both, the protein ligand binding cavity and the ligand are solvated and 
thus energy is needed to remove their water shells to allow the transfer of the ligand to the 
protein environment.(10) The computational prediction of solvation free energies of small 
molecules is still an insufficiently resolved challenge in computational chemistry and 
modestly predictive models require computationally demanding quantumchemical or 
molecular dynamics calculations.(11,12) As a result they are not appropriate for the screening 
of large compound libraries. Moreover, the correlation between predicted and 
experimentally derived values is not really convincing, it is only applicable to rather small 
uncharged molecules and a meaningful factorization into enthalpy and entropy 
contributions is not possible.(13,14) In contrast the experimental approach based on vapor 
phase-to-water partition experiments in order to obtain data on the ligand desolvation 
process is promising but unfortunately limited to non-ionic and volatile molecules.(15) The 
enthalpic and entropic contributions for desolvation of the protein binding site are even 
more difficult to determine experimentally. They can be computed indirectly when all other 
binding contributions such as net protein-ligand interactions (ΔG°PL), ligand desolvation 
(ΔG°solvL) and the sum of all remaining contributions (ΔG°obs) are factorized into the enthalpic 
and entropic terms.(16) It is obvious that the overall deconvolution into the individual terms 
of the binding process is a complex task and can only be addressed by a combination of 
theoretical and experimental methods.  
As the complete deconvolution is hardly tractable, we tried to reduce the complexity of the 
binding process. We will focus on terms which can be addressed experimentally by 
Isothermal Titration Calorimetry (ITC) across a congeneric series of closely related ligands. 
These ITC accessible binding terms include ΔG°obs, ΔH°obs and -TΔS°obs. Even though these 
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binding parameters describe the overall contribution to the entire binding event, the 
thermodynamic and crystallographic examination within a narrow series of systematically 
varied ligands revealed insights, ranging from enthalpy-entropy compensation(17), 
hydrohobic interactions(18) to cooperativity effects(19,20). In this contribution, thrombin was 
chosen as a model system to study the influence of water. The S1 pocket of thrombin hosts a 
negatively charged Asp189 at its bottom and is useful to investigate the influence of water 
molecules on the binding process. Previously, we studied substituted P1 benzyl derivatives 
and no additional water molecule near Asp189 could be found.(21) Here, we expand our 
study by introducing polar nitrogen atoms into the aromatic benzyl moiety at different 
positions (o-, m- and p-position, see Table 1) to make the ligand competent for putative 
water mediated contacts with the protein, however, keeping the spacial requirements of the 
P1 moiety virtually unchanged. A subsequent methylation of the introduced pyridine 
nitrogen results in the creation of a permanent charge supposed to displace potentially 
picked-up water molecules as a methyl group can approximately occupy the space of a water 
molecule potentially interacting with the pyridine nitrogen. High resolution crystal structures 
tracing the displacement of water molecules from the binding pockets are investigated along 
with thermodynamic data to disentangle the different structural and energetic contributions 
to the binding event.  
  
3.4 Results & Discussions 
3.4.1 Analysis of the crystal structures and binding constants 
The crystal structures of 10 tripeptide-like thrombin inhibitors with D-Phe-Pro-XXX scaffold 
(2-11, Table 1) in complex with human α-thrombin have been determined with medium to 
high resolution (1.90-1.27 Å). The electron density for the D-Phe-Pro portion is well defined 
in all examples as exemplarily shown in Figure 1 for 2. Among the series there were no 
structural differences in the binding mode of the D-Phe-Pro portion. The benzyl moiety of 
the D-Phe portion occupies the hydrophobic S3/4 pocket and the five-membered ring of 
proline is well accommodated in the S2 pocket which is formed by Tyr60A and Trp60D of the 
60‘s loop (see Figure 2 for a schematic view). Aside from hydrophobic binding features a β-
sheet-like H-bond interaction is observed with Gly216 of the protein backbone. The terminal 
amino group and the carbonyl functionality of the inhibitor interact within a range of 2.7 - 
3.1 Å with the corresponding atoms of Gly216. Superposition of all studied complexes does 
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not show any significant structural differences of adjacent protein binding site residues 
except Glu192 at the entrance of the S1 pocket. This amino acid is observed in several 
orientations which are apparently not induced by the inhibitor. This is in agreement with a 
previously performed alignment of thrombin crystal structures from the PDB(22) (Protein 
Data Bank), showing the remarkable flexibility of this glutamate(23). Despite marginal 
changes our structures exhibit only pronounced differences next to the modified P1 
substituent. 
The previously studied derivative 1 with an unsubstituted benzyl group (PDB code 2ZFF(21)) 
will be used as reference. It shows no water molecule inbetween the terminal phenyl ring 
and Asp189. However, the indicated enhanced residual mobility of the aromatic portion and 
the entropically favored binding profile of 1 suggests some available space that could 
potentially accommodate an additional water molecule, provided the bound inhibitor is 
modified with an appropriate polar group. Accordingly, we conceived the current study of a 
series of pyridine derivatives.  
The nitrogen atom introduced in the meta position provides the pyridine derivative 2. It 
binds water-mediated to the negatively charged aspartate at the bottom of the S1 pocket 
(Figure 3a). This crystallographically well-defined water molecule is tetra-coordinated by 
four neighbouring atoms and thus can be considered as an optimal mediator of hydrogen 
bonds. The short distances of 2.7 Å to the pyridine nitrogen, 2.9 Å to Asp189 and 2.6 Å to a 
further water molecule indicate, at first glance, a favorable position of this water molecule. 
All interactions to this water molecule are formed in a plane. The resulting water 
coordination does not form a short fourth interaction to the adjacent water molecule next to 
Tyr228 (4.1 Å). Interestingly, the aromatic moiety of the unsubstituted benzyl group of 1 is 
accommodated 1.1 Å closer to Asp189 compared to 2. Obviously, this displacement does not 
allow the complex with 1 to pick-up a water molecule as seen with 2. Comparing the binding 
affinities of both inhibitors suggests a slightly enhanced overall binding upon release of the 
water molecule (Ki = 11.2 ± 6.7 μM for 1 and 33.4 ± 19.0 μM for 2) from the complex with 1. 
The corresponding N-methylated pyridinium derivative 3 displaces the water molecule 
picked-up by 2 (Figure 3b). The positively charged nitrogen is 4.8 Å away from the closest 
oxygen of Asp189. Most likely, the bulky interstitial methyl group shields the electrostatic 
attraction of the negatively charged Asp189 and prevents a shorter distance due to steric 
repulsion.  
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Table 1: Chemical structures of the studied ligands together with the kinetically determined 
inhibition contants (Ki in μM) and the standard deviation
(a) towards human thrombin.  















74.8 ± 20.5 
4 
 
69.3 ± 0.1 
5 
 
132.2 ± 35.3 
6 
 
64.0 ± 20.0 
7 
 
22.5 ± 13.2 






1.9 ± 0.8 
9 
 
63.5 ± 13.6 
10 
 
2.6 ± 1.1 
11 
 
55.4 ± 21.4 
a)
The error is given as the standard deviation calculated from at least three measurements (in μM). 
 
Figure 1: Inhibitor 2 in complex with human thrombin. View of the active site with the solvent-
accessible surface of thrombin in grey.  
 
 
Figure 2: A schematic view of the binding pocket of thrombin in complex with the studied ligand 
scaffold in blue. R represents the modifications of the S1 occupant (see Table 1). 
 
3. Impact of ligand and protein desolvation 
46 
 
Figure 3: Binding modes of the studied ligands in the S1 pocket. The Fo-Fc difference electron density 
is shown in green at 2σ  for inhibitor 2 (a), 3 (b), 4 (c), 5 (d), 6 (e), 7 (f), 8 (g), 9 (h), 10 (i) and 11 (j) 
together with the Asp189 bound water molecule if present. The benzyl derivative 1 (black) is 
superimposed in a, c and e to emphasize the impact of the introduced nitrogen. Favourable 
interactions with the corresponding distances in Å are depicted with broken lines. Distances in red 
indicate very short contacts. Values in brackets indicate short distances found for the specific atom 
which are mentioned in the text. Nitrogen is shown in blue, chlorine in green, oxygen in red and 
carbon in orange (ligand site) and cyan (protein site). 
a) in complex with 2                         b) in complex with 3  
     
 
c) in complex with 4           d) in complex with 5 
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e) in complex with 6            f) in complex with 7 
   
 
g) in complex with 8           h) in complex with 9 
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i) in complex with 10                                                       j) in complex with 11 
   
 
This suboptimal location of the positively charged nitrogen in the methylpyridinium portion 
results in a loss of binding affinity by a factor of 2 (Ki = 74.8 ± 20.5 μM for 3). Supposedly, it is 
partly compensated by the favorable displacement of the water molecule found in the 
complex with 2 and the uncomplexed protein. 
Interestingly, the binding mode is different when the pyridine nitrogen is placed in ortho 
position in 4. The pyridine ring now adopts two alternative conformations which could be 
refined to 39 % occupancy for conformation A and 61 % for B (Figure 3c). Remarkably, at the 
above-described position in 2 again a water molecule is found close to Asp189. With respect 
to conformation A it would clash (2.3 Å) with a ring carbon atom of the ligand. In addition 
some negative electron density appeared around the water position when refined with 100 
% occupancy. The twisted conformation B provides sufficient space to accommodate a water 
molecule. We therefore refined the water molecule with the same occupancy as the 
inhibitor in the twisted conformation B and a negative electron density disappeared. 
Obviously, the water molecule can only be present if the pyridyl moiety adopts the twisted 
conformation B. In conformation A, this moiety repels the water molecule. Interestingly 
enough, the latter conformation A corresponds to the geometry found for the benzyl portion 
in 1. The pyridine nitrogen does not find a favorable interaction partner, neither in 
conformation A nor in B. The occurance of the second tilted conformer B cannot be 
explained by a favorable interaction with the protein as the closest contact to a 
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neighbouring protein atom is 3.7 Å (Ser195). The coplanar, stacking-type interaction 
observed in conformation A of aromatic moieties seems to be a general feature in the S1 
pocket of trypsin-like serine proteases(24). Most likely it renders an energetically favorable 
contact geometry. We assume that the pronounced desolvation costs of the highly buried 
aspartate are responsible for the only partially achieved displacement of the water molecule 
and the concurrent disorder of the P1 portion. As mentioned, the described water position is 
also occupied in the uncomplexed structure of thrombin (PDB code 2UUF(25)) indicating the 
favorable solvation of Asp189. The partial water displacement seems to correspond to the 
best compromise between the entropic costs associated with water trapping and the 
enthalpic advantage to recover the original solvation shell of Asp189. Furthermore, in 
conformation B the pyridine nitrogen experiences a long contact distance with unfavorable 
directionality to form a hydrogen bond to Ser189 and in conformation A virtually no 
beneficial interactions are experienced. We therefore believe that the ortho nitrogen is 
unfortunately placed. The low binding affinity of 4 confirms this hypothesis as it exhibits a Ki 
of only 69.3 ± 0.1 μM.  
Similarly, the N-methylated ortho pyridinium derivative 5 adopts a binding mode featuring 
two conformations and a water molecule in very similar positions (Figure 3d) as in case of 4. 
The even closer distance of 1.8 Å to one ring carbon in conformation A clearly evidences 
partial occupancy of the water molecule. The refinement of the occupancy revealed 59 % for 
conformation A which diplaces the water molecule and 41 % for B which maintains the 
original solvation of Asp189. Both observed binding modes show the methylated and 
positively charged nitrogen in an area unable to efficiently interact with Asp189 or one of 
the negatively polarized S1 residues. The unfavorable placement and the partial release of 
the water molecule account for the weakest binding affinity (Ki = 132.2 ± 35.3 μM) in this 
ligand series.   
The crystal structure of the para pyridyl derivative 6 reveals a surprising binding feature 
(Figure 3e). Two well defined dump-bell shaped difference electron densities in the data set 
resolved to 1.30 Å arrange next to Asp189 which suggests the presence of water molecules 
scattered over the three sites. In a first refinement model three simultaneously present 
water molecules were assigned to full occupancy, however, we received very close distances 
of 2.0 Å and 2.2 Å between the water sites. The resulting distances do not support a model 
with fully occupied hydration sites. In a second model the three water sites were assigned to 
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50 % occupancy. A reasonable model with close distances and acceptable contacts to 
Asp189 (2.6 Å, 2.5 Å and 2.6 Å) could be found. The refinement of this model with a 
geometrical restraint to keep the close water contacts to 2.1 Å with σ = 0.3 Å resulted in B 
factors of about 23.0 Å2 which is in agreement with those for the water position in most of 
our structures. In addition to the short distances to the negatively charged oxygens of 
Asp189 (2.5 Å) and the backbone carbonyl oxygen of Gly219 (3.0 Å), an interaction with the 
lone pair of the adjacent pyridine nitrogen can be found (3.0 Å). Protonation of this pyridine 
nitrogen can be excluded due to our ITC experiments which do not indicate superimposed 
protonation steps as the recorded heat signal shows no significant (≤ 0.2 mol protons) buffer 
dependence (Figure 4).  
As the distances around the central water site suggest some kind of a distorted pentahedral 
coordination, occupancy by a sodium ion was also taken into consideration. Unfortunately, 
water and a sodium ion exhibit similar diffraction power making differentiation impossible. A 
CSD(26) (Cambridge Structural Database) search on sodium ion contacts performed by Harding(27) 
revealed a common coordination number of five or six limiting the coordination sphere to 
2.7 Å. According to Harding a mean distance between a sodium ion and a neighboring 
oxygen of 2.42 Å is found in the CSD. A subsequent analysis of protein structures in the PDB 
revealed a somewhat larger distance of 2.57 Å as mean Na+···O and 2.58 Å as mean 
Na+···OH2 contact distance.
(27) These values are not in aggreement with the distances found 
in the present complex. We therefore exclude the unlikely presence of a sodium ion and 
assume a binding model with a highly disordered water network near Asp189 to explain the 
dumb-bell shaped difference electron density. The binding affinity of 6 is rather low with a Ki 
of 64.0 ± 20.0 μM. Interestingly, the para pyridine derivative 6 does not experience a strong 
enough pKa shift to adopt a positively charged state forming a direct charge-assisted H-bond 
with Asp189. Instead an incomplete replacement of the favorable solvation shell of Asp189 
is recognized. As a matter of fact this obstacle prevents a strong affinity contribution to 
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Figure 4: The observed enthalpy Hobs for binding of 2, 4 and 6 to thrombin as a function of the 
ionization enthalpy Hion of the applied three buffers tris, hepes and tricine at pH 7.8. The slope of 
the linear regression yields the molar ratio of protons captured during the binding reaction. 
 
 
The N-methylated para-pyridinium analog 7 displaces part of the disordered water network 
adjacent to Asp189 found in the previous complex (Figure 3f). At one of the water sites full 
occupancy is observed. The orientation of the ring and the bulky methyl substituent prevent 
the positive charge at nitrogen to experience a short electrostatic contact to the aspartate as 
indicated by the long distance of 4.6 Å. We determined an inhibition constant of 22.5 ± 13.2 
μM for 7 which displays the strongest binding in the methylpyridinium series. Possibly this 
enhanced binding reflects the closer distance of the positive charge to Asp189 compared to 
the complexes with the ortho or meta derivatives 3 and 5. Nevertheless, none of the 
methylpyridinium derivatives exhibits a binding affinity even in the range of the highly 
potent benzamidine analog (Ki = 4 nM
(21)) which shows impressively that sole placement of a 
positive charge into the S1 pocket is not sufficient for strong binding.   
In the next step, we introduced a chlorine atom into ligands 2-5 in order to explore the 
competition between a polar, H-bond acceptor group, a positively charged substituent and a 
hydrophobic group with respect to binding geometry and achieved affinity. Particularly the 
m-chlorosubstituted benzyl derivative is known to bind with high affinity (K i = 180 nM
(21)) to 
the S1 pocket of thrombin experiencing strongly favorable chloro-aromatic contacts with the 
adjacent Tyr228. The determinant influence of this interaction is underlined by the complex 
geometries of 8 and 9 which bear a chlorine atom located in meta position and pyridine 
nitrogen or a N-methylated pyridinium nitrogen in ortho position (Figure 3g and 3h). They 
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orient their meta-chloro substituent towards Tyr228 to form the chlorine-aromatic 
interaction. The opposing positive charge in ortho position of 9 is placed similarly to 5 in 
conformation B. Disorder with a second conformation allowing for partial residual solvation 
of Asp189 is not observed. Obviously, the energetic benefit of chloro-aromatic interactions 
over compensates for the costs to fully desolvate Asp189.  
The complexes with 8 and 9 should be compared with those of 10 and 11, where the chloro-
substituent is moved to ortho position and the pyridine nitrogen or the N-methylated 
pyridinium group occupy the meta position (Figure 3i and 3j). Different from the binding 
modes of 2 and 3 neither the pyridine nitrogen nor the positively charged N-methylated 
group are placed next to Asp189, instead they are pointing in opposite direction towards the 
carbonyl backbone groups of Gly216 and Gly219 as similiarly observed in 4 and 5 in 
conformation A which repels the water molecule adjacent to Asp189. The N-methyl group in 
11 occupies virtually the same region as in the topological isomer 8. Also the contacts to the 
neighbouring polar groups are of comparable length. The ortho chloro-substituents of 10 
and 11 are oriented towards the opposite face, however for stereochemical reasons they 
cannot establish a short favorable contact to Tyr228. Interestingly enough, both complexes 
show again the crucial water molecule in the vacant space next to Asp189. The occupancy of 
these water molecules could be refined to 100 %. With respect to binding affinity, both 
ligand pairs 8/10 and 9/11 exhibit almost the same values (Table 1). This agrees with the 
other examples in this series, however a large drop in affinity is experienced relative to the 
plain meta-chloro benzyl derivative which experiences 180 nM potency(21).  
 
3.4.2 Thermodynamic results and correlation to described structural characteristics 
Due to the weak binding of the inhibitors of this series the thermodynamic characterization 
is challenging as it does not allow direct titrations. In a direct titration, the resulting curves 
show incomplete typical sigmoidal shape, thus the determination of the thermodynamic 
parameters will be associated with large errors and the inflection point of such titration 
curves, which indicates the dissociation constant, cannot be fitted properly. However, in 
order to obtain thermodynamic data of sufficient accuracy and to reduce consumption of 
protein material we profiled the ligands by displacement titrations. We followed a procedure 
recently suggested by us (unpublished). The solution of thrombin is saturated by the ligand 
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under investigation and subsequently titrated with a stronger binder to displace in a step-
wise fashion the weak-binding ligand from the active site. We selected two tight binders (see 
Table 2 for chemical structures) with different thermodynamic profiles (Table 3) since similar 
enthalpies of weak and strong binders will result in a very low difference signal. If the heat 
signal was too low in the displacement titration with the first reference ligand, the 
experiment was repeated with the second tight binder in order to avoid unfortunate 
compensating heat effects.  
As described below, the thermodynamic results suggest that large costs in desolvation 
enthalpy are responsible for the weak binding of the N-methylated pyridinium derivatives 
(see Table 3). The closer the positive charge has been found in the crystal structures to the 
negatively charged Asp189, the better the price for the high desolvation enthalpy can be 
compensated. The largest distances are observed for the N-methylated pyridinium 
derivatives with the positive charge in ortho position. They place it the most remote distance 
from Asp189. Here we observe a loss in binding enthalpy (ΔΔH8/9) of - 7.0 kJ/mol for the 
chloro substituted pair 8/9 and - 4.3 kJ/mol for analogous chlorine free pair 4/5. For the pair 
2/3 bearing the nitrogen or the N-methylated group in meta position shorter distances to 
Asp189 are experienced which correlates with a slightly more favorable enthalpic difference 
by ΔΔH2/3 of 1.0 kJ/mol. Finally, for the para analogs 6/7, the N-methylated derivative places 
its positive charge the closest to the negative aspartate. Here the enthalpy improvement for 
N-methylation amounts to ΔΔH6-7 of 4.9 kJ/mol. The series suggests that the large 
desolvation cost of the protein and the ligands, assumed to be of the same magnitude for all 
derivatives, is increasingly compensated by an enthalpic electrostatic contribution 
experienced in the considered derivatives along with a decreasing distance. 
In addition to the desolvation effects in this series it is interesting to note, that only in some 
cases an entropic signal can be related to the displacement of a water molecule. Comparing 
the crystal structure of the benzyl derivative 1 with that of 2 shows one extra water in the 
latter structure. Indeed, the less solvated benzyl ligand 1 shows a favorable entropy term 
compared to 2 (- TΔΔS2-1 = + 10.0 kJ/mol) due to the release of an ordered water molecule.  
In contrast, a clearly defined water molecule, present in the complex with 2, is displaced 
from the S1 binding pocket in the complex with 3. The expected entropic benefit cannot be 
detected as indicated by an unfavorable - TΔΔS2-3 term of - 2.9 kJ/mol. We calculated the 
average B factors for the ligand’s P1, P2 and P3 side chains and the surrounding binding site 
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residues to investigate whether changes in residual mobility could possibly account for the 
entropic effects recorded by our ITC experiments.  
 
Table 2: The chemical structures used in the displacement titration as competitive binder together 
with the kinetically determined inhibition contants (Ki in nM) and the standard deviation
(a) towards 
human thrombin.  
Competitive Ligand 1 (12) 
 
2.2  
Competitive Ligand 2 (13) 
 
62.9 ± 19.8 
a)The error is given as the standard deviation calculated from at least three measurements (in nM). 
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B ligand B binding site B ligand/ 
B binding 
site 






B D-Phe + 
Pro 
1(21) - 31.7 - 13.6 -18.1 26.2 18.9 1.39 26.2 24.9 25.5 28.2 1.11 
2 - 25.8 ± 0.0 - 17.7 ± 0.3 - 8.1 ± 0.2 17.7 15.9 1.11 16.0 15.9 16.0 21.8 1.37 
3 - 23.9 ± 0.4 - 18.7 ± 1.4 - 5.2 ± 1.0 15.2 15.1 1.01 15.2 14.9 15.1 15.4 1.02 
4 - 25.0 ± 0.2 - 19.8 ± 0.4 - 5.2 ± 0.2 Highly disordered as indicated by multiple conformations 
5 - 21.4 ± 0.1 - 15.5 ± 0.3 - 5.9 ± 0.3 Highly disordered as indicated by multiple conformations 
6 - 24.2 ± 0.3 - 18.7 ± 0.1 - 5.5 ± 0.3 20.3 17.2 1.18 19.2 19.3 19.3 22.6 1.17 
7 - 24.0 ± 0.1 - 23.6 ± 0.7 - 0.4 ± 0.5 16.0 16.0 1.00 15.3 15.8 15.6 17.0 1.09 
8 - 31.5 ± 0.3 - 30.3 ± 0.3 - 1.2 ± 0.5 36.2 24.8 1.46 35.1 41.1 38.1 33.8 0.89 
9 - 23.7 ± 0.4 - 23.3 ± 3.8 - 0.4 ± 3.4 14.1 12.0 1.18 14.0 14.3 14.2 14.0 0.99 
11 - 24.3 ± 0.2  - 22.4 ± 0.8 - 1.9 ± 1.0 23.4 20.1 1.16 22.2 22.4 22.3 25.5 1.14 
12 - 47.3 ± 0.9 - 40.2 ± 0.9 - 7.1 ± 1.9  
13 - 37.6 ± 0.3 -34.5 ± 1.1 - 3.1 ± 1.4  
Ligands 2-11 were determined in a displacement titration using ligands 12 or 13 as competitive binder. The thermodynamic data of 12 and 13 were determined in a direct 
ITC titration. The binding pocket includes all residues within 4 Å from the inhibitor. Errors indicate the standard deviation from at least duplicate measurements. 
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We followed a protocol recently suggested in a previous contribution (Baum et al.(21)) by 
comparing ratio’s of B factors (see Table 3 for definition of B factor ratio’s). The ratio of B 
factors of the ligand’s S1 occupant relative to the remaining D-Phe-Pro moiety of 2 is actually 
higher by a factor of 1.37 (Table 3) indicating higher residual mobility of the P1 portion in 
this complex compared to a value of 1.02 determined for the related N-methylated 
pyridinium derivative 3. Despite similiar desolvation costs for the aspartate, 1 is entropically 
clearly favored compared to the charged ligand 3 (- TΔΔS3/1 = - 12.9 kJ/mol). For the complex 
with 1 we observe a higher B factor ratio (1.11) suggesting higher residual mobility of the 
benzyl substituent compared to the S1 occupant of 3 which shows almost no enhanced 
residual motion (1.02). It seems that the entropic benefit which is assigned to the 
displacement of an ordered water molecule from the binding site is compensated by an 
unfavorable entropic contribution arising from the reduced residual motion of the P1 
portion of 3. Furthermore, both ligands differ significantly in the free desolvation energy. 
Possibly, this strong effect will also influence the partitioning of enthalpy and entropy and 
can still be reflected in a deviating profile observed for both complexes.  
The P1 side chains in 4 and 5 are scattered over at least two conformations, nevertheless, 
we cannot exclude even further conformers to be populated. Both derivatives exhibit similar 
entropic contributions (- TΔΔS4/5 = + 0.7 kJ/mol) upon complex formation and have similar 
crystallographic results with comparable disorder and displacement of overall 0.5 mol water 
molecules. The most surprising binding profile difference is indicated for the ligand pair 6/7 
showing an unfavorable entropic signal (- TΔΔS6/7 = - 5.1 kJ/mol) upon displacement of much 
of the water network near Asp189 observed with 6 but lacking with 7. In the case of 7 only 
one ordered water molecule adjacent to Asp189 is found whereas in 6 with experimental 
accuracy 1.5 water molecules can be assigned to the scattered difference electron density. 
This number results as an average value if all of the water positions would in fact be 
occupied at 50 %. Apparently, the striking difference in the thermodynamic signature of both 
complexes cannot be correlated with the amount of replaced water molecules since both 
complexes feature almost the same quantity. Nevertheless, why is 6 entropically more 
favored than 7? To answer this we have to compare both structures to the apo form of 
thrombin. Here we find two well-ordered water molecules bound to Asp189 which occupy 
the most right and left sites also seen in the complex with 6 (Figure 3e). Upon binding of 6 
one (or 1.5) water molecule is still present in the complex, however, highly scattered over 
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several positions whereas in the complex with 7 one ordered water molecule (most left site) 
is preserved. As it seems binding of 6 drives the water molecules present in the apo 
structure in a highly disordered state. As such water molecules are then quite disordered in 
the protein-bound state, their beneficial contribution to the ordering parameters of the 
complex leads to a more favored entropic signature. This entropic contribution of the 
disordered water molecules is missing in 7. Beside these effects it is likely that the S1 
occupant of 6 is not firmly fixed in its position because it interacts with the disordered water 
molecules via hydrogen bonds. Most likely the pyridine moiety will therefore experience also 
some influence from the “adjacent disorder”. All these entropically beneficial effects on the 
ordering parameters of 6 in bound state are not present in 7. For the latter we observe a 
more favorable enthalpic term (ΔΔH6/7 = + 4.9 kJ/mol) which most likely also reflects the 
strong electrostatic interaction to Asp189 across short distance. 
To sum this up, the observed disorder around Asp189 corresponds to a poorly solvated 
hydration shell and the participating water molecules are therefore unlikely to be forming 
strong H-bonds requiring firmly fixed positions. We therefore assign the entropically 
favorable thermodynamic signature of 6 to the reorganization of the originally well ordered 
solvation pattern adjacent to Asp189 to a more dynamic state.  
 
3.4.3 Calculation of free energies of solvation 
Our hypothesis suggests that large costs for desolvation of the ligands and the protein 
binding site play a major role in the thermodynamic binding inventory and explain the 
observed weak binding of the positively charged inhibitors. In order to confirm the 
hypothesis, we calculated solvation free energies for the ligand series by a quantumchemical 
approach using SM8 and PCM implicit solvation models(28). Both models show different 
absolute values but indicate basically the same trends that ligands carrying a positive charge 
are more costly to desolvate than the neutral species (Table 4). The latter ones show 
solvation energies in the range of - (56-66) kJ/mol whereas introducing a charge at the 
pyridine ring dramatically increases the solvation energies [- (218-246) kJ/mol, SM8 model]. 
Basically, the same trend was found in the PCM model but with lower absolute values, - (10-
13) kJ/mol for the neutral and - (123-139) kJ/mol for the charged analogs.  
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Table 4: Solvation free energies(a) of the studied inhibitors. The calculation of these energies was 






1 - 55,9 - 11,3 
2 - 63,3 - 13,4 
3 - 242,9 - 138,7 
4 - 62,4 - 9,7 
5 - 218,1 - 128,8 
6 - 62.4 - 9.3 
7 - 245,8 - 138,2 
8 - 59,6 - 11,2 
9 - 231,0 - 135,3 
10 - 66,4 - 10,8 
11 - 223,1 - 123,2 
a)The values for the neutral inhibitors are in blue and the charged derivatives in red. 
 
Table 5: Experimentally determined solvation free energies from literature of some compounds 
containing nitrogen either as pyridines or primary, secondary or tertiary amines(29) and the 







aniline - 23.0 - 301.2 anilinium 
CH3NH2 - 19.2 - 309.6 CH3NH3+ 
(CH3)2NH - 18.0 - 280.3 (CH2)2NH2+ 
(CH3)3N - 13.4 - 263.6 (CH2)3NH+ 
pyridine - 19.6 
2-methylpyridine - 19.3 
3-methylpyridine - 20.0 
4-methylpyridine - 20.6 
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At first glance, the values appear rather high, however, experimental data for pyridine and 
other amines compared to its charged analogs support our calculated values. Pyridine and its 
methyl derivatives exhibits an experimental solvation energy of - (19.3-20.6) kJ/mol.(29) For 
our much larger inhibitors the SM8 model suggests about - 60 kJ/mol.  
Introducing a charge in the molecules is associated with a large increase in solvation energy 
which was measured for the charged amine species to be an order of magnitude higher 
*∆GSolv = - (264-310) kJ/mol, Table 5]. These findings firmly support our calculations which 
suggest a strongly increased desolvation contribution for our N-methylated pyridinium 
derivatives.    
 
3.5 Conclusion 
Herein we presented a comprehensive study of 10 thrombin inhibitors demonstrating the 
importance of the desolvation of the ligand functional groups and deeply buried charged 
protein residues. These aspects have to be considered in the analysis of ligand binding to a 
target protein. It is generally accepted that water molecules play an important role in the 
ligand binding but most efforts fail to fully implement water contributions in scoring 
functions to predict binding affinities. Our ligand series shows impressively how decisive the 
cost in free energy can be if charges are present in a ligand and only weak interactions can 
be formed to the protein residues. Large penalties in enthalpy have to be paid for ligand 
desolvation especially of the charged N-methylated pyridinium derivatives. They are 
responsible for a large drop in the binding affinity by a factor of 20 - 30 (compared to the 
neutral non-methylated analogs) in case of the chloro-substituted ligands. As the ligands 
adopt a geometry with the chlorine substituent placed close to the neighboring tyrosine 
residue, the charged group is located in a region not favorable to form strong interactions to 
Asp189. In contrast, in the derivatives lacking the chlorine substituent, the positive charge is 
placed as close as possible to the negatively charged aspartate. This way, the P1 substituent 
compensates the price to be paid for desolvation compared to the neutral analogs (only by a 
factor of about 2 less in affinity). Consequently, improvement in binding affinity is obtained 
when the positive charge is placed adjacent to the deprotonated Asp189 in the para 
derivative 7. Furthermore, the contributions to be paid to desolvate the protein binding site 
are important for the binding process. Especially, the desolvation of buried and 
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deprotonated aspartate residues requires a large free energy penalty of desolvation and has 
to be appropriately compensated by newly formed interactions if a high affinity complex is 
to be formed. In our series, we identify a strongly bound water molecule next to the 
deprotonated residue Asp189 which is present in the uncomplexed structure. Because of the 
rather costly displacement of this water molecule, even distorted and most likely less 
favorable ligand conformations are partially populated which still allow this water molecule 
to be accommodated. Its complete displacement requires high desolvation costs. 
Consequently, for 4 and 5 only about 50 % of the water molecules are displaced from the S1 
pocket.  
The 3-pyridine derivative 2 binds to the S1 pocket with the water molecule still bound to 
Asp189. It shows reduced binding affinity compared to the unsubstituted benzyl derivative 
1, however these complexes exhibit a reversed thermodynamic signature; 1 repels the water 
molecule from Asp189 and shows remarkable residual mobility in the pocket. Its binding is 
accompanied by a favorable entropic contribution. 2 binds with a more enthalpically favored 
profile. It also shows compared to 1 reduced residual mobility of its P1 portion in bound 
state but enhanced motion with respect to 3. However, compared to the complex with 1, 
Asp189 remains in 2 partially solvated and only the enhanced desolvation of the pyridine 
nitrogen has to be paid for. Overall this results in an enthalpy-driven binding of 2 and 3.  
In addition to direct and well defined water-mediated interactions, we provide evidence that 
also highly disordered water molecules can serve this purpose. Interestingly enough, the 
replacement of these disordered water molecules is determinant for an entropically 
unfavorable signature. Waters already disordered in the bound state, cannot make much of 
an impact on the entropic component once released to the bulk solvent. Consequently, the 
enthalpic component dominates as newly formed interactions of the repelled water 
molecules are experienced in the bulk phase.  
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3.7 Materials and Methods 
3.7.1 Bioassay 
Kinetic inhibition of human thrombin (from Beriplast®, CSL Behring, Marburg, Germany) was 
determined photometrically at 405 nm using the chromogenic substrate Pefachrom tPa 
(LoxoGmbH, Dossenheim, Germany) as described(30) under the following conditions: 50 mM 
Tris–HCl, pH 7.4, 154 mM NaCl, 5 % DMSO, 0.1 % polyethylene glycol 8000 at 25°C using 
different concentrations of substrate and inhibitor. Ki values (n ≥ 3) were determined as 
described by Dixon(31). 
 
3.7.2 Isothermal titration calorimetry 
ITC experiments were performed using an ITC200™ system from Microcal (now part of GE 
Healthcare, Northhampton, MA, USA).  Thrombin was freshly prepared for each experiment 
by dialysis of a thrombin sample in the buffer used for titration experiments (50 mM Hepes, 
100 mM NaCl, 1 % PEG8000, pH 7.8). After dialysis the weak-binding ligand was added from 
a stock solution (50 mM, 100% DMSO) to the solution of thrombin (27 μM) in order to obtain 
the required ligand concentration for sufficient saturation (1.25 - 1.5 mM). The final DMSO 
concentration was subsequently adjusted to 3 %. Either competitive ligand 12 or 13 (500 – 
625 μM) were filled in the syringe and then titrated into the stirred sample cell (200 μL) 
containing the thrombin solution (27 μM) saturated with the weak-binding ligand under 
investigation. The resulting titration curve of the displacement titration was analysed using 
the Origin 7.0 software by fitting a single-site binding isotherm. The derived parameters are 
used as Ka obs and ΔHobs in equation 1 and 2
(32) to calculate the thermodynamic properties Ka 
WL and ΔHWL of the weak-binding ligand. The values Ka SL and ΔHSL for 12 or 13 were taken 
from a separate experiment carried out in the beginning of the experiment. 
 
Equation 1 
Ka obs = Observed association constant from the ITC displacement experiment 
Ka WL = Association constant of weak binder   
Ka SL = Association constant of strong binder from a direct ITC experiment 
[Lfree] = Concentration of weak-binding ligand in the saturated protein solution 





ΔHWL = Enthalpy change of weak binder 
ΔHobs = Observed enthalpy change of strong binder in the displacement experiment 
ΔHSL = Enthalpy change of strong binder 
Ka WL = Association constant of weak binder 
[Lfree] = Concentration of weak binder in the saturated protein solution 
 
The concentration of the free ligand [Lfree] (Equ. 3) is unknown. As the concentration of the 
weak-binding ligand is much larger than that of the protein [Ltot] >> [Ptot], the free ligand 
concentration [Lfree] is practically equal to [Ltot]. Thus [Ltot] was used in the further analysis.   
 Equation 3 
All ITC experiments were started at 25 °C after a stable baseline had been achieved. The 
experimental design comprises an initial ligand injection of 0.3 μL followed by 15 injections 
of 1.1 - 1.4 μL with a 300 s interval between each injection. 
All measurements were performed in duplicate. Raw data were collected and the area under 
each peak was integrated, followed by correction for heats of dilution and mixing by 
subtracting the final baseline consisting of small peaks of the same size to zero. The initial 
data point was deleted from the integrated data because this injection usually reflects an 
erroneous amount of heat due to the possible exchange of liquids between syringe and cell 
when inserting the syringe into the calorimetric cell and the backlash error in the motorized 
screw mechanism in the injector.(33) Representative titration curves are shown in the 
supplementary data. 
 
3.7.3 Solvation energy calculation 
The calculation has been completed by the program package Q-chem ver4.0. The solvation 
energy has been calculated by density functional theory B3LYP method with 6-31G** basis 
set, along with PCM or SM8 implicit solvent model respectively.(28) 
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3.7.4 Crystallization and soaking 
Human α-thrombin (from Enzyme Research Laboratories, South Bend, USA) was dissolved in 
the crystallization buffer (20 mM NaH2PO4, 350 mM NaCl, 2 mM benzamidine, pH 7.5) at 10 
mg/ml. A hirudin fragment called Acetyl-Hirudin (54-65) purchased from Bachem 
(Bubendorf, Switzerland) was dissolved in crystallisation buffer at 2.5 mg/ml. In the next 
step, 40 μL of the solution of the hirudin fragment was mixed with 160 μL of the thrombin 
solution. After incubation for 2 h at 4 °C, crystallization was carried out at 4 °C by the 
hanging-drop method. One 1 μL of the hirudin/thrombin solution was placed in the centre of 
a cover slip and mixed with 1 μL reservoir solution (20 mM NaH2PO4, 27 % polyethylene 
glycol 8000, pH 7.5). Immediately after the mixing of protein and reservoir buffer 
microseeding was done. The wells of the crystallization trays were filled with 500 μL of the 
reservoir buffer. Subsequently, the cover slips were placed on the wells and sealed. Crystals 
of good diffracting quality could be produced within 7 days. For soaking DMSO stock 
solutions of the inhibitors (50 mM) were diluted 1:10 with a solution containing 50 % 
crystallization and 50 % reservoir buffer resulting in the final soaking concentration 
containing 5 mM of the inhibitor and 10 % DMSO. Medium-size crystals without visible 
imperfections were selected and transferred into the soaking solution for 24 h.  
 
3.7.5 Data collection and processing 
Crystals were prepared for data collection at 110 K using a cryoprotectant solution of 20 % 
glycerol in reservoir buffer. The data sets for 2, 3, 4, 5, 7 and 10 were collected with 
synchrotron radiation at SLS (Villingen, Switzerland) on a Marmosaic 225 mm CCD detector. 
Complex structures for 8, 9 and 11 were collected at BESSY beamline 14.2 (Berlin, Germany) 
on a Rayonix MX 225 CCD detector. The data set for 6 was collected at ESRF ID29 beamline 
(Grenoble, France) on a Pilatus 6M detector. Data processing and scaling were performed 
using the HKL2000 package(34). Data processing and scaling were done with XDS in case of 
5.(35)     
 
3.7.6 Structure determination and refinement 
The coordinates of human thrombin (PDB code 1H8D)(36) were used for initial rigid body 
refinement of the protein molecules followed by repeated cycles of maximum likelihood 
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energy minimization, simulated annealing and B-factor refinement using the CNS program 
package(37). Refinement of structure 2 was done with SHELXL(38) and structures 3, 4, 5, 6, 7, 8, 
9, 10 and 11 were refined with PHENIX(39). The temperature factors for structures 2, 6 and 9 
were anisotropically refined whereas for structures 3, 4, 5, 7, 8, 10 and 11 TLS refinement 
was applied. The definition of the TLS groups were done with the TLSMD server(40,41). A 
randomly chosen 5 % of all data were used for the calculation of Rfree and were not used in 
the refinement. Amino acid side chains were fit into σ-weighted 2Fo – Fc and Fo – Fc electron 
density maps using Coot(42). After the first refinement cycle, water molecules and 
subsequently ions and ligands were located in the electron density and added to the model. 
Restraints were applied to bond lengths and angles, planarity of aromatic rings and van der 
Waals contacts. Multiple side chain conformations were built in case an appropriate electron 
density was observed and maintained during the refinement, and if the minor populated 
side chain showed at least 20 % occupancy. The final models were validated using PHENIX 
own validation options or MolProbity(43). The Ramachandran plot’s were calculated with 
PROCHECK(44). Data collection, unit cell parameters and refinement statistics are given in 
Table 6. Analysis of temperature factors was done with Moleman(45) and fconv(46). The 
naming of the protein amino acids was done according to Bode et al.(47). The figures were 
prepared using Pymol 0.99. The Protein Data Bank accession codes of the coordinates and 
structure factors of all X-ray structures are given in Table 6.  
 
3.7.7 Protein Data Bank and accession numbers 
Coordinates and structure factors have been deposited in the Protein Data Bank with the 
following accession codes: THR-2 complex 3P17; THR-3 complex 3QTO; THR-4 complex 3SI3; 
THR-5 complex 3SI4; THR-6 complex 3SV2; THR-7 complex 3QTV; THR-8 complex 3SHC; THR-
9 complex 3QX5; THR-10 complex 3SHA; THR-11 complex 3QWC. 
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Table 6: Data collection and refinement statistics for the ten thrombin complex structures determined in this publication. 










A. Data collection and processing      
No. Crystals used 1 1 1 1 1 
Wavelength (Å) 1.00 1.00 1.00 1.00 0.9686 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
    a, b, c (Å) 70.0, 71.4, 72.5 69.8, 71.4, 72.5 70.1, 71.4, 72.3 70.4, 71.2, 72.6 70.0, 71.4. 72.2 
    β (°) 100.3 100.3 100.1 100.4 100.3 
Matthews coefficient (Å3/Da) 2.7 2.5 2.5 2.5 2.5 
Solvent content (%) 51 51 51 51 51 
      
B. Diffraction dataa      
Resolution range (Å) 50 – 1.43 50 – 1.52 50 – 1.55 50 – 1.27 50 – 1.30 
 (1.45 – 1.43) (1.55 – 1.52) (1.58 – 1.55) (1.29 – 1.27) (1.38 – 1.30) 
Unique reflections 63,603 (3,046) 53,781 (2,645) 50,679 (2,310) 91,193 (4,405) 85,743 (11,030) 
R(I)sym (%) 4.6 (39.3) 6.5 (49.7) 6.6 (47.0) 3.8 (47.1) 2.7 (49.2) 
Completeness (%) 98.1 (95.7) 99.8 (99.5) 99.3 (91.6) 98.4 (95.2) 93.6 (88.6) 
Redundancy 2.5 (2.5) 3.1 (2.9) 3.7 (3.0) 2.7 (2.5) 3.6 (3.5) 
I/σ(I) 19.5 (2.3) 17.0 (2.2) 20.0 (2.0) 26.4 (2.2) 18.2 (2.5) 
      
C. Refinement      
Resolution range (Å) 10 – 1.43 35.7 – 1.52 35.7 – 1.55 34.6 – 1.27 35.7 – 1.30 
Reflections used in refinement 56,991 / 3,021 51,053 / 2,584 47,831 / 2,396 86,393 / 4,347 80,045 / 4,025 
    (work/free)      
Final R values for all reflections 14.0 / 17.6 15.5 / 16.5 15.6 / 18.1 13.7 / 15.9 14.0 / 16.5 
    (work/free) (%)      
Protein residues (L chain/H chain) 27 / 251 28 / 251 28 / 251 28 / 251 28 / 251 
Sodium ions 2 2 2 2 2 
Inhibitor atoms 26 27 26c / 36d 27c / 38d 26 
Water molecules 276 366 350 401 328 
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RMSD from ideality      
    Bond lengths (Å) 0.011 0.008 0.010 0.008 0.012 
    Bond angles (°) 2.2 1.1 1.1 1.1 1.3 
Ramachandran plot       
    Residues in most favoured regions (%)  86.1 85.8 85.8 85.8 86.2 
    Residues in additionally allowed           13.9 13.8 13.8 14.2 13.4 
        regions (%)      
    Residues in generously allowed - 0.4 0.4 - 0.4 
        regions (%)      
Mean B-factor (Å2)      
    Protein (L + H chain) 18.8 17.8 18.3 18.1 19.9 
    Binding siteb 15.9 15.1 15.1 16.3 17.2 
    Inhibitor 17.7 15.2 14.7e 17.9e 20.3 
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Structure (PDB entry) THR-7 complex 
(3QTV) 









A. Data collection and processing        
No. Crystals used 1 1 1 1 1   
Wavelength (Å) 1.00 0.91841 0.91841 1.00 0.91841   
Space group C2 C2 C2 C2 C2   
Unit cell parameters        
    a, b, c (Å) 69.9, 71.3, 72.4 70.4, 71.4, 72.8 70.2, 71.1, 72.8 69.8, 71.4, 72.2 70.6, 71.5, 72.7   
    β (°) 100.4 100.6 100.6 100.0 100.6   
Matthews coefficient (Å3/Da) 2.5 2.5 2.5 2.5 2.5   
Solvent content (%) 51 51 51 51 52   
        
B. Diffraction dataa        
Resolution range (Å) 50 – 1.63 50 – 1.90 30 – 1.35 50 – 1.52 30 – 1.75   
 (1.66 – 1.63) (1.93 – 1.90) (1.37 – 1.35) (1.55 – 1.52) (1.78 – 1.75)   
Unique reflections 43,364 (2,129) 27,888 (1,411) 74,225 (2,719) 51,764 (2,454) 34,739 (1,776)   
R(I)sym (%) 6.8 (45.9) 7.9 (40.0) 4.8 (29.3) 4.4 (37.4) 5.5 (40.7)   
Completeness (%) 99.7 (96.1) 99.5 (100.0) 96.0 (71.2) 96.1 (92.3) 96.1 (98.4)   
Redundancy 3.1 (2.4) 3.1 (2.7) 3.0 (2.0) 2.2 (2.1) 2.2 (2.1)   
I/σ(I) 16.7 (1.9) 13.2 (2.7) 22.3 (2.8) 15.7 (2.2) 14.7 (2.5)   
        
C. Refinement        
Resolution range (Å) 35.7 – 1.63 24.8 – 1.90 24.8 – 1.35 31.9 – 1.52 24.9 – 1.75   
Reflections used in refinement 41,532 / 2,090 26,703 / 1,297 71,675 / 3,635 48,953 / 2,468 32,908 / 1,642   
    (work/free)        
Final R values for all reflections 15.5 / 17.6 15.9 / 19.7 13.2 / 15.6 16.1 / 19.0 15.4 / 17.9   
    (work/free) (%)        
Protein residues (L chain/H chain) 28 / 251 28 / 251 28 / 251 28 / 251 28 / 251   
Sodium ions 2 2 2 2 2   
Inhibitor atoms 27 27 28 27 28   
Water molecules 331 223 450 328 260   
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RMSD from ideality        
    Bond lengths (Å) 0.009 0.010 0.008 0.009 0.010   
    Bond angles (°) 1.075 1.062 1.127 1.091 1.070   
Ramachandran plot         
    Residues in most favoured regions (%)  85.4 87.4 84.6 86.2 86.2   
    Residues in additionally allowed           14.6 12.6 15.4 13.4 13.8   
        regions (%)        
    Residues in generously allowed - - - 0.4 -   
        regions (%)        
Mean B-factor (Å2)        
    Protein (L + H chain) 19.4 24.6 15.9 19.6 22.7   
    Binding siteb 16.0 24.8 12.0 15.5 20.1   
    Inhibitor 16.0 36.2 14.1 15.1 23.4   
    Water molecules 32.8 33.3 35.0 32.6 33.7   
a)Numbers in parenthesis are for the highest resolution shell. 
b)Definition of the binding site: all amino acids which are 4 Å away from inhibitor. 
c)The inhibitor atoms from the additional disordered part were not considered. 
d)All inhibitor atoms which were included in the refinement model.  
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4  Enthalpic and entropic changes caused by a stepwise 
disruption of a water network in the S3/4 subsite of thrombin: 




4.1 Introductory remarks 
This study was done in cooperation with the group of Prof. Dr. Steinmetzer (Philipps-
University Marburg). The following text will be submitted to a scientific journal. Frank Sielaff 
from the Steinmetzer group will be included as second author.  
 
4.2 Abstract 
The aim of this study is to examine the influence of the displacement of firmly bound water 
molecules from a hydrophobic cavity on binding affinity and the thermodynamic signature. 
The binding of a series of ligands with gradually increasing hydrophobicity and sterical 
requirements to thrombin has been studied using isothermal titration calorimetry (ITC) and 
X-ray crystallography. The inhibitors vary systematically at the P3 position by Gly, D-Ala, D-
Val, D-Leu and D-cyclohexylalanine (D-Cha) which address the well-hydrated S3/4 pocket in 
the apoenzyme. Two congeneric series were studied which differ only in the group 
addressing the S1 subpocket of thrombin. As S1 occupants 2-(aminomethyl)-5-
chlorobenzylamide and 4-amidinobenzylamide were used which show different interaction 
pattern in the S1 pocket. Nevertheless, they turn out to be almost equally potent. Crystal 
structure analysis reveals that both scaffolds exhibit also different binding modes of the 
terminal benzylsulfonyl moiety, whereas the systematically modified P3 substituents address 
the hydrophobic S3/4 pocket in a comparable way. Small modifications (D-Ala) are not 
capable of disrupting the hydration pattern also seen in the ligand free enzyme whereas 
larger substitutions (up to D-Cha) gradually displace these water molecules. Accordingly for 
mid-size groups even a hydration pattern with partially occupied water molecules is 
recorded. The improvement in binding affinity from nano- to picomolar range correlates well 
with the observed water displacement and with the extent of buried van-der-Waals 




contacts. The potency gain is mainly attributed to a favorable entropic contribution which 
correlates with a water release. The Gly derivatives drop out of the series since they show a 
deviating binding mode. Nonetheless and most remarkably, no significant changes in the 
thermodynamic profile are detected for the Gly vs D-Ala derivatives clearly indicating that 
conserved thermodynamic signature is by no means a reliable indicator for conserved 
binding mode. Aspects, such as differences in the accessible conformational space of Gly vs 
D-Ala in solution prior to protein binding and an equivalent total water release from the 
entire binding site might be responsible for these balanced thermodynamic profiles. An 
additional crystallographically remarkable finding is the binding of a second inhibitor 
molecule in some complexes with 4-amidinobenzylamide inhibitors. Interestingly, this 
second inhibitor molecule virtually maps the same region occupied by a characteristic loop 
formed by amino acids present in the fibrinogen α-chain, the natural thrombin substrate.      
 
4.3 Introduction 
Molecular recognition is of fundamental importance in molecular biology and drug 
discovery. Especially in drug design, the demand for modulating the recognition features 
between a small molecule ligand and a target protein is of utmost importance as it provides 
an opportunity to interfere with a pathogenic mechanism where the target molecule takes a 
crucial role. Inhibition or enhancement of the activity of this target protein is one of the 
most popular approaches for the treatment of the associated disease. The binding process of 
a small ligand to a protein, no matter whether it results in inhibition or activation, is 
mediated by non-covalent interactions. Hydrogen bonds and hydrophobic van-der-Waals 
contacts are in this context the most important interactions and they are believed to exert 
major part of binding affinity. Therefore, detailed understanding of the contributions of 
these types of interactions to the overall binding affinity is a prerequisite for the 
development of new and effective drugs against a target protein. In this respect, the 
accurate prediction of binding affinity of a drug candidate under consideration is pivotal to 
the idea of rational drug design. For example, how much does a newly formed hydrogen 
bond in a designed complex structure contribute to binding affinity or is it virtually cancelling 
out due to enthalpy/entropy compensation(1,2,3), what is the role of water molecules in the 
binding event(4,5) and how can we exploit hydrophobic interactions to achieve optimal 
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modulation of ligand affinity(6). This is only a small number of questions which need to be 
addressed to enable medicinal chemists to optimize their lead structures towards potent 
drug candidates.(7) Our understanding of hydrophobic contributions to protein-ligand 
interactions is still rather incomplete despite enormous research efforts which went into the 
characterization of the hydrophobic effect. In its classical view the hydrophobic effect 
experienced between interacting hydrophobic species is driven by the reorganization of 
water molecules upon protein-ligand binding.(8) Hydrophobic cavities in proteins and 
hydrophobic patches on ligand surfaces are contacted by water molecules prior to complex 
formation. These contacting water molecules are assumed to be well ordered and thus 
associated with an unfavorable entropic component. According to textbook knowledge, the 
release of such water molecules from hydrophobic interfaces to the bulk water phase leads 
to a favorable entropic signal upon complex formation as the released water molecules gain 
additional degrees of freedom. The association of hydrophobic species is therefore assumed 
to be driven by an entropic enhancement. However, an impressive number of hydrophobic 
complex formations in biology and host-guest chemistry have been reported that follow an 
opposed enthalpy-driven thermodynamic profile and would thus intuitively contradict the 
classical view on the hydrophobic effect. Smithrud et al.(9), for instance, tested the binding of 
benzene and pyrene derivatives to cyclophanes and their results suggest a strongly 
exothermic signal upon complexation despite interaction of hydrophobic binding partners. 
The same could be observed for accommodating apolar molecules in the cavity of 
cyclodextrins(10,11) and in the narrow AT-rich region of the DNA minor groove(12,13). With 
respect to protein-ligand complex formation examples were provided by Bingham et al.(14) 
and Englert et al.(15) In the first case, binding of two pyrazine derivatives with propyl or butyl 
substituents to the hydrophobic binding pocket of the major urinary protein (MUP-1) was 
studied by ITC and resulted in an enthalpy-driven process. In the example of Englert et al. 
thermolysin was selected as model protein and its large hydrophobic S1‘ pocket was 
addressed by ligand portions of gradually increasing size (methyl, propyl, isobutyl and 
benzyl). The protein-ligand association was investigated by ITC and suggested also enthalpy-
driven hydrophobic interactions. Notably, in both examined proteins the binding pocket 
appears to be suboptimally hydrated(15,16) prior to ligand binding and indeed this common 
feature could explain the observed paradoxical enthalpic signal as proposed by Homans(17). 
In a subsequent study, a deconvolution of the binding process in the MUP-1 case was done 




and it indicates that poor solvation of the uncomplexed pocket makes its desolvation even 
favorable. With other words, if a subsite is poorly solvated only little energy is required for 
its full desolvation in order to allow ligand binding. In the binding inventory the unspent 
enthalpy pays off in an unexpectedly high enthalpy term as the released water molecules 
find enthalpically favorable interactions in the bulk water phase. These examples underline 
the importance to study the solvation properties of hydrophobic ligands and hydrophobic 
protein pockets prior to complex formation to correctly consider their contributions to 
binding. This aspect is also decisive with respect to hydrophobic ligand optimization since 
addressing a poorly hydrated pocket could require a different design concept to enhance 
binding affinity than dealing with well-solvated pockets. To shed more light on the complex 
thermodynamic signature of hydrophobic binding, we investigated the occupancy of a rather 
well-solvated hydrophobic pocket to better characterize the driving forces for complex 
formation. We selected the large hydrophobic S3/4 pocket of thrombin as model system and 
in contrast to the above- described examples, this pocket is well hydrated in the 
uncomplexed state (PDB code 2UUF(18)). A feasible approach to evaluate the contributions 
from hydrophobic complex formation is to examine the influence of successive ligand 
structural variations on the binding thermodynamics. We systematically varied the P3 
substituent of substrate-analogue peptidomimetics by incorporation of a Gly, D-Ala, D-Val, D-
Leu and a D-Cha to become increasingly more hydrophobic and sterically demanding. To 
study these effects on a broader scope we synthesized two inhibitor series with two 
different S1 occupants (see Table 1). Either, a 2-(aminomethyl)-5-chlorobenzylamide 
(ACB)(19,20) and a 4-amidinobenzylamide (AMBA)(21) anchor are known to be very potent 
binders for the S1 pocket. An experimental approach comprising ITC measurements, kinetic 
characterization and high resolution crystal structure determination was applied to study the 
influence of a stepwise removal of water molecules from the hydrophobic S3/4 pocket of 
thrombin due to variations of the P3 residues.    
  
4.4 Results & Discussion 
4.4.1 Introducing part to the crystal structures 
To systematically probe the replacement of water molecules from a binding pocket by 
crystallographic means requires high resolution crystal structures as the number of observed 
water molecules can suffer from the resolution of the diffraction data.(22)  
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Table 1: Chemical structures of scaffold of the studied ligands in the ACB and AMBA series. The 
designed variants R are given with the kinetically determined inhibition contants (Ki in nM) towards 
human thrombin. 




















1.5 ± 0.1 
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3.7 ± 0.6 
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2.2 ± 0.4 
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0.788 ± 0.070 
8 
 
1.290 ± 0.347 
4 
 
0.259 ± 0.024 
9 
 
0.891 ± 0.115 
5 
 
0.052 ± 0.005 
10 
 
0.119 ± 0.010 
The error is given as the standard deviation calculated from at least three measurements (in nM). 
 
Statistics show that, on average, at 2.0 Å resolution one water molecule per residue is 
included in the model, while at 1.0 Å resolution about 1.6-1.7 are crystallographically 
located. We therefore used synchrotron radiation to achieve the best possible resolution of 
our complex structures. In total, ten crystal structures of human thrombin in complex with 1-
10 were determined with medium to high resolution (1.78-1.23 Å). 
 
4.4.2 Binding mode of the scaffold of the ACB series 
As the derivatives with a Gly P3 residue show completely different binding modes with 
respect to the remaining part of the designed series, we will present their data in a separate 
section. The complex structures of 2 to 5 exhibit a comparable binding mode and the series 
will be exemplified using ligand 2 (Figure 1a). The chlorine atom of the S1 occupant points 
towards the center of Tyr228 with a distance of 4.3 Å which suggests a strong halogen-π 
interaction.(23) The aminomethylene anchor takes remarkable preorganizing influence on the 
overall binding mode as it is involved in strong intra- and intermolecular interactions. It 
hydrogen-bonds to the backbone carbonyl of Gly219 (3.1 Å) and intramolecularly to the 
oxygen atom of the inhibitor’s own sulfonyl moiety (3.2 Å) and to the P2 carbonyl (3.1 Å). 
This binding motif associates a water molecule which mediates an additional contact 
between both moieties. As we assume the primary amino group to be largely protonated at 
the applied pH 7.5 this interaction pattern is supposedly charge assisted. The pyrrolidine ring 
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of proline is accommodated in the S2 pocket capped by Tyr60A and Trp60D of the 60’s loop 
(Figure 1b). The methyl group of the P3-alanine is pointing into the S3/4 specificity pocket. 
The sulfonamide NH group and the adjacent central carbonyl functionality form an 
antiparallel β-sheet-like binding motif to Gly216. This binding feature has already been 
observed in an inhibitor series bearing a terminal amino group at this position.(24) With 
respect to the sulfonyl group one oxygen is engaged in a hydrogen bond to the NH of Gly219 
(3.1 Å) and as mentioned with the aminomethylene anchor (3.2 Å) while the other oxygen is 
pointing towards the bulk solvent. The intramolecularly preorganized binding geometry 
within this ligand series forces the terminal benzyl group to adopt an orientation that largely 
exposes this group to the bulk solvent without additional van-der-Waals contacts since it is 
mostly surrounded by hydrophilic amino acids (Arg221, Glu217, Lys224).  
 
4.4.3 Binding mode of the scaffold of the AMBA series 
The scaffold of ligand 7 will be used to describe the binding features within the AMBA series. 
The AMBA anchor is placed into the S1 pocket to form a salt bridge with short distances (2.9 
and 2.8 Å) to the deprotonated Asp189 at the bottom of this pocket (Figure 1c). The proline 
portion fits perfectly under the 60’s loop of the S2 pocket and the ligand’s central amide NH 
and the adjacent carbonyl function form the above-mentioned β-ladder-type binding motif 
to the backbone of Gly216 with comparable distances (3.1 and 2.9 Å, Figure 1d). The sulfonyl 
takes a different role in this inhibitor series. It forms a short hydrogen bond (3.0 Å) to the 
backbone carbonyl of Gly219. In contrast to the ACB series, we could not observe any 
intramolecular hydrogen bonds in the AMBA examples. The lack of the aminomethylene 
anchor is most likely responsible for a different positioning of the terminal benzyl portion. It 
orients in opposite direction compared to the ACB series and it is now able to form a strong 
hydrophobic interaction to one of the sulfur atoms of a disulfide bridge (3.7 Å). A van-der-
Waals contact is found to the carboxyl group of Glu192 with a distance of 3.6 Å. Additionally, 
strong intramolecular hydrophobic contacts are observed between the terminal benzyl 
moiety and the phenyl ring of the AMBA (3.6 Å) and the inhibitor’s own P2 carbonyl oxygen 
(3.3 Å). The U-shaped inhibitor conformation most likely results from a hydrophobic 
collapse. It is worth mentioning that the flexibility of the Glu192  side chain is strongly 
reduced as the adjacent benzyl moiety restricts its accessible conformational space. In this 




series only one single Glu192 conformer is observed, whereas it is disordered in many other 
thrombin complexes.(25)   
 
Figure 1: The binding modes of ligands 2 and 7 are shown. (a, c) The main focus is on the 
preorganizing interactions between the aminomethylene and the sulfonyl group in 2 (a) and on the 
interaction pattern near the disulfide bond in 7 (c). (b, d) The binding mode of ligands 2 (b) and 7 (d) 
in complex with thrombin is shown with the protein’s solvent-accessible surface. Colors are assigned 
to all atoms in (b) and (d) according to their temperature factors, from blue (low B-factor) to green 
and to red (high B-factor). Nitrogen is shown in blue, chlorine in green, sulfur in orange, oxygen in 
red and carbon in yellow (ligand site) and cyan (protein site). The distances are indicated in Å.  
a)  molecular interactions in complex with 2               b)  in complex with 2 with protein surface 
    
c)  molecular interactions in complex with 7                        d)  in complex with 7 with protein surface 
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4.4.4 Crystallographic tracing of displacement of water molecules and implications on the 
binding affinity in the ACB series 
In the following, focus will be attributed to the displacement of water molecules from the 
S3/4 pocket. Ligand 2 with P3 D-Ala leaves the hydrophobic pocket well hydrated as the 
methyl group penetrates only slightly and does not reach the hydration shell (Figure 2a). The 
distance of the methyl group to the closest water molecule is 4.0 Å. Interestingly, the water 
network in this pocket shows remarkable features: The most deeply buried water molecule 
is bound to the backbone carbonyl of Asn98 (2.9 Å) and it is oriented towards the center of 
the indole moiety of Trp215 (3.1 Å) to form a polar π-interaction(26). The neighbouring water 
molecule is rather losely bound to the protein site (3.4 Å to Glu97A) and it is fixed in position 
by the two flanking water molecules (2.9 Å each). The third water is located close to the rim 
of the pocket and interacts with the hydroxyl group of Tyr60A (2.9 Å). Besides one van-der-
Waals contact to a carbon of Trp215 (4.2 Å) the P3-methyl group is not able to form any 
further interactions to the hydrophobic S3/4 binding pocket. Nevertheless, 2 exhibits a 
binding affinity of Ki = 2.2 ± 0.4 nM although no strong interactions with the pocket residues 
are experienced and no water displacement could be observed. 
Replacement of the P3 methyl side chain in 2 by a larger isopropyl group in 3 changes little 
the ligand’s conformation (Figure 3). Hardly any modifications of the solvation pattern of the 
S3/4 pocket are apparent (Figure 2b). Obviously, the P3 D-Val seems to be too small to 
disrupt the S3/4 water network. The isopropyl group forms here a contact with CD1 of Ile174 
(4.0 Å). Suprisingly, the isopropyl group does not point into the pocket but to the bulk 
solvent. This reorientation provokes a shift of the center of the terminal benzyl moiety by 1.5 
Å compared to that in 2 (Figure 3). This movement is required to preserve a close contact 
between isopropyl group and benzyl moiety (now 3.9 Å). Furthermore, this slighly changed 
benzyl position induces the carboxyl group of Glu217 to adopt an orientation also found in 
the apo structure of thrombin whereas in the complex with 2 the carboxyl group is rotated 
by approximately 90° to allow binding of the benzyl portion (Figure 3). Compared to 2 no 
additional water molecule is displaced, the improved affinity (Ki = 0.788 ± 0.070 nM) by a 
factor of 3 might be related by the formation of two additional van-der-Waals contacts. 
The D-Val/D-Leu exchange at P3 reveales some interesting binding features with disordered 
molecular portions either on the side of the protein and ligand (see Figure 2c). The P3 
isobutyl side chain could be refined in two orientations with conformation A (occupancy: 58 




%) inside and B (occupancy: 42 %) outside the pocket. Conformation B induces a second 
orientation of Ile174 preventing too close contacts with the inhibitor.  
Two populated water sites can be detected in the S3/4 pocket. They would be too close to 
conformation A (distance of 2.3 and 2.1 Å) and refinement of these water sites with full 
occupancy resulted in negative density (σ = 4.5). This encouraged us to refine these sites 
with partial occupancy as the water molecules can only be present in unit cells hosting 
conformation B.  
Refinement of the latter water model with an occupancy of 42 % revealed no difference 
electron density. The observed disorder of the P3 D-Leu portion is therefore most likely 
correlated to the residual hydration of the S3/4 pocket. Despite the overall hydrophobic 
character of the S3/4 pocket a perfect interaction network among the waters and to the 
protein is formed. In consequence, a significant energetic price of desolvation has to be paid 
for this well hydrated subsite, which has to be compensated by the binding of 4. Apparently, 
as a compromise, disorder is observed where in about half of the cases the S3/4 binding 
pocket remains solvated. Interestingly, in a previous contribution we showed a similar 
example with partial replacement of water molecules upon ligand binding in case of the S1 
pocket of thrombin.(5) In the present case, we assume on average replacement of one water 
molecule from the S3/4 pocket upon binding of 4. The kinetic measurement revealed a 
binding affinity of Ki = 0.259 ± 0.024 nM which is by a factor of 3 stronger than the affinity of 
the D-Val derivative 3 for which no water displacement has been observed.  
The exchange of D-Leu by D-Cha in 5 showed significant changes of the S3/4 water network 
with displacement of two water molecules (Figure 2d). Only one water molecule at the 
border of the pocket is still retained and it appears to be tightly bound to Tyr60A (2.8 Å). 
Detailed structural analysis shows remarkable van-der-Waals interactions between the 
cyclohexyl ring adopting chair conformation and the protein subsite. The contact distance to 
Trp215 is 3.6 Å and to Ile174 4.2 Å. Interestingly, we could not define two conformations for 
the sidechain of Ile174 as observed with 4. We assume a disfavored conformation as that is 
not observed in the apo structure and in complexes with 2 and 3. Some close contacts (3.4 
Å) are experienced by C-H vectors at the cyclohexyl ring and the carbonyl backbone of 
Glu97A or the hydroxyl group of Tyr60A.  
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Figure 2: Binding modes of the ligands with the ACB anchor group emphasizing the structural 
changes in the S3/4 region and in the ligand‘s P3 position. The Fo-Fc difference electron density is 
shown in green at 2σ  for inhibitor 2 (a), 3 (b), 4 (c) and 5 (d) together with the bound water 
molecules in the S3/4 pocket if present. Favourable interactions with the corresponding distances in 
Å are depicted with broken lines. Values in red indicate short distances found for the specific atom 
which is mentioned in the text. Nitrogen is shown in blue, chlorine in green, sulfur in orange, oxygen 
in red and carbon in yellow (ligand site) and white (protein site). Water molecules are red spheres. 
a) in complex with 2                        b) in complex with 3  
   
c) in complex with 4           d) in complex with 5 









Figure 3: Superposition of ligand 2 and 3 to emphasize the shift of Glu217 and the movement of the 
benzyl portion of ligand 3. Colors are assigned to all atoms according to their temperature factors, 
from blue (low B-factor) to green and to red (high B-factor). The solvent-accessible surface is shown. 
The distances with broken lines are indicated in Å. 
 
 
Most likely the displacement of two firmly bound water molecules and the extensive 
hydrophobic contacts to the P3 cyclohexyl side chain result in a further 5-fold improved 
affinity (Ki = 0.052 ± 0.005 nM) compared to 4. The overall binding affinity was improved 42-
fold from 2.2 nM for 2 to 0.052 nM for 5.      
 
4.4.5 Crystallographic tracing of the displacement of water molecules and implications on 
the binding affinity in the AMBA series 
Using the AMBA series, we wanted to confirm the water displacement from the S3/4 pocket 
and study whether the different orientation of the terminal benzyl moiety takes any impact 
on the interaction pattern in the hydrophobic S3/4 pocket. Unfortunately, it turned out that 
the displacement of the water molecules could not be analyzed directly. As expected, the D-
Ala derivative 7 orients its P3 methyl group into the S3/4 pocket. However, to our surprise 
the remaining active site is filled by an additional inhibitor molecule showing 54 % 
occupancy (Figure 4a). In this case, the benzylsulfonyl portion of the second ligand fits 
perfectly into the S3/4 pocket resulting in partial desolvation. In agreement with the partial 
occupancy of this second ligand, the diffraction data indicate at a position nearly coinciding 
with the benzyl moiety (1.3 Å) a density peak which suggests a partially occupied water 
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molecule as a remainder of  the above described water network (Figure 5a). Occupancy of 
this water molecule was refined with 46 % population indicating its presence solely in 
absence of the second bound ligand. The hydrophobic portion of this extra ligand exhibits 
pronounced van-der-Waals contacts (3.3 Å to 3.6 Å) with hydrophobic residues in the active 
site. The sulfonyl group shows an intramolecular hydrogen bond (3.3 Å) to the NH group of 
its P2-P1 amide bond. The D-Ala and L-Pro portions are solvent exposed with no remarkable 
interactions to the protein. The positively charged amidino function is weakly hydrogen 
bonded (3.2 Å and 4.0 Å) to the sulfonyl part of the fully populated ligand. The overall 
geometry adopted by the extra ligand resembles also a U-shaped conformation. We checked 
whether any crystal packing effects could account for this unexpected crystallographic 
result. However, we could not detect any further hydrogen bonds to a symmetry-related 
protein molecule. The closest contact was found between the methyl group of the D-Ala 
portion and Glu13 of a neighbouring crystal mate exhibiting rather large distance of 5.4 Å. 
Ligand 7 posseses comparable potency (Ki = 5.2 ± 0.8 nM) as the corresponding D-Ala 
derivative of the ACB series. 
The D-Val derivative 8 reveals the same behaviour also exhibiting two inhibitor molecules in 
the active site (Figure 4b). The isopropyl group of the first fully populated ligand points 
towards the S3/4 pocket. Also here the solvation pattern of this pocket is difficult to define 
due to the presence of a second inhibitor molecule. The binding modes of both ligands show 
similiarity to the previously described case. The extra ligand refines to an occupancy of 42 % 
and the adjacent water sites converge to 58 % occupancy (Figure 5b). All contacts found for  
8 compare well with whose detected for 7 whereas the binding affinity of 8 is increased by a 
factor of 3 to Ki = 0.788 ± 0.070 nM.   
For the D-Leu derivative 9 we receive an even more complex situation in the S3/4 pocket 
(Figure 4c). Again, two inhibitor molecules are found in the binding site. The first ligand is 
fully populated and well defined. The difference electron density suggests very similar 
binding mode in line with the other members of the series. In contrast, the electron density 
of the second extra-bound ligand is poorly defined and we could only include the 
benzylsulfonyl part in our refinement model.  
 
 




Figure 4: Binding modes of the ligands with the AMBA anchor group. Especially, the structural 
changes in the S3/4 region and in the ligand‘s P3 position are emphasized. The Fo-Fc difference 
electron density is shown in green for the fully populated and in blue for the partially populated 
ligand at 2σ  for 7 (a), 8 (b), 9 (c) and 10 (d) together with the bound water molecules in the S3/4 
pocket if present. Favourable interactions with the corresponding distances in Å are depicted with 
broken lines.  
a) in complex with 7                                      b) in complex with 8 
   
c) in complex with 9            d) in complex with 10 
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Figure 5: View from top on the S3/4 pocket to show close water contacts. The Fo-Fc difference 
electron density is shown in green for the fully populated and in blue for the partially populated 
ligand at 2σ for 7 (a) and 8 (b) together with the bound water molecule in the S3/4 pocket. 
Favourable interactions with the corresponding distances in Å are depicted with broken lines. Values 
in red indicate short distances found for the specific atoms. 
a)                            b)   
    
 
The D-Leu side chain of the fully populated ligand of 9 is scattered over two conformations, 
each populated by 50 %. The orientation outside the S3/4 pocket would allow binding of the 
second extra ligand forming the double hydrogen bond between the amidino group and the 
SO2 group of the first molecule. Most likely, the orientation inside the pocket further reduces 
the occupancy of the extra ligand resulting in its minor population. In consequence, solely 
the benzylsulfonyl moiety could be assigned to the difference electron density. Inhibitor 9 
has a slightly improved affinity likely due its larger P3 residue (Ki = 0.891 ± 0.115 nM for 9).  
The cyclohexyl portion of 10 is large enough to fully occupy the S3/4 pocket. It completely 
disrupts the water network concomitantly displacing two water molecules from the S3/4 
pocket (Figure 4d). This ligand binds only with one copy to the active site. As no space 
remains in S3/4 pocket, no extra ligand binding is indicated. 10 proved to be the strongest 
binder in the AMBA series with an affinity of Ki = 0.119 ± 0.010 nM. The increasing 
hydrophobicity from methyl to cyclohexyl improved the affinity by a factor of 40. This is 
consistent with the first series. In general, the ACB inhibitors are always slightly more potent 
than the corresponding AMBA derivatives despite the lack of the salt bridge to Asp189. 
 




4.4.6 Comparison of the binding mode of the second additionally bound ligand to the 
natural substrate of thrombin 
Thrombin has a central role in blood coagulation. After activation from inactive prothrombin 
(II) to active thrombin (IIa), it converts soluble fibrinogen to insoluble fibrin which becomes 
crosslinked by factor XIIIa to form a stable clot.(27) Upon activation of the fibrinogen α-chain 
the fibrinopeptide A (FPA), which is composed of 16 amino acids (ADSGEGDFLAEGGGVR), is 
cleaved off. Three crystal structures of human or bovine thrombin have been determined in 
complex with FPA or slightly modified analogs.(28-30) Superposition of both inhibitor 
molecules of 8 with a FPA-analog (Figure 6) shows impressively that our bound ligands map 
well the binding geometry of the FPA in complex with thrombin. In early days of thrombin 
research it was a surprise that FPA binds with its P9 Phe into the S3/4 pocket. It then leaves 
the cleavage site, forms a loop of 6 residues (Leu9-Gly14) to return with its Val residue 
(Val15) into the S2 pocket. The second extra ligand in our study binds similarly with its benzyl 
portion to the S3/4 specificity pocket and the loop of FPA bulging out of the site is traced by 
the ligand’s remaining parts.  
 
4.4.7 Crystal structure analysis of the Gly derivatives 1 and 6 
The Gly derivatives 1 and 6 of both series exhibit a different binding mode compared to the 
Cα substituted examples. For 1 and 6 the geometry of the respective S1 occupants and the 
central proline are consistent with all other members of the series. Differences occur at P3 
and involve the terminal benzylsulfonyl moiety. The latter hydrophobic portion is used to 
occupy the S3/4 pocket which results in the displacement of two water molecules as 
similiarly observed for the cyclohexyl derivatives 5 and 10 (Figure 7a). The altered binding 
mode of 1 requires that the intramolecular water-mediated H-bond between the sulfonyl 
oxygen and the P1 aminomethylene anchor (present in 2-5) is sacrified. The aromatic ring of 
the terminal benzylsulfonyl moiety in 1 orients nearly perpendicular to the indole ring of 
Trp215 with a distance of 3.5 Å. Ile174 adopts a single conformation and rotates out of the 
pocket to avoid close contact with the benzyl moiety (3.8 Å).  
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Figure 6: Stereo view of the active site region of thrombin in complex with the double-bounded ligand 8 and a FPA analog (PDB code 1UCY(28)) containing a 
stable ketomethylene group (Argψ*CO-CH2]Gly) instead of a scissile P1-P1’ peptide bond. The solvent-accessible surface of thrombin is depicted in grey. 
Nitrogen is shown in blue, sulfur in orange, oxygen in red and carbon in yellow for ligand 8 and in cyan for the FPA derivative. 
 




Figure 7: Binding mode of the glycine derivatives 1 (a) and 6 (b). The Fo-Fc difference electron density 
is shown in green at 2σ. Favourable interactions with the corresponding distances in Å are depicted 
with broken lines.  
a) in complex with 1             b) in complex with 6 
         
 
Both sulfonyl oxygens are exposed to the solvent. Despite of the displacement of two water 
molecules from the S3/4 pocket and remarkable van-der-Waals contacts, the Gly derivative 
1 exhibits no significant gain in binding affinity (1.5 ± 0.1 nM) compared to the D-Ala analog 2 
where the pocket is completely solvated.  
The AMBA analog 6 adopts a comparable binding mode (Figure 7b). Again its benzylsulfonyl 
portion is located in the S3/4 pocket and the sulfonyl oxygens are oriented towards the bulk 
solvent. Also this ligand exhibits nearly the same affinity as the D-Ala analog (3.7 ± 0.6 nM for 
6).  
 
4.4.8 Thermodynamic characterization of the hydrophobic interaction in the S3/4 pocket 
of thrombin 
We used Isothermal Titration Calorimetry (ITC) to determine the thermodynamic profiles of 
both series, and to factorize Gibbs free energy of binding into enthalpic and entropic 
components. ITC is usually restricted to a range up to 5 nM using direct titrations. However, 
inhibitors investigated in this study show high potency from nano to picomolar range. In 
such situations direct measurements of tight binders is not possible and we therefore 
decided to apply displacement titrations to attain an accurate thermodynamic profile. 
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Hence, the dissociation constant of the strong binder must be formally lowered to a range 
which can be recorded accurately by ITC.(31) In the displacement strategy, the protein 
solution is saturated by a „weak“ binder such as 11 or 12 (Table 2). In the following step the 
tight binder is titrated into the protein solution saturated by the first ligand (see Material & 
Methods for details). During this titration the „weak“ binder is displaced by the strong one 
and the resulting sigmoidal titration curve can be analyzed according the displacement 
theory developed by Sigurskjold(32).  
 
Table 2: The chemical structures used in the displacement titration as competitive binder together 
with the thermodynamically determined dissociation contants (KD in nM) towards human thrombin.  
Competitive Ligand 1 (11) 
 
232 ± 48  
Competitive Ligand 2 (12) 
 
255 ± 16 
The error is given as the standard deviation calculated from at least three measurements (in nM). 
 
The measured heat signals showed dependence on the three buffers applied for the 
titrations (Table 3). This indicated protonation reactions superimposed onto the binding 
event. The net binding enthalpy can be extracted from these titrations by extrapolation 
(Figure 8). We observed comparable dependencies for all studied ligands suggesting a 
release of n = 0.43 ± 0.12 mol protons upon binding (Fig. 9). For a related series of ligands 




showing similar effects, Baum et al.(25) pointed out that His57 is responsible for the observed 
buffer dependency. As the functional groups in our ligands that could change protonation 
state (amidino group, aminomethylene group, sulfonamide group) are either too basic or 
very close to neutral pH, we anticipate that no ligand functional groups are involved in the 
protonation changes. Therefore, more likely the imidazole moiety of His57 is partially 
protonated in the uncomplexed state and releases protons upon ligand accommodation.(33) 
After buffer correction, factorization of the Gibbs free energy shows increasingly entropy-
driven binding which is consistent with the classical hydrophobic effect. The D-Ala derivative 
2 reveals a thermodynamic profile which is clearly dominated by its enthalpic component 
(ΔH = - 32.1 kJ/mol for 2). The entropic contribution amounts to about the half of the 
enthalpy term (- TΔS = - 15.1 kJ/mol for 2). With growing size of the hydrophobic P3 
substituent we observe a constant increase of the entropic component and a slight decrease 
of the enthalpic signal. This thermodynamic signature is reversed from an enthalpy- to a 
more entropy-driven binding as larger hydrophobic portions are introduced at P3. Ligand 5 
with largest hydrophobic portion binds with a balanced thermodynamic profile where both, 
the enthalpy and entropy term, contribute almost equally to binding affinity (ΔH = - 28.7 
kJ/mol and - TΔS = - 25.8 kJ/mol for 5). In our series we observe a slight overall decrease of 
enthalpy (ΔΔH2-5 = - 3.4 kJ/mol) however, fortunately the entropy term overcompensates 
this enthalpy loss (– TΔΔS2-5 = 10.7 kJ/mol). Therefore, a net gain in Gibbs free energy could 
be observed of ΔΔG2-5 = 7.3 kJ/mol.  
 
4. A stepwise disruption of a water network 
93 
 













- TΔS0 (kJ/mol) Number of 
proton release 
(mol/mol) 
1 - 47.8 ± 0.1 - 59.3 ± 1.3 - 50.5 - 46.1 - 35.4 - 12.4 0.49 
2 - 47.2 ± 0.9 - 54.2 ± 0.6 - 49.6 - 40.9 - 32.1 - 15.1 0.48 
3 - 54.2 ± 0.2 - 61.5 ± 0.7 - 51.6 - 47.7 - 36.2 - 18.0 0.52 
4 - 54.3 ± 1.4 - 55.9 ± 1.9 - 47.5 - 41.3 - 30.1 - 24.2 0.54 
5 - 54.5 ± 0.1 - 50.6 ± 0.1 - 38.8 - 39.8 - 28.7 - 25.8 0.43 
6 - 44.9 ± 1.1 - 41.9 ± 0.1 - 32.7 - 26.3 - 14.3 - 30.6 0.58 
7 - 42.6 ± 0.2 - 26.9 ± 0.5  - 20.6 - 21.6 - 15.9 - 26.7 0.21 
8 - 47.1 ± 0.1  - 35.0 ± 1.0 - 27.7 - 23.1 - 13.8 - 33.3 0.44 
9 - 51.9 ± 1.0 - 28.4 ± 2.3 - 23.5 - 17.9 - 10.4 - 41.5 0.38 
10 - 53.7 ± 0.8 - 24.9 ± 0.1 - 19.3 - 17.7 - 11.4 - 42.3 0.27 
11 - 37.9 ± 0.5 - 17.1 ± 1.1 
 
  - 20.8 ± 1.7  
12 - 37.6 ± 0.2 - 37.5 ± 0.1 
 
  - 0.1 ± 0.2  
Ligands 1-10 were determined in a displacement titration using ligands 11 or 12 as competitive binder. The thermodynamic data of 11 and 12 were determined in a direct 
ITC titration in tris buffer. ΔH0 was measured in three different buffers. Errors indicate the standard deviation from at least duplicate measurements. Since the one point 
measurements in hepes and tricine indicate the expected constant rate of proton release, these experiments were not performed in duplicate in order to save protein 
material (Figure 8). 




Figure 8: The measured heat signal is plotted against the ionization enthalpy of the buffer system 
(Tris, hepes and tricine) in order to extract the enthalpy of binding. The circles represent the values 
from the ACB series (1-5) and the squares the ligands from the AMBA series (6-10). 
 
 
Comparable results are observed for the AMBA series, however the thermodynamic 
signature starts from a different partitioning (Figure 9b). Here, the entropy term clearly 
governs the binding across the entire series (ΔH = - 15.9 kJ/mol and - TΔS = - 26.7 kJ/mol for 
7). 6 falls out of the series, but from 7 to 10 the entropic influence gradually increases during 
hydrophobic optimization, consistent with the findings in the ACB series. The entropic 
component of 10 is about four times the enthalpic signal (ΔH = - 11.4 kJ/mol and - TΔS = - 
42.3 kJ/mol for 10) but the entropic enhancement is comparable to the ACB series. Again, 
we experience a slight decrease in the enthalpic term (ΔΔH7-10 = - 4.5 kJ/mol) overbalanced 
by a huge favorable entropic contribution (– TΔΔS7-10 = 15.5 kJ/mol).  
The Gly derivatives 1 and 6 adopt quite different binding modes compared to the remaining 
examples of the two series. Surprisingly, this is not reflected in the thermodynamic profiles, 
as those for 1 and 6 fit quite reasonably into the series. Therefore a closer comparison of the 
corresponding Gly and D-Ala derivatives should be regarded. Although 1 displaces two water 
molecules from the S3/4 pocket, we could only observe overall a sligthly increased entropy 
component (– TΔΔS1-2 = 2.7 kJ/mol) and basically no impact on the Gibbs free energy (ΔΔG1-2 
= - 0.6 kJ/mol) in comparison to 2. As both ligands position their benzyl moieties differently, 
we must consider whether a displacement of water molecules might occur at the hydrophilic  
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Figure 9: Thermodynamic parameters determined by ITC for ligands 1-5 (a) and 6-10 (b). The buffer 
corrected enthalpy terms are  shown.   
a)                        ACB series                                                            
 








site next to Glu217, Lys224 and Arg221 which is occupied in case of 2. 1 is able to desolvate 
the S3/4 pocket but leaves the adjacent Glu217/Lys224/Arg221 region solvated (Figure 10a). 
In contrast, ligand 2 leaves the S3/4 pocket solvated but disrupts the solvation shell in the 
neighboring Glu217/Lys224/Arg221 region through accommodation of the benzyl portion 
(Figure 10b). Due to its polar character this site is well solvated and the crystal structure of 1 
leaving this area unoccupied does show here six bound water molecules whereas in 2 only 
three water molecules are present. Possibly the water replacement in different subpockets 
observed for 1 and 2 might result in very similar thermodynamic signature. Furthermore, we 
observe a difference in the residual mobility of the benzyl portions of 1 and 2 which should 
also influence the entropic term. We analyzed the B factor ratio’s of the benzyl portions 
relative to the remaining inhibitor molecules in order to estimate the degree of mobility. The 
benzylsulfonyl group of 1 exhibits low mobility [B (benzyl)/B (P1+P2+P3) = 1.26] as it is 
tightly fixed in the S3/4 pocket whereas in 2 this portion shows substantially higher mobility 
[B (benzylsulfonyl)/B (P1+P2+P3) = 2.06]. This enhanced motion of the benzylsulfonyl portion 
is a common structural feature of 2-5 (1.90 for 3, 1.69 for 4 and 1.77 for 5). The polar region 
next to Glu217/Lys224/Arg221A (Figure 3) is structured as a rather shallow crevice which is 
not suited to perform strong interactions with benzyl portion at this protein site. As a 
consequence, we observe this portion with pronounced residual mobility.  
A similar situation is observed for 6 and 7. Two water molecules are released to the bulk 
solvent by 6 but now with a slight advantage with respect to the entropy (– TΔΔS6-7 = - 3.9 
kJ/mol). This parallels a small loss in the free energy term (ΔΔG6-7 = - 2.3 kJ/mol). 
Unfortunately, we can not discuss the hydration of the binding pocket as done in 1/2 
because the second bound ligand molecule in the AMBA series prevents detailed insights. 
Suprisingly, the study of the B factor ratio’s for the benzylsulfonyl portions reveals in this 
series equivalent values suggesting equal mobility [B (benzyl)/B (P1+P2+P3) = 1.58 for 6 and 
B (benzyl)/B (P1+P2+P3) = 1.51 for 7]. All benzylsulfonyl moieties placed in this region next 
to the disulfide bridge reveal less mobility compared to the corresponding examples of the 
ACB series. It shows that the vicinity to the disulfide bridge fixes the benzyl portion in 7 
better than the polar environment of Glu217/Lys224/Arg221A in 2 (Figure 1b and d). This 
positioning of the phenyl ring is also known from inhibitor complexes with the related serine 
proteases factor Xa(34) and urokinase(35).  
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As a further aspect, that will affect the partitioning of enthalpy and entropy of the Gly and D-
Ala derivatives, the conformational properties in solution has to be considered. The Gly 
derivative which lacks a Cα substituent will gain access to a larger conformational space in 
solution prior to protein binding compared to the D-Ala example. This will be related to a 
stronger loss in the entropic position of the Gly derivatives upon binding. This might 
compensate to some degree for the entropically beneficial water release and make the 
entropic signal less pronounced for 1 and 6.  
 
Figure 10: Binding mode of 1 (a) and 2 (b). The 2Fo-Fc contour electron density is shown in blue at 1σ 
for water molecules. Favourable interactions with the corresponding distances in Å are depicted with 
broken lines.  
a) in complex with 1           b) in complex with 2 
   
 
4.5 Conclusion           
We performed a comprehensive study on water displacement upon binding of hydrophobic 
ligand portions to thrombin’s well hydrated S3/4 pocket. We wanted to collect evidence for 
thermodynamic signature that drives the effect. Several studies in literature showed that 
hydrophobic interactions are much more complex than generally believed as in some 
examples the binding of hydrophobic species is accompanied with a clearly favorable 
enthalpy component instead of the expected entropy signal. As two studies(14,15) propose 
that a poorly defined hydration state of the protein pocket could be an explanation for an 
enthalpy-driven hydrophobic effect, we decided to address a hydrophobic pocket which is 




according to a high-resolution structure of uncomplexed thrombin well hydrated and 
accessible to water molecules. Additionally, the study was performed with pico to 
nanomolar ligands which is in terms of thermodynamic characterization still a rather rarely 
explored field. The applied displacement titration are elaborate as two titrations are 
necessary but the results are reliable and well reproducible. 
Two series with different S1 occupants were designed and synthesized which were 
systematically varied by hydrophobic residues (Gly, D-Ala, D-Val, D-Leu and D-Cha) in the P3 
position addressing the S3/4 pocket. In both series the affinity improvement is correlated 
with the size of the hydrophobic P3 side chain except the Gly inhibitors. The largest P3 
substituent, D-Cha, shows highest affinity whereas D-Ala in this position is in both series the 
weakest binder. The ACB series was optimized by a factor of 42 which is similar to the factor 
obtained in the AMBA series (40).  
As mentioned in the introduction, the ACB anchor is well known to show high potency 
towards thrombin but we found only two deposited thrombin complexes with this type of 
ACB anchor group (PDB codes 1ZRB36 and 3EQ0). These sparse structural data are quite 
surprising since the ACB portion is high potent and less basic which may lead to even better 
pharmacokinetic properties.(20) In order to better understand the superior properties of this 
portion we elucidated the structural and energetic basis for the high potency of the ACB 
anchor group which turned out in our study to possess always slightly better binding 
compared to the corresponding AMBA anchor.       
We observed a significant change in the binding mode of the P4-P3 segment moving from 
the Gly derivatives to Cα substituted residues. The Gly derivatives 1 and 6 occupy the S3/4 
pocket and displace two water molecules whereas the corresponding D-Ala analogs 2 and 7 
do not penetrate this pocket and leave it solvated. Suprisingly, no significant differences in 
the thermodynamic profile of these ligands are observed indicating that unchanged 
thermodynamic signature is by no means a reliable indicator for conserved binding modes. 
The most likely experienced beneficial entropic contributions resulting from water 
displacement by 1 and 6 are compensated as another site remains hydrated, differences in 
the residual mobility of the alternatively placed positions are experienced and differences in 
the accessible conformational space in solution prior to binding have to be taken into 
account. 
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The structural investigation of the AMBA series revealed some surprising results. To the best 
of our knowledge it is the first reported case where a small size peptidomimetic is bound 
twice to the active site of thrombin. Superimposing the binding modes of both inhibitor 
skeletons with that of the cleavage product (FPA) of the natural substrate (Fibrinogen) 
revealed remarkable similarities with their binding regions. It is worth mentioning that the 
soaking procedure was carried out at rather high inhibitor concentrations. Since we could 
not find evidence that the binding of the second extra ligands is only supported by crystal 
packing effects, possibly this additional binding mode could also be of some relevance in 
solution when working with high inhibitor concentration. Nevertheless, we assume the 
observed second bound molecule is of no relevance for enzyme inhibition under in vivo 
conditions. Interestingly, it can provide a remarkable mapping of the substrate recognition 
area on the surface of the protease. 
The thermodynamic characterization clearly suggests that the stepwise increase of the 
hydrophobic P3 substituent results in a growing potency which is associated with an 
enhanced entropic term. Both series started out with the Gly/D-Ala derivatives having the 
smallest entropic contribution and end up with the cyclohexyl derivative with a 
thermodynamic profile, remarkably dominated by its entropic component. In this respect, 
our results support the current understanding of the classical hydrophobic effect being 
mainly of entropy driven nature and resulting from the release of firmly fixed water 
molecules from a well-hydrated pocket.  
 
4.6 Acknowledgements 
We kindly acknowledge CSL Behring, Marburg, for supplying us with generous amounts of 
human thrombin from the production of Beriplast®.  
We thank the beamline support staff at SLS and BESSY for their advice during data collection. 
This work was supported by the Bundesministerium für Bildung und Forschung (BMBF, 
Förderkennzeichen 0315161C) and by the ERC grant 268145-DrugProfilBind kindly provided 








4.7 Materials and Methods 
4.7.1 Bioassay  
We characterized the potent inhibitors by a fluorogenic assay. Kinetic data were obtained 
using Tos-Gly-Pro-Arg-AMC(37) (tosyl-Gly-Pro-Arg-aminomethylcoumarin) as the fluorogenic 
substrate with a Safire II platereader (Tecan, Schweiz, ex = 380 nm, em = 460 nm). This 
substrate allows us to work at a protein concentration of 0.050 nM which is sufficiently 
lower than the lowest applied ligand concentration (0.780 nM). The experimental buffer 
contained 50 mM Tris-HCL, 154 mM NaCl, 0.1 % polyethylene glycol 8000 and 5 % DMSO at 
pH 7.4. The Km of the substrate (1.1 ± 0.4 μM) was measured at ten different substrate 
concentrations and the resulting curve was analyzed using GraFit 4 software(38). Cleavage of 
the substrate was measured by monitoring the change in fluorescence over a dilution series 
of at least ten inhibitor concentrations (500 nM – 0.780 nM) at 5 μM substrate (S) over 600 
sec. The fluoroscence signal was plotted against time and after linear regression the reaction 
rates (ν) were calculated. The latter values (ν) were plotted against the respective inhibitor 
concentration (I) and the resulting curve was fitted with ORIGIN software using equation 1. 
All measurements were performed at least in triplicate.  
 Equation 1 
4.7.2 Isothermal titration calorimetry 
ITC experiments were performed using an ITC200™ system from Microcal (now part of GE 
Healthcare, Northhampton, MA, USA).  Thrombin Beriplast® was freshly prepared for each 
experiment by dialysis of a thrombin sample in the buffer used for titration experiments (50 
mM Tris, 100 mM NaCl, 0.1 % polyethylene glycol 8000, 3 % DMSO, pH 7.8). The ITC 
displacement experiment is composed of two titrations. The first experiment was done with 
one of the “weak-binding” ligands in a typical direct titration. For this purpose, after dialysis 
the final 11 or 12 concentration was achieved after dilution of the stock solution (40 mM, 
100 % DMSO) to the required ligand concentration (0.5 mM). The final DMSO concentration 
was subsequently adjusted to 3 %. This titration was started after the syringe was placed in 
the sample cell containing the thrombin solution (27 μM). The collected data were analyzed 
using ORIGIN Software (Microcal Inc.), by fitting a single-site-binding isotherm that yields 
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ΔH0 (enthalpy of binding) and KD (dissociation constant). These data represent the 
thermodynamic profiles of the “weak-binding” ligands which are important for further 
analysis of the strong binders. After this first direct titration the syringe was cleaned and 
filled with a solution of a strong binder (0.5 mM). The syringe was then placed into the 
sample cell which now contains the thrombin solution saturated with the “weak-binding” 
ligand from the first titration. During the titration the strong ligand displaced step-by-step 
the “weak-binding” ligand from the binding pocket of thrombin. The experiment was 
stopped after small peaks of dilution indicated complete displacement of the “weak-binding” 
ligand from the binding site by the strong binder. The resulting curves were then analyzed 
using the competitive binding fitting function implemented in the ORIGIN Software which 
was originally developed by  Sigurskjold(32). Each strong binder was characterized by this 
protocol applying two titrations in tris buffer. These experiments were performed at least in 
duplicate.  
ITC experiments in different buffers indicate a protonation reaction upon binding of the 
strong binders. The thermodynamic data were thus collected in addition to tris buffer in 50 
mM tricine and 50 mM hepes buffer in a direct titration to achieve just the enthalpy 
component. Since these one point measurements indicate the expected constant rate of 
proton release these experiments were not performed in duplicate in order to save protein 
material. The observed enthalpy values were plotted against the enthalpy of ionization of 
the applied buffer and fitted by linear regression to determine the intersection point with 
the y axis which represents the enthalpy of binding corrected by the buffer contribution 
(Figure 8). 
All ITC experiments were started at 25 °C after a stable baseline had been achieved. The 
experimental design comprises an initial ligand injection of 0.3 μL followed by 15 injections 
of 1.1 - 1.4 μL with a 180 s interval between each injection. 
Raw data were collected and the area under each peak was integrated, followed by 
correction for heats of dilution and mixing by subtracting the final baseline consisting of 
small peaks of the same size to zero. The initial data point was deleted from the integrated 
data because this injection usually reflects an erroneous amount of heat due to the possible 
exchange of liquids between syringe and cell when inserting the syringe into the calorimetric 
cell and the backlash error in the motorized screw mechanism in the injector.(39) 
 




4.7.3 Crystallization and soaking 
Human α-thrombin (from Enzyme Research Laboratories, South Bend, USA) was dissolved in 
the crystallization buffer (20 mM NaH2PO4, 350 mM NaCl, 2 mM benzamidine, pH 7.5) at 10 
mg/ml. A hirudin fragment called Acetyl-Hirudin (54-65) achieved from Bachem (Bubendorf, 
Switzerland) was dissolved in crystallisation buffer at 2.5 mg/mL. In the next step, 40 μL of 
the solution of the hirudin fragment was mixed with 160 μL of the thrombin solution. After 
incubation for 2 h at 4 °C, crystallization was carried out at 4 °C by the hanging-drop method. 
One 1 μL of the hirudin/thrombin solution was placed in the centre of a cover slip and mixed 
with 1 μL reservoir solution (20 mM NaH2PO4, 27 % polyethylene glycol 8000, pH 7.5). 
Immediately after the mixing of protein and reservoir buffer microseeding was done. The 
wells of the crystallization trays were filled with 500 μL of the reservoir buffer. Subsequently 
the cover slips were placed over the wells and sealed. Crystals of good diffracting quality 
were obtained after 7 days. For soaking, DMSO stock solutions of the inhibitors (50 mM) 
were diluted 1:10 with a solution containing 50 % crystallization and 50 % reservoir buffer 
resulting in the final soaking concentration containing 5 mM of the inhibitor and 10 % 
DMSO. Medium-size crystals without visible imperfections were selected and transferred 
into the soaking solution for 24 h.  
 
4.7.4 Data collection and processing 
Crystals were prepared for data collection at 110 K using a cryoprotectant solution of 20 % 
glycerol in reservoir buffer. The data sets for 1, 2, 5, 6 and 7 were collected with synchrotron 
radiation at SLS (Villingen, Switzerland) on a Marmosaic 225 mm CCD detector. Complex 
structures for 3, 4, 8, 9 and 10 were collected at BESSY beamline 14.2 (Berlin, Germany) on a 
Rayonix MX 225 CCD detector. Data processing and scaling were performed using the 
HKL2000 package(40).  
 
4.7.5 Structure determination and refinement 
The coordinates of human thrombin (PDB code 1H8D)(41) were used for initial rigid body 
refinement of the protein molecules followed by repeated cycles of maximum likelihood 
energy minimization, simulated annealing and B-factor refinement using the CNS program 
package(42). Structures 1-10 were refined with PHENIX(43). The temperature factors for 
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structures 5, 8 and 10 were anisotropically refined whereas for structures 1, 2, 3, 4, 6, 7 and 
9 TLS refinement was applied. The definition of the TLS groups was done with the TLSMD 
server(44,45). A randomly chosen 5 % of all data were used for the calculation of Rfree and were 
not used in the refinement. Amino acid side chains were fit into σ-weighted 2Fo – Fc and Fo – 
Fc electron density maps using Coot
(46). After the first refinement cycle, water molecules and 
subsequently ions and ligands were located in the electron density and added to the model. 
Restraints were applied to bond lengths and angles, planarity of aromatic rings and van der 
Waals contacts. Multiple side chain conformations were built in case an appropriate electron 
density was observed and maintained during the refinement, and if the minor populated 
side chain showed at least 20 % occupancy. The final models were validated using PHENIX 
own validation options or MolProbity(47). The Ramachandran plot’s were calculated with 
PROCHECK(48). Data collection, unit cell parameters and refinement statistics are given in 
Table 4. Analysis of temperature factors was done with Moleman(49) and fconv(50). The 
naming of the protein amino acids was done according to Bode et al. (51). The figures were 
prepared using Pymol 0.99. The Protein Data Bank accession codes of the coordinates and 
structure factors of all X-ray structures are given in Table 4.  
 
4.7.6 Protein Data Bank and accession numbers 
Coordinates and structure factors have been deposited in the Protein Data Bank with the 
following accession codes: THR-1 complex 3RML; THR-2 complex 3RMM; THR-3 complex 
3RMN; THR-4 complex 3T5F ; THR-5 complex 3RMO; THR-6 complex 3RLW; THR-7 complex 








Table 4: Data collection and refinement statistics for the thrombin complex structures 1-10. 










A. Data collection and processing      
No. Crystals used 1 1 1 1 1 
Wavelength (Å) 1.00 1.00 0.91841 0.91841 1.00 
Space group C2 C2 C2 C2 C2 
Unit cell parameters      
    a, b, c (Å) 69.3, 71.2, 72.4 70.1, 71.1, 72.7 69.9, 71.1,72.9 70.2, 71.0, 73.0 70.1, 71.0, 72.8 
    β (°) 99.9 100.4 100.6 100.5 100.4 
Matthews coefficient (Å3/Da) 2.5 2.5 2.5 2.5 2.5 
Solvent content (%) 50 51 51 51 51 
      
B. Diffraction dataa      
Resolution range (Å) 50 – 1.53 50 - 1.58 50 – 1.78 50 – 1.45 50 – 1.40 
 (1.56 – 1.53) (1.61 – 1.58) (1.81 – 1.78)  (1.48 – 1.45) (1.42 – 1.40) 
Unique reflections 50,478 (2,436) 48,248 (2,403) 32,972 (1,610) 60,276 (2,698) 64,957 (3,195) 
R(I)sym (%) 3.5 (35.7) 5.8 (47.8) 7.8 (47.6) 3.5 (33.9) 3.4 (37.0) 
Completeness (%) 96.4 (92.2) 99.8 (99.6) 97.9 (99.4) 96.5 (85.6) 94.0 (92.2) 
Redundancy 2.9 (2.7) 3.8 (3.7) 3.0 (2.9) 2.0 (2.0) 2.4 (2.4) 
I/σ(I) 29.2 (2.7) 22.9 (3.0) 14.2 (2.1) 20.8 (2.2) 24.2 (2.2) 
      
C. Refinement      
Resolution range (Å) 35.7 – 1.53 49.5 – 1.58 34.4 – 1.78 22.7 – 1.45 24.7 – 1.40 
Reflections used in refinement 47,916 / 2,389 45,959 / 2,302 31,209 / 1,551 57,070 – 2,875  61,099 / 3,089 
    (work/free)      
Final R values for all reflections 15.9 / 18.6 15.5 / 17.9 15.4 / 18.5 14.0 / 17.2 13.4 / 16.5 
    (work/free) (%)      
Protein residues (L chain/H chain) 28 /251 28 /251 28 /251 28 / 251 28 / 251 
Sodium ions 2 2 2 2 2 
Inhibitor atoms 32 33 35 36b / 41c 39 
Water molecules 297 305 314 325 349 
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RMSD from ideality      
    Bond lengths (Å) 0.009 0.009 0.008 0.009 0.008 
    Bond angles (°) 1.08 1.08 1.06 1.04 1.05 
Ramachandran plot       
    Residues in most favoured regions (%)  85.8 85.0 85.8 86.2 85.0 
    Residues in additionally allowed           14.2 14.6 14.2 13.4 15.0 
        regions (%)      
    Residues in generously allowed - 0.4 - 0.4 - 
        regions (%)      
Mean B-factor (Å2)      
    Protein (L + H chain) 22.9 21.5 20.6 19.9 18.2 
    Binding sited 18.5 16.7 15.8 16.2 14.8 
    Inhibitor 17.5 21.0 18.5 22.4e 16.5 






















Structure (PDB entry) THR-6 complex 
(3RLW) 









A. Data collection and processing        
No. Crystals used 1 1 1 1 1   
Wavelength (Å) 1.00 1.00 0.91841 0.91841 0.91841   
Space group C2 C2 C2 C2 C2   
Unit cell parameters        
    a, b, c (Å) 70.5, 71.3, 72.5 70.3, 71.4, 72.4 70.5, 71.3, 72.5 70.3, 71.2, 72.4 69.8, 71.5, 71.9   
    β (°) 100.6 100.3 100.5 100.7 99.9   
Matthews coefficient (Å3/Da) 2.5 2.5 2.5 2.5 2.5   
Solvent content (%) 51 51 51 51 51   
        
B. Diffraction dataa        
Resolution range (Å) 50 – 1.69 50 – 1.51 50 – 1.34 50 – 1.50 50 – 1.23   
 (1.72 – 1.69) (1.54 – 1.51) (1.36 – 1.34) (1.53 – 1.50) (1.25 – 1.23)   
Unique reflections 38,822 (1,961) 55,139 (2,742) 78,347 (3,850) 55,148 (2,816) 99,085 (4,675)   
R(I)sym (%) 5.9 (49.0) 5.1 (48.7) 5.1 (51.9) 5.3 (46.8) 4.7 (38.7)   
Completeness (%) 97.7 (98.8) 99.9 (99.6) 98.7 (97.3) 97.3 (98.5) 97.9 (91.7)   
Redundancy 2.5 (2.4) 3.7 (3.5) 3.3 (3.3) 2.7 (2.6) 2.8 (2.1)   
I/σ(I) 14.6 (2.0) 24.8 (2.7) 22.3 (2.2) 17.7 (1.9) 21.2 (2.0)   
        
C. Refinement        
Resolution range (Å) 34.7 – 1.69 35.6 – 1.51 21.5 – 1.34 22.5 – 1.5 20.1 – 1.23   
Reflections used in refinement 36,443 / 1,826 52,718 /2,659 74,108 / 3,761 52,016 / 2,635 92,538 /4,685   
    (work/free)        
Final R values for all reflections 16.2 / 19.2 15.5 / 17.2 14.0 / 16.6 16.0 / 18.3 14.0 / 16.3   
    (work/free) (%)        
Protein residues (L chain/H chain) 28 /251 28 / 251 28 / 251 28 / 251 28 /251   
Sodium ions 2 2 2 2 2   
Inhibitor atoms 32 33f / 33g 35f / 35g 32f / 11g 39   
Water molecules 243 347 361 349 390   
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RMSD from ideality        
    Bond lengths (Å) 0.008 0.009 0.008 0.018 0.008   
    Bond angles (°) 1.060 1.114 1.112 1.095 1.111   
Ramachandran plot         
    Residues in most favoured regions (%)  87.0 85.0 85.4 86.2 85.4   
    Residues in additionally allowed           13.0 15.0 14.6 13.8 14.6   
        regions (%)        
    Residues in generously allowed - - - - -   
        regions (%)        
Mean B-factor (Å2)        
    Protein (L + H chain) 22.9 19.1 18.0 17.7 17.4   
    Binding siteb 18.5 14.9 14.4 16.5 13.9   
    Inhibitor 22.3 17.4h / 26.7i 15.7h / 16.9i 17.7h / 21.1i 15.0   
    Water molecules 31.4 32.4 31.5 33.6 33.3   
a Numbers in parenthesis are for the highest resolution shell. 
b The inhibitor atoms from the additional disordered part were not considered. 
c All inhibitor atoms which were included in the refinement model.  
d Definition of the binding site: all amino acids which are 4 Å within the inhibitor. 
e Average B value for the ordered and fully ocupied inhibitor portion, the disordered portions were not considered. 
f Number of inhibitor atoms for the fully occupied ligand. 
g Number of inhibitor atoms for the partially occupied ligand.  
hMean B-factor for the fully occupied ligand. 
i
 Mean B-factor for the partially occupied ligand.                          
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5 Water Makes the Difference: Rearrangement of Water 
Solvation Layer Triggers Non-additivity of Functional Group 
Contributions in Protein-Ligand Binding 
 
 
5.1 Introductory remarks 
This study was done in cooperation with the group of Prof. Dr. Hangauer (University of 
Buffalo). The following text is submitted to the scientific journal ChemMedChem.  
 
5.2 Abstract 
The binding of four congeneric peptide-like thermolysin inhibitors has been studied by high-
resolution crystal structure analysis and isothermal titration calorimetry. The ligands differ 
only by a terminal carboxylate and/or methyl group. A surprising non-additivity of functional 
group contributions for the carboxylate and/or methyl groups is detected. Adding first the 
methyl and then the carboxylate group results in a small Gibbs free energy increase and 
minor enthalpy/entropy partitioning for the first modification, whereas the second involves 
strong affinity increase combined with huge enthalpy/entropy changes. Adding however first 
the carboxylate and then the methyl group yields reverse effects: now the acidic group 
attachment causes minor effects whereas the added methyl group provokes huge changes. 
As all crystal structures show virtually identical binding modes, affinity changes are related 
to rearrangements of the first solvation layer next to the S2’ pocket. About 20-25 water 
molecules are visible next to the studied complexes. The added COO- groups perturb the 
local water network in both carboxylated complexes and the attached methyl groups 
provide favorable interaction sites for water molecules. In all complexes, apart one example, 
a contiguously connected water network between protein and ligand functional groups is 
observed. In the complex with the carboxylated ligand, still lacking the terminal methyl 
group, the water network is unfavorably ruptured. This results in the surprising 
thermodynamic signature showing only minor affinity increase upon COO- group 
attachment. Since the further added methyl group provides a favorable interaction site for 
water, the network can be re-established and strong affinity increase with huge 
enthalpy/entropy signature is then detected.   





Hit-to-lead optimization generally follows chemical modifications which involve addition and 
replacement of functional groups at a given parent scaffold. This idea of adding chemical 
groups by forming and breaking chemical bonds has strongly influenced our conceptional 
thinking in assigning particular functional group contributions to estimate by how much an 
added group will enhance binding affinity of a promising lead candidate.(1-3) Following this 
approach, however, completely ignores that every novel molecule is on its own a new 
species that will interact with the target protein in its own specific way. From a 
physicochemical point of view this strategy of designing molecules by adding affinity 
contributions of functional groups and assigning Gibbs free energy increments to particular 
interactions is perhaps pragmatic, but fundamentally wrong and can therefore be quite 
misleading. Binding affinity is a free energy, composed by enthalpy and entropy and cannot 
be additive in terms of functional group contributions.(4) The importance of this non-
additivity (sometimes also named 'cooperativity') has been first indicated by Williams et al.(5-
7) Kawai et al. reported on non-additive effects with respect to chemical ligand modifications 
in HCV protease binding using a chemical double-mutant cycle.(8) In a recent series of studies 
on ligand binding to thrombin we reported on non-additivity of hydrogen bonding related to 
the simultaneous formation of hydrophobic contacts.(9,10) On the molecular level the 
observed non-additivity is explained by differences in residual mobility of bound ligand 
portions: The strength of a hydrogen bond takes influence on the dynamic properties of a 
formed complex. 
Therefore properties such as the degree of hydrophobic surface portions of a ligand in a 
binding pocket that becomes buried upon complex formation have to be regarded under 
dynamic conditions. If larger residual mobility is given, formally the burial is less efficient (or 
less frequently experienced on the time scale) than if the residual mobility is reduced, e.g. in 
consequence of an adjacent more tightly fixed hydrogen bond. 
Often such effects are not highly transparent in binding affinity as, with respect to 
thermodynamic factorization, enthalpy and entropy mutually compensate each other and 
only a minor contribution to the Gibbs free energy remains.(11,12) However, by partitioning 
enthalpy and entropy along with the investigation of structural properties these effects 
become obvious.  




Dynamic properties are one explanation on the molecular level for the incident of non-
additivity. Likely, many more mechanisms are responsible for such phenomena. In the 
current study we will report on non-additivity determined by changes in the local hydration 
pattern that is formed next to a binding site and will be perturbed and influenced by the 
presence of the bound ligands. 
The importance of water in the binding process receives increasing appreciation in drug 
design.(13-15) However, it is predominantly focused on general contributions of solvation and 
desolvation, the release or pick-up of water molecules in a formed complex or the role of 
water at interstitial sites mediating contacts between ligand and protein. The influence of 
water next to a binding site and mediating the transition from the bound ligand to the bulk 
water phase is hardly taken into consideration. However, also these immediate layers of 
structured (or well-ordered) water molecules arranged in contiguous, but locally perturbed 
networks is determining for binding and, as will be shown in this contribution, and with a an 
alternate approach to interpreting the data but coming to a similar general conclusion that 
water is involved in cooperativity by Nasief et al.,(16) can take substantial influence on non-
additivity of functional group contributions and the partitioning of enthalpy and entropy in 
the binding process.(17) 
As model system we investigated the binding of four congeneric peptidomimetic 
phosphonamidate inhibitors to thermolysin (TLN), a zinc endopeptidase from B. 
thermoproteolyticus. This protease has been broadly characterized and frequently used as 
representative for the entire class of zinc-dependent metalloproteinases.(18-20) A combined 
study of high-resolution crystallography and isothermal titration calorimetry has been 
performed. Lucky enough, the crystals of the four investigated complexes diffracted 
sufficiently well to disclose important parts of the solvation pattern of the first water layer 
around the S2' pocket of the protease, the region in which the chemical structure of the 
studied ligand series has been modified. At their terminus either an additional methyl group 
or carboxylate group were attached or both modifications were considered simultaneously 
(Fig. 1, 1-4). 




5.4 Results - Crystallography 
5.4.1 Resolution required for determining solvation patterns.  
To study systematically the changes in the water arrangement next to a binding pocket by 
crystallography, highly resolved crystal structures are required as the number of observed 
water molecules can suffer from resolution of the diffraction data.(21) Statistics show that, on 
average, at 2.0 Å resolution one water molecule per residue is included in the model, while 
at 1.0 Å resolution about 1.6-1.7 are crystallographically located.(21) The data presented in 
this study were recorded by use of synchrotron radiation to achieve the best possible 
resolution of the thermolysin complexes of 1-4 determined with good to excellent resolution 
(1.60-1.28 Å). The assignment of the different water molecules was based on the 
interpretation of the difference electron density maps. At least a peak has to exhibit a height 
of three sigma in the difference electron density map to be interpreted as a water molecule.  
 
5.4.2 Binding Mode of the Ligand Scaffolds 
The crystal structures of the four inhibitors comprising a Cbz-Gly-(PO2)
¯-L-Leu-XXX scaffold 
(Cbz = Carboxybenzyl, XXX= CH3 (1), CH2CH3 (2), CH2COOH (3), CH(CH3)COOH (4), Fig. 1) have 
been determined in complex with thermolysin. For all, the difference electron density of the 
scaffold is well defined; a representative depiction is shown for 4 (Fig. 2). The Cbz-Gly-(PO2)
¯-
L-Leu portions of all four ligands bind virtually in identical manner (Fig. 2). The terminal Cbz 
groups are located with highly conserved geometry next to the zinc ion in the unspecific S1 
pocket. The perpendicular orientation of the CH2 groups to the attached phenyl rings 
corresponds to the preferred torsion angle for this connection. The phenyl rings of these 
groups interact with CD2 of Phe114 through van-der-Waals contacts (4.0 - 4.1 Å) and they 
find additional interactions with Phe114 and Tyr106 of a neighboring crystal mate. 
Furthermore, they are fixed in position by interactions of the carbonyl oxygen of the 
adjacent Trp115 which orients towards the center of the neighboring Cbz phenyl rings (3.8 - 
4.1 Å). Below the Cbz phenyl ring in all complexes a glycerol molecule, captured from the 
cryo buffer, is detected and a neighboring DMSO molecule is present in the crystal packing. 
In all examples the carbonyl group of the Cbz carbamide group adopts two conformations. In 
one conformer, the carbonyl oxygen orients towards Phe114 (3.4 - 3.6 Å to CB), in the other 
the carbonyl oxygen is involved in an adjacent network of water molecules (s. below). The 




occupancy of the two conformations refined to 50-63 % for the conformer towards Phe114 
and between 37 % and 50 % towards the water network.  
 
Figure 1:  Thermodynamic cycle for the structural changes from 1 (orange) to 2 (blue), 3 (magenta) 
and 4 (green). Along the red pathways attachment of an additional methyl group is performed, the 
green pathways involve addition of an extra carboxylate group. The relative differences in the 




With regard to the contacts to the zinc ion, the phosphonamidate scaffold interacts in a 
mono-dentate fashion with one oxygen being directed towards zinc (1.9 - 2.0 Å) and the 
other oxygen towards OE1 of Glu143 (2.5 - 2.6 Å, Fig. 2b). The adjacent phosphonamidate 
NH group hydrogen-bonds to the backbone carbonyl of Ala113 (2.8 – 2.9 Å). The isobutyl 
group of the central leucine portion fits perfectly well into the hydrophobic S1‘ pocket and 
forms multiple van-der-Waals contacts to the neighboring hydrophobic pocket residues (e.g. 
Phe130, Leu133, Val139, Ile188 and Leu202, Fig. 2b). The distances of these van-der-Waals 
contacts range from 3.7 Å to 4.1 Å.  
The four inhibitors differ by their terminal XXX group. Nevertheless, also here remarkable 
conservation of the binding modes is given. Thus, the terminal CH3 group in 2 matches well 
with that in 4 and the carboxylate groups of 3 and 4 superimpose perfectly. The carboxylate 
groups of 3 and 4 form a most likely charge-assisted stacking interaction (3.4 - 3.7 Å) with 




the side chain of His231. In summary with respect to the binding modes, all four inhibitors of 
the series show virtually the same orientations. In all complexes above the carboxyamide 
terminus of Asn112 a further glycerol molecule is found. 
 
Figure 2: Overall binding mode as observed in the representative crystal structure of TLN-4, water 
molecules omitted for clarity. (a) The protein binding pocket is indicated by the grey solvent-
accessible surface and the green mesh circumvents the Fo-Fc difference electron density at 3 σ level. 
The Cbz group is oriented towards the S1’ pocket which shows a glycerol molecule below the phenyl 
ring of the Cbz group. Adjacent a DMSO molecule is found. A further glycerol molecule is detected 
next to Asn 112 in the S2’ pocket. (b) The ligand coordinates in mono-dentate fashion the catalytic 
zinc ion (blue-grey sphere). Coordinating residues are shown with prominent interactions indicated 




5.4.3 Solvation Structure Around the Ligands  
Due to the remarkable diffraction power of the studied crystals, the first layers of the 
solvation structure next to the binding pockets are well determined and can be compared 
across the four complexes. Major differences become obvious next to the S2’ pocket, in 
particular as here the four inhibitors differ in their substitution pattern. Obviously, the 
terminal methyl and negatively charged carboxylate groups induce different degrees of 
ordering (Fig. 3 and 4, color coding: TLN-1 orange, TLN-2 blue, TLN-3 magenta, TLN-4 green).  
In all complexes in the local neighborhood of the S2’ pocket (10 Å sphere around P2’ 
substituent) more than 20 water molecules can be assigned to the difference electron 
density (Fig. 3). They are found with mutually distances between 2.5 up to 3.2 Å suggesting 
formation of an extended H-bonding network that also involves contacts to functional 
groups of either the ligand or the protein. Motifs of contiguous chains and rings are 




observed (Fig. 3). Cyclic patterns with five and six water molecules are generated that have 
frequently been detected – at least in part – next to protein surfaces.(22) The four complexes 
show slightly different numbers of assigned water molecules which seems to correlate with 
the resolution of the determined crystal structures, e.g. the complex with 4 (Fig. 3d) which 
diffracted to 1.28 Å resolution shows the largest number of water molecules. This fact makes 
it difficult to compare the absolute numbers of water molecules across the series of 
complexes, particular with respect to a relative inventory of released or picked-up water 
molecules. The distances along the water chains vary and possibly they correlate with the 
strength of the formed hydrogen bonds. The occupancies and B-factors of the refined water 
positions change with increasing distance from the protein surface and the presence of 
adjacent polar groups which can reinforce a more firm fixation. Accordingly, the determined 
spatial accuracy of individual water positions will be affected by, e.g. residual mobility. 
Therefore, we want to refrain from any detailed considerations of H-bond length variations. 
Some confidence in the relevance of the observed water networks is suggested by the fact 
that recurrently the same motifs are indicated in all four complexes, but with some 
important local perturbations induced by the attachment of the different XXX substituents. A 
two-membered water chain (highlighted by yellow cycles, Fig. 3a-d) is formed between the 
C=O group of the Cbz portion and the carboxamide of Asn227 and the carboxylate group of 
Asp226. In the complexes TLN-1 and TLN-2 the first water molecule in this chain interacts via 
an additional water molecule (Fig. 3a,b, cyan cycle) with the carboxamide group of Asn112; 
in TLN-3 and TLN-4 the latter water molecule is replaced by one of the carboxylate oxygens. 
In the complexes with 1 and 2 a water network (highlighted by red bars) is formed that 
wraps around the terminal hydrophobic methyl or ethyl group. It contiguously connects the 
carboxyamide of Asn112 with the backbone carbonyl group of Asn111. Due to the steric 
demand of the larger ethyl group in TLN-2 two water molecules hydrogen-bonded to 
Asn111(C=O) which are present in TLN-1 (Fig. 3a, green cycles) are repelled from the 
complex. Instead, two new water molecules are detected next to the terminus of the ethyl 
group in TLN-2 (Fig. 3b, red cycles). Interestingly enough in TLN-4 the latter two water 
molecules are observed at very similar spatial positions (Fig. 3d, red cycles). The two 
derivatives 3 and 4 introduce the strongly polarizing carboxylate group. It forms along its anti 
direction(23) hydrogen bonds to two water molecules (Fig. 3c, d). Furthermore, it perturbs 
the water network along the distal syn direction and one water molecule (Fig. 3a-d, black 




cycles) is dragged into an H-bond with the carboxylate group. This slight movement of the 
water molecule towards the carboxylate group (cf. Fig. 4 b,c) has consequences for TLN-3. 
Different from the other three cases, TLN-3 lacks the contiguously closed water network 
pattern: it breaks next to the water molecule in syn direction of the COO- group (Fig. 3c, 4d, 
light blue broken arrow). To trace this difference between TLN-3 and TLN-4 we carefully 
inspected the electron density map in this region (Fig. 5 a, b). Although there is little residual 
difference electron density at 3σ level next to the water molecule in syn direction of the 
carboxylate group in TLN-3, this density extension is too close (1.3 Å) to assign an additional 
water site, more likely it indicates enhanced anisotropic motion of the latter water molecule. 
Therefore, we can conclude that no additional water is present to mediate a fully closed 
water network.  
 
Figure 3: Binding modes of 1-4 together with the local water pattern as observed in the crystal 
structures, the protein binding pocket is indicated by the solvent accessible surface of 4. (a) TLN-1, 
carbon atoms and water molecules in orange, (b) TLN-2, carbon atoms and water molecules in blue, 
(c) TLN-3, carbon atoms and water molecules in magenta, (d) TLN-4, carbon atoms and water 
molecules in green. Important residues next to the S2’ pocket are labeled. The local water network 
which wraps around the terminal ligand group (1: CH3, 2: CH2CH3, 3: CH2COO-, 4: CH (CH3)COO
-) is 
highlighted by red bars. In all complexes, a two-membered water chain (encircled in yellow) is 
formed between the ligands and Asn227/Asp226. In TLN-1 and 2 the water network which wraps 
around the terminal groups starts with the water molecule encircled in cyan. In 1, 2 and 4 it shows a 
contiguous chain connecting all the way from Asn112 to the backbone carbonyl group of Asn111.  
Next to the latter group two water molecules (encircled in green) are repelled from the complexes 
with 2 and 4. In contrast, the latter ligands capture two water molecules (encircled in red) through 
van-der-Waals contacts with the terminal methyl group. The water molecule encircled in black 
becomes involved in a hydrogen bond with the carboxylate group in 3 and 4. The water network 
breaks in TLN-3 (blue broken arrow). 
                   




                   
 
Figure 4: Mutual superposition of the crystal structures of (a) TLN-1 (orange) and TLN-2 (blue), (b) 
TLN-1 (orange) and TLN-3 (magenta), (c) TLN-2 (blue) and TLN-4 (green) and (d) TLN-3 (magenta) and 
TLN-4 (green), same view direction as in Fig. 3. (a) and (d) with the solvent accessible surface of 4: 
Two water molecules (encircled and crossed in green) are repelled next to the backbone carbonyl 
group of Asn 111 (for labels, see Fig. 3) due to the additional steric requirements of the extra methyl 
group in 2; however, two water molecules are picked-up at sites next to the added methyl group 
(encircled in red and arrows). (b) and (c): The introduced carboxylate group strongly perturbs the 
water network and replaces water molecules in close neighborhood (black crosses). Simultaneously, 
the water molecule next to the carboxylate’s distal syn site (encircled in black) is dragged into a 
hydrogen bond and shifts slightly in space. In TLN-3 this results in a rupture of the water-mediated 
network (d, blue broken arrow). 
                     
 




                     
 
Figure 5: 2Fo–Fc (blue, contour level 1σ) and Fo-Fc (green, contour level 3σ) electron density in (a) 
TLN-3 (ligand shown in magenta) and (b) TLN-4 (ligand shown in green) next to the region where the 
water network is ruptured. The protein binding pocket is indicated by the grey solvent accessible 
surface of 4. Only in TLN-4 a contiguously connected network of water molecules is found, in TLN-3 
the network is broken. 
                   
 
 
5.5 Results - Isothermal Titration Calorimetry 
5.5.1 Displacement and Protonation Steps 
The binding thermodynamics have been characterized for all four inhibitors to TLN by ITC. 
Unfortunately, no absolute binding data could be recorded as the titrations are 
superimposed by the displacement of the protolysis product Val-Lys from the protein. 
Thermolysin tends, in particular in high concentrations, to autoprotolysis whereby the last 
two C-terminal residues Val-Lys are cleaved off. Therefore, all measured thermodynamic 
a b 




data are overlaid by a constant contribution resulting from the displacement of Val-Lys upon 
inhibitor binding.(24) We can assume with high confidence that this contribution is the same 
in all cases; however, since we are only interested in relative differences within the ligand 
series, the portion of the dipeptide replacement cancels out in the inventory. In the 
following descriptions and discussions only reference to the relative differences will be taken 
(Fig. 1). Furthermore, ligand binding to TLN is superimposed by the pick-up of a proton. As 
described in detail elsewhere (Biela et al. to be published), the additional proton binds to 
Glu143 next to the zinc ion. The heat of ionization involving this protonation step will be 
constant across our narrow congeneric ligand series. Accordingly, this contribution also 
cancels out in the attempted relative comparison. 
 
5.5.2 Thermodynamic Data 
Ligand 1 is the weakest binder. The addition of a second methyl group to the terminal NCH3 
group of 1 to reveal 2 relates to a more exergonic binding of ΔΔG1→2 = - 2.2 kJ/mol and 
partitions into an endothermic ΔΔH1→2  contribution of 2.5 kJ/mol and an entropically 
favorable portion of –TΔΔS1→2 = - 4.7 kJ/mol (Fig. 1). These minor effects are also found if the 
terminus of 1 is decorated by a carboxylate function to form 3. Gibbs free energy enhances 
only by ΔΔG1→3 = - 1.0 kJ/mol, again this effect factorizes into a small exothermic ΔΔH1→3 
portion of - 3.5 kJ/mol and a nearly compensating unfavorable entropic effect of –TΔΔS1→3 = 
2.5 kJ/mol. Remarkably, the addition of an acid group to the already methylated derivate 2 
to achieve 4 improves affinity by ΔΔG2→4 = - 4.5 kJ/mol and the addition of a methyl group to 
the carboxylated 3 to afford 4 reveals a ΔΔG3→4 = - 5.7 kJ/mol. Even more surprising, these 
affinity enhancements factorize into a huge exothermic and an unfavorable entropy 
contributions (ΔΔH2→4 = - 19.3 kJ/mol, -TΔΔS2→4 = 14.9 kJ/mol, ΔΔH3→4 = - 13.3 kJ/mol, -
TΔΔS3→4 = 7.7 kJ/mol). The thermodynamic data underscore strikingly the observation of 
non-additivity effects in this ligand series.   
 
5.6 Discussion 
Usually drug optimization is performed in a step-wise fashion by adding functional groups to 
a parent scaffold. In the present example the addition of a methyl group to 1 enhances 
affinity by ΔΔG = - 2.2 kJ/mol and the attachment of a carboxylate group only reveals an 
improvement of - 1 kJ/mol. In a medicinal chemistry program these rather disappointing 




effects would have possibly stopped further efforts addressing the S2’ pocket. Nonetheless, 
the combined affinity enhancement achieved by adding both groups simultaneously to 1 
featuring 4 succeeds in the remarkable effect of - 6.7 kJ/mol. As this accounts to more than 
one order of magnitude in the binding constant this optimization would have likely been 
claimed as promising.  
We can describe the observations also differently (Fig. 1). Taking the pragmatic, however 
theoretically incorrect picture of additivities of functional group contributions into 
consideration, the methyl group attachment from 1 → 2 enhances ΔΔG by - 2.2 kJ/mol, 
whereas it adds - 5.7 kJ/mol from 3 → 4. Similarly, the additional carboxylate group 
enhances affinity from 1 → 3 by only -1 kJ/mol, whereas it improves binding from 3 → 4 by -
4.5 kJ/mol. This effect of non-additivity clearly demonstrates that models of functional group 
additivities come to an end and can be rather misleading. 
Considering the thermodynamic factorization along the four optimization pathways provides 
a more differentiated picture. Remarkably, the steps 1 → 2 and 1 → 3, which improve 
affinity only minor, also factorize only slightly into enthalpy and entropy, even though some 
mutual compensation can to be recognized. Following steps 2 → 4 and 3 → 4, along which 
more significant affinity enhancements are recorded, huge enthalpic and entropic effects are 
experienced, however, they largely compensate. Nevertheless, they suggest major changes 
in the binding and interaction features.  
At this point crystal structure analyses should be consulted. As a matter of fact, in the 
present case all four inhibitors adopt virtually the same binding mode. Thus, any explanation 
of the observed non-additivity is hardly evident from the ligand binding geometries. 
Accordingly, what else can take impact on binding affinity and perturb the thermodynamic 
signature in this congeneric ligand series? As the addition of either a hydrophobic methyl 
group (1 → 2) or the attachment of a polar carboxylate function (1 → 3) result both in minor 
affinity enhancements, a sole explanation in terms of ligand desolvation costs cannot be 
made responsible for the observed trends.  
For the sake of high crystal quality, our crystals diffracted to high resolution and insights into 
the local water structure formed next to the bound ligands becomes available. It describes 
the gradual transition from the ligand-accommodated binding pocket to the surrounding 
bulk water phase. Remarkable differences in the produced water networks are evident. In all 
structures several water molecules mediate in chain-type fashion interactions between the 




partly exposed ligand functional groups and protein functional groups unsheltered from the 
interior and next to the catalytic center. Multiple polygonal and mutually fused ring patterns, 
composed by several water molecules are observed, but they are perturbed by the different 
substituents attached to 1 – 4 at their terminal end. An extensive water chain wraps around 
the exposed hydrophobic alkyl chain. It is even capped by an additional water molecule in 
the complexes with 2 and 4 as the terminal methyl group provides additional van-der-Waals 
contacts to host this water in favored position (Fig. 3 b, d and 4 c, d, red cycles and arrows). 
In contrast, the latter complexes release two water molecules originally bound to the 
backbone carbonyl group of Asn111 (Fig. 3 a, c and 4 a, d, green cycles). The terminal methyl 
groups in 2 and 4 require too much space to still host these water molecules.  
Crystallography provides, with the necessary care in discussing the geometry of such surface 
water layers, a fair number of perturbations across the different networks. How does this 
structural evidence translate into changes of the thermodynamic signature? The 
contributions of water to ligand binding are rather tricky. In more simple cases, single water 
molecules that are captured on interstitial positions to mediate an interaction between 
ligand and protein show minor contributions to the Gibbs free energy of binding.(25,26) 
Nevertheless, much larger changes in enthalpy and entropy are experienced. An enthalpic 
gain is found due to the formation of new water-mediated hydrogen bonds between protein 
and ligand. This effect is virtually compensated by entropy as capturing the water molecule 
is entropically unfavorable. Possibly these effects are less outweighed if charges are 
involved.(27) Thus, on first glance, it appears rather difficult to relate the observed network 
changes with the thermodynamic signature discovered for the different complexes. 
In three of the four complexes (1, 2, 4) a contiguous water chain spans from the carbonyl 
oxygen of the Cbz group all the way through to the backbone carbonyl oxygen of Asn111 and 
wraps around the terminal ends of the bound ligands. The attached COO- groups in 3 and 4 
replace some (most likely three, Fig. 4 b, c) of the water molecules present in TLN-1 and TLN-
2 and drag the water network towards their polar oxygens (Fig. 3 a, c and Fig. 4 b, c, black 
cycles), particularly to form the syn hydrogen bond. In the complex with 3, however, the 
generated water network remains ruptured and leaves a supposedly unfavorable break. In 4 
the water chain shows up again with continuous geometry, most likely supported by the 
stabilizing van-der-Waals contacts to the now adjacent methyl group. This observation is 
underscored by the fact that in TLN-2 at very similar site, an additional water molecule is 




captured (Fig. 4 c, red cycles and arrows). The stabilizing effect of the methyl group is also 
indicated by a second water binding site which only exists in TLN-2 and TLN-4 (Fig. 3 b, d, 4 a, 
c, d, red cycles and arrows). To support this stabilizing contribution of this water-to-methyl 
contact we inspected the occurrence frequency of such contacts in crystal structures (Fig. 
6).(28) 
Compared to 1, 3 shows only minor affinity enhancements with little enthalpy and 
unfavorable entropy even though a polar carboxylate group is introduced. Supposedly the 
costly water network rupture prevents any affinity enhancement resulting from the added 
polar group. 
The addition of a methyl group from 3 → 4 results in a huge affinity increase, which is 
enthalpically driven and partly compensated by an entropic loss. The wrapping water chain is 
closed again and further stabilized by the water molecule picked up at the capping position 
(Fig. 3 b, d, 4 a, c, d, red cycle). This latter site likely experiences electrostatic interactions in 
TLN-4 with the adjacent carboxylate group (3.6 Å); in TLN-3 no water molecule is found at 
this position. Following the path from 1 → 2 shows minor exergonic effects but falls into a 
range also found in other examples for methyl group attachments.(29,30) The observed small 
enthalpy/entropy signature most likely results from the higher desolvation price to be paid 
for the added hydrophobic ligand portion. Finally, the step 2 → 4 which adds the COO- group 
to the ligand returns a fairly strong affinity enhancement. It factorizes into a huge enthalpic 
gain and a strong entropic loss. This agrees with a signature expected for the introduction of 
a polar functional group which creates significant electrostatic effects and restructures the 















Figure 6: (a) Five water molecules in TLN-4 with close contacts (yellow dashed line) to the terminal 
methyl group of the ligand (3.8 – 4.0 Å). One water molecule occupies a site perpendicular to the 
carboxylate group (cyan arrow). (b) Frequency distribution of intermolecular contacts between a 
water molecule and a terminal methyl group in crystals structures deposited in the PDB. The 
histographic distribution has been transformed according to the formalism in Drugscore (DSX)(28) into 
the depicted smoothed distribution. The maximum indicates high occurrence frequency at 380 pm 
(3.8 Å), correlating with an energetically favorable arrangement. (c) Distribution of intermolecular 
contacts as compiled in IsoStar between a carboxylate group and water molecules. Apart from 
formed hydrogen bonds in the plane of the carboxylate group also at a position above the best plane 
contacting water molecules are observed. The frequent population at this site indicates favorable 




The present structural and thermodynamic study of binding properties of four closely 
related, highly congeneric ligands demonstrates the effects of non-additivity of functional 
group contributions. As the binding mode of all four inhibitors remains virtually unchanged, 
the observed affinity differences must result from other contributions. Attachment of a 
methyl group to the parent scaffold increases affinity by about - 2 kJ/mol, a value expected 
for a favorable methyl group placement. It also factorizes only slightly into enthalpy and 
entropy. Adding a further carboxylate group results in a pronounced affinity gain combined 




with huge, however, largely compensating exothermic and entropically unfavorable effects. 
Also such a profile is perhaps expected for the attachment of a polar group, well suited to 
establish strong interactions with its environment. It introduces charge-assisted hydrogen 
bonds assumed to be enthalpically favorable. At the same time the intermolecular contacts 
become more stringent which provokes a loss in entropy. Performing the attachments with 
inverted sequence results in effects with reverse order. Why is the carboxylate attachment 
now only yielding about - 1 kJ/mol in Gibbs free energy and why is hardly any 
enthalpy/entropy compensation detected? Instead the subsequently added methyl group 
provokes the strong affinity increase with huge enthalpy/entropy compensation. Three of 
the complexes show a contiguous and complete water network which wraps around the 
terminal hydrophobic substituent and involves the carboxylate group. In the complex with 
the carboxylated ligand 3, which still lacks the additional methyl group and does not achieve 
the expected affinity boost, the water network is broken and appears incomplete. 
Supposedly this rupture is enthalpically unfavorable and entropically beneficial as it captures 
less water molecules. Overall this counterbalances any favorable contributions resulting 
from the introduction of the polar functional group. This is, however curated with the 
introduction of an additional methyl group as it allows the network to be re-established via 
the supply of a favorable interaction site to host a water molecule (Fig. 6 a).  
Two aspects can be learned from this study. First, non-additivity of functional group 
contributions can have different molecular origins; apart from dynamics also local solvation 
patters can be responsible. Second, binding affinity and the enthalpy/entropy signature can 
be strongly influenced by the water network formed as solvation layer next to a binding 
pocket, as similarly concluded by Nasief et al.(16) even though using different arguments 
based on different considerations. Regarding our currently used routine computer tools for 
modeling(31) none of these effects will be reflected by any means. This demands for future 
developments to improve such tools.  
 
5.8 Materials and Methods 
5.8.1 Synthesis 
The compounds were kindly provided by Nasief and Hangauer (SUNY, Buffalo, USA) and the 
synthesis is described and discussed elsewhere.(16) 
 




5.8.2 Isothermal titration calorimetry (ITC) 
ITC experiments were performed using an ITC200™ system from MicroCal (now part of GE 
Healthcare, Northhampton, MA, USA). Thermolysin from Calbiochem was freshly prepared 
for each experiment in the buffer applied in the measurements. The comparison of the 
thermodynamic data of the dialysed and undialysed protein solution revealed no significant 
difference. Therefore the undialysed protein solution was used in this study. The inhibitor 
solution was freshly prepared in the experimental buffer to the required concentration. The 
ITC experiments were done at 25 °C in a buffer composed of 20 mM Hepes, 500 mM NaSCN, 
2 mM CaCl2 at pH 7.5. Inhibitor solutions (1-1.5 mM) were titrated into the sample cell 
containing the TLN solution (45.0 μM) after a stable baseline was achieved. ITC experiments 
comprised of initial ligand injection of 0.3 μl followed by 15 injections of 1-2 μl with a 300 s 
interval between each injection. The ITC cell volume was 200 μl. Raw data were collected 
and the area under each peak was integrated, followed by correction for heats of dilution 
and mixing by subtracting the final baseline consisting of small peaks of the same size to 
zero. The initial data point was deleted from the integrated data because this injection 
usually reflects an erroneous amount of heat due to the possible exchange of liquids 
between syringe and cell when inserting the syringe into the calorimetric cell and the 
backlash error in the motorized screw mechanism in the injector.(32) Data were analysed 
using ORIGIN Software (Microcal Inc.), by fitting a single-site-binding isotherm (33) that yields 
ΔH0 (enthalpy of binding) and Kd (dissociation constant). Measurements were performed at 
least in duplicate and show on the mean esds of 0.4 kJ/mol. 
 
5.8.3 Crystallization and soaking 
Native thermolysin (purchased from Calbiochem) was crystallized as described by Holmes 
and Matthews (34) applying slight modifications. Thermolysin was dissolved in 100 % DMSO 
at 8 mM. Subsequently, the DMSO solution was diluted with the buffer 1:1 (100 mM 
Tris/HCl, 5 M CsCl, pH 7.5). The suspension was then vortexed and centrifuged for two 
minutes. The so achieved supernatant was used in the crystallization trial. This final solution 
contained 50 % DMSO and 2.5 M CsCl. The final protein concentration in the crystallization 
drop was 4.0 mM. Crystals were grown at 18 °C by the sitting drop vapor diffusion method 
using water as reservoir solution. Protein-ligand complex crystals were obtained via soaking 
crystals in a solution of 100 mM Tris/HCl, 2 mM CaCl and 10 % DMSO. For soaking ligand 




concentration varied between 1 and 5 mM. When low solubility was given, saturated 
solutions were used. Crystals were soaked between one and two days before freezing. 
 
5.8.4 Data collection and processing 
Crystals were prepared for data collection at 110 K using a cryoprotectant solution of 20 % 
glycerol in a buffer containing 10 mM Tris/HCl, 10 mM Ca(CH3COO)2, 5 % DMSO at pH 7.3. 
The data sets for 1 and 3 were collected with synchrotron radiation at SLS (Villingen, 
Switzerland) on a Marmosaic 225 mm CCD detector. Complex structures for 2 and 4 were 
collected at BESSY beamline 14.2 (Berlin, Germany) on a Rayonix MX 225 CCD detector. Data 
processing and scaling were performed using the HKL2000 package.(35)  
 
5.8.5 Structure determination and refinement 
The coordinates of thermolysin (PDB code 8TLN)(36) were used for initial rigid body 
refinement of the protein molecules followed by repeated cycles of maximum likelihood 
energy minimization, simulated annealing and B-factor refinement using the CNS program 
package.(37) Subsequently, all structures were refined with PHENIX.(38) The temperature 
factors for structure 4 were anisotropically refined whereas for structures 1 – 3 TLS 
refinement was applied. The definition of the TLS groups was done with the TLSMD 
server.(39,40) A randomly chosen 5 % of all data were used for the calculation of Rfree and were 
not used in the refinement. Amino acid side chains were fit into σ-weighted 2Fo – Fc and Fo – 
Fc electron density maps using Coot.
(41) After the first refinement cycle, water molecules and 
subsequently ions and ligands were located in the electron density and added to the model. 
Restraints were applied to bond lengths and angles, planarity of aromatic rings and van der 
Waals contacts. Multiple side chain conformations were built in case an appropriate electron 
density was observed and maintained during the refinement, and if the minor populated 
side chain showed at least 20 % occupancy. The final models were validated using PHENIX 
own validation options or MolProbity.(42) The Ramachandran plot’s were calculated with 
PROCHECK.(43) Data collection, unit cell parameters and refinement statistics are given in 
Table 1. Analysis of temperature factors was done with Moleman(44) and fconv.(45) The 
figures were prepared using Pymol 1.2r3pre.(46) The Protein Data Bank accession codes of 
the coordinates and structure factors of all X-ray structures are given below.  
 




5.8.6 Protein Data Bank and accession numbers 
Coordinates and structure factors have been deposited in the Protein Data Bank with the 
following accession codes: TLN-1 complex 3T73; TLN-2 complex 3T8F; TLN-3 complex 3T8G; 
TLN-4 complex 3T74. 
 
Table 1: Data collection and refinement statistics for the four thermolysin complex structures 
determined in this publication.                                                 












A. Data collection and 
processing 
    
No. Crystals used 1 1 1 1 
Wavelength (Å) 1.00 0.91841 1.00 0.91841 
Space group P6122 P6122 P6122 P6122 
Unit cell parameters     
    a, b (Å) 92.7, 92.7 92.6, 92.6 92.7, 92.7 92.4, 92.4 
    c (Å) 130.8 131.0 130.1 131.2 
Matthews coefficient 
(Å3/Da) 
2.4 2.4 2.4 2.4 
Solvent content (%) 48 48 48 48 
     
B. Diffraction dataa     
Resolution range (Å) 50 – 1.50 50 – 1.28 50 – 1.60 50 – 1.44 
 (1.53 – 1.50) (1.30 – 1.28) (1.63 – 1.60) (1.46 – 1.44) 
Unique reflections 53,702 83,375 44,226 60,157 
R(I)sym (%) 7.9 (49.9) 5.2 (32.6) 8.0 (49.5) 6.2 (27.2) 
Completeness (%) 99.9 (99.5) 97.3 (95.4) 100.0 (100.0) 99.7 (96.2) 
Redundancy 20.7 (18.5) 5.7 (5.7) 16.3 (15.1) 5.0 (4.3) 
I/σ(I) 41.1 (6.6) 30.4 (5.3) 35.9 (6.5) 22.0 (5.4) 
     
C. Refinement     
Resolution range (Å) 40.1 – 1.50 22.8 – 1.28 43.7 – 1.60 30.4 – 1.44 
Reflections used in 









Final R values for all 
reflections (work/free) (%) 
14.2 / 15.6 10.5 /12.7 14.3 / 16.6 14.2 / 15.9 
Protein residues  316 316 316 316 
Calcium /zinc ions 4 / 1 4 / 1 4 / 1 4 / 1 
Inhibitor atoms 28b / 32c 29b / 33c 25b  / 29c 26b  / 30c 
Water molecules 442 499 400 477 
RMSD from ideality     
    Bond lengths (Å) 0.012 0.013 0.012 0.012 




    Bond angles (°) 1.054 1.318 1.055 1.048 
Ramachandran plot      
    Residues in most 
favoured regions (%)  
88.1 88.1 88.5 88.9 
    Residues in additionally 
allowed  regions (%)         
10.7 10.7 10.7 10.4 
    Residues in generously 
allowed regions (%) 
0.7 0.7 0.4 0.4 
    Residues in disallowed 
regions (%) 
0.4 0.4 0.4 0.4 
Mean B-factor (Å2)     
    Protein  11.9 9.4 14.2 10.3 
    Binding sited 9.1 6.7 11.2 7.6 
    Inhibitor 12.0e 8.4e 14.4e 9.2e 
    Water molecules 28.0 27.1 30.5 26.9 
a
 Numbers in parenthesis are for the highest resolution shell. 
b The inhibitor atoms from the additional disordered part were not considered 
c All inhibitor atoms which were included in the refinement model  
d Definition of the binding site: all amino acids which are 4 Å away from inhibitor. 
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6 Dissecting the Hydrophobic Effect on Molecular Level: The Role 




6.1 Introductory remarks 
This study was done in cooperation with the group of Prof. Dr. Hangauer (University of Buffalo). 
The following text will be submitted to a scientific journal. Nader Nasief from the Hangauer 
group is included as second author.  
 
6.2 Abstract 
The hydrophobic effect in protein-ligand complex formation is related to the successive 
replacement of binding-site water molecules by hydrophobic ligand portions. Even though it is 
assumed that the hydrophobic effect is primarily entropy-driven, detailed studies have revealed 
a much more complex picture involving either enthalpic or entropic effects. In thermolysin, 
adjacent to the ligand’s P2’substituents of increasing size and hydrophobicity, we observed in 
eight congeneric high resolution crystal structures systematic changes and perturbations of the 
local water network in the first solvation layer around the protein. These changes correlate 
remarkably well with differences in the thermodynamic signature of protein-ligand binding. The 
substituents of increasing size and hydrophobicity replace a growing number of water 
molecules, however, depending on the local binding features of the perturbed water molecules 
and their embedding in the local water network a more enthalpic or entropic signature is 
created. With respect to the Gibbs free energy of binding pronounced enthalpy/entropy 
compensation is in operation. However, there are no arguments why the hydrophobic effect 
should be predominantly enthalpic or entropic, small structural changes in the binding features 
of the water molecules finally determine whether hydrophobic binding to the hydrophobic 









The hydrophobic effect is attributed to the general driving force of nonpolar substances with 
extented lipophilic molecular surfaces to aggregate in aqueous solution excluding water 
molecules from the formed interfaces.(1,2) It is usually quoted to explain why a mixture of oil 
and water spontaneously separates, why soluble proteins fold with architecture showing 
hydrophobic core and hydrophilic outer surface(3,4), why membrane components assemble in 
lipid bilayers and micelles, why membrane proteins accommodate in membrane segments or 
why small molecules associate in protein binding pockets with mutual burial of hydrophobic 
surface portions.(5) In the later instance, it is a general strategy in medicinal chemistry to 
enhance protein-ligand binding through tailored increase of the ligand’s hydrophobic surface 
which becomes buried in hydrophobic pockets of the target protein. In all cases, the 
hydrophobic effect serves as an explanation for the association. On molecular level, the 
observed phenomena are related to the displacement of water molecules and entropic effects 
are made responsible to drive this association. Arguments are related to a change in the 
degrees of ordering and the extent of dynamic properties of the water molecules which are 
assumed to be more ordered and fixed next to surfaces than in the bulk water phase to where 
they are released upon hydrophobic association. Recent studies have demonstrated, however, 
that hydrophobic binding phenomena can originate either from enthalpy-driven or entropy-
driven binding, which makes the assumed clear-cut picture more blurred(6-12).  
To create a better understanding on the molecular level for the hydrophobic effect in case of 
protein-ligand binding we embarked on the systematic study of thermolysin (TLN)(6), a 
thermostable bacterial zinc metalloprotease from Bacillus thermoproteolyticus which exhibits 
three specificity pockets of predominantly hydrophobic nature (Figure 1). Despite of 
remarkable sequence differences to other zinc metalloproteases, this protein has been 
considered prototype for the entire class of enzymes(13) due to a highly conserved active-site 
architecture. It has frequently been used as surrogate for the development of new drugs 
against other metalloenzymes or served as a model system to test ideas and methodological 
concepts, e.g. in identifying potential drug candidates(14-17) or to investigate probe 
molecules(18,19) and fragments.(20) TLN was one of the first metalloproteases for which a crystal 
structure was determined.(21,22) Its easily accessible catalytic center consists of the central zinc 
ion coordinated by His142, His146 and Glu166. The adjacent S1 subsite is rather unspecific and 




accommodates hydrophobic ligand portions.(23) In contrast, the S1’ pocket is a deep and well-
defined cavity and it also accommodates preferentially hydrophobic residues such as the side 
chains of valine, leucine, or phenylalanine and determines substrate specificity of TLN.(24) The 
neighboring S2’ pocket is shallow and flat. Even though it has clearly hydrophobic 
characteristics, it is well accessible to the bulk water phase. Nevertheless, with respect to the 
binding of ligand side chains, it hosts similar groups as the S1’ pocket. Based on recently 
determined high-resolution crystal structures, a sophisticated arrangement of a complex water 
network has been observed next to the S2’ pocket that takes dominant influence on binding 
properties of accommodated ligands.(25,26) 
Potent TLN inhibitors are often designed as transition state analogs addressing both 
hydrophobic S1’ and S2’ pockets, e.g., the highly potent phosphoramidon comprises a 
phosphinate group to coordinate the catalytic zinc ion in bidentate fashion.(23,27,28) Besides zinc 
binding, the occupancy of both hydrophobic cavities is of utmost importance. Inhibitors 
occupying the S1’ pocket with an isobutyl instead of a methyl side chain exhibit a dramatic 800-
fold enhanced potency whereas for S2’ a 50-fold increase is experienced.
(6) Furthermore, 
increasing the hydrophobic interactions in the S1’ pocket is strikingly enthalpy-driven and not, 
as assumed for the classical hydrophobic effect, entropically beneficial.(6) The favorable 
enthalpic signal, observed for growing hydrophobicity of the P1’ substituent in the congeneric 
series, was attributed to “poor solvation” of the S1’ pocket. The latter property most likely does 
not relate to a water-free enzyme pocket in unbound state but to the accommodation of 
several highly mobile water molecules which are scattered over multiple positions and thus are 
hardly detectable by crystal structure analysis.  
Homans et al.(7,8) reported on a similar enthalpy-driven hydrophobic interaction which has also 
been attributed to suboptimal solvation of a protein pocket. The desolvation enthalpy of the 
protein binding pocket is strongly reduced that overall the thermodynamic signature shifts to 
an overwhelmingly enthalpy-driven Gibbs free energy of the binding process. Synder et al.(9) 
also received an enthalpy-driven thermodynamic profile for heterocyclic aromatic sulfonamides 
with increasing hydrophobic properties against carbonic anhydrase. They explain the observed 
differences with changes in the number and organization of well-ordered water molecules in 
the binding site. In a study regarding the displacement of several well-ordered water molecules 
from the S3/4 pocket of thrombin by increasingly hydrophobic P3 substituents of peptidomimetic 
inhibitors we observed an entropy-driven signal.(10) In the field of host-guest chemistry several 




examples of complex formation have been reported that either relate to enthalpy or entropy 
increase.(11,12) These studies indicate that the thermodynamic signature of hydrophobic binding 
is determined by changes in the water structure and the observed thermodynamic signature is 
obviously dependent on the status of the water molecules being reorganized during the binding 
process.  
Since the S1’ and S2’ pockets of TLN exhibit opposing features with respect to the observed 
solvation pattern and shape but can host chemically similar molecular ligand portions, we 
embarked on the study of a congeneric series of peptidomimetics with step-by-step 
modifications in the P2’ side chain addressing the S2’ pocket. The complex structures are 
analyzed crystallographically to investigate changes in the water structure, modulated by 
interactions of the P2’ side chains. Isothermal Titration Calorimetry (ITC) data were recorded to 
complement crystallographic findings and to reveal the driving forces associated with 
hydrophobic binding to the S2’ pocket of TLN.  
 




6.4 Results  
6.4.1 Analysis of the binding mode of the parent scaffold 
The crystal structures of 8 TLN inhibitors containing the Cbz-Gly-(PO2)¯-L-Leu-L-X scaffold (Cbz = 
carboxybenzyl, X = Gly 1, Ala 2, Et-Gly 3, Val 4, nPr-Gly 5, Ile 6, Leu 7, Phe 8; s. Table 1) in 
complex with thermolysin have been determined with high resolution (1.28 - 1.66 Å). Crystal 




structures with ligands 1, 2 and 7 have been studied previously by us,(6,25) for TLN-7 the original 
data have been newly refined to apply the same protocol to all complexes. As the binding mode 
of the parent scaffold has already been described,(25) we will only briefly depict the 
predominant interactions of the ligand to TLN’s active site and focus on novel structural 
features in the series.  
 
Table 1: The designed ligands are given along with the kinetically determined inhibition contants and the binding 
free energies. 
 
Ligand name Modification R Ki (nM) ΔG (kJ/mol) from Ki 
1 
 
472.3 ± 36.0 - 36.1 ± 0.2 
2 
 
19.1 ± 0.6 - 44.0 ± 0.1 
3 
 
4.8 ± 0.2 - 47.4 ± 0.1 
4 
 
5.7 ± 1.2 - 47.0 ± 0.5 
5 
 
5.5 ± 0.9 - 47.1 ± 0.4 
6 
 













10.3 ± 1.3 - 45.6 ± 0.3 
8 
 
54.0 ± 13.6 - 41.5 ± 0.6 
 
The electron density of the scaffold is well defined for all the studied inhibitors 
(representatively shown for 3 in Figure 2), and no significant changes in the binding mode are 
observed among all ligands (Figure 3). Their Cbz moiety binds to the unspecific S1 pocket, the 
central phosphonamidate group coordinates the zinc ion, and the leucyl P1’ and structurally 
varied P2’ substituents interact with the hydrophobic environment of the S1’ and S2’ pockets. 
The phenyl ring of the Cbz moiety is able to interact with CD2 of Phe114 through van-der-Waals 
contacts (4.0 Å, Figure 4 a). Furthermore, this moiety is fixed in position by the interaction with 
the carbonyl oxygen of the adjacent Trp115 (3.5-3.7 Å) and a glycerol molecule immobilized 
below the phenyl ring. The binding position of the Cbz moiety is clamped by intermolecular 
contacts to a neighboring mate in crystal packing. In all studied inhibitors, apart 5 and 7, we 
observed a second conformer for the Cbz carbonyl group. One conformer orients the carbonyl 
oxygen towards Phe114 (3.5 Å, Figure 4 a), in the second the carbonyl oxygen interacts water-
mediated through short H-bonds with unperturbed geometry (distances 2.4 and 2.7 Å, angle: 
104.6°) with the inhibitor’s terminal carboxylate group. The occupancy of the second conformer 
refines to 37 % for 3, across the whole series it ranges between 37 % and 48 %. Likely, resolving 
this binding feature strongly depends on the accuracy of the determined crystal structure. For 
TLN-5 and TLN-7 where no additional conformer for the Cbz carbonyl group of the ligand is 
evidenced, the resolution amounts to 1.66 Å and 1.56 Å respectively, in all the other structures 
with the additional conformer present, a resolution < 1.60 Å is experienced.  
The inhibitor’s phosphonamidate group interacts with the zinc ion in monodentate fashion 
positioning one oxygen towards the zinc ion (2.0 Å) and the other towards OE1 of Glu143 (2.6 
Å, Figure 4 b). The NH group of the phosphonamidate is strongly hydrogen-bonded to Ala113 
(2.8 Å). The isobutyl group of the leucine fragment fits perfectly well into the S1’ pocket forming 




multiple van-der-Waals contacts (3.7 - 4.1 Å) to hydrophobic residues in this pocket (e.g. 
Leu133, Val139, Ile188 and Leu202, Figure 4 c).  
 
Figure 2: Inhibitor 3 in complex with TLN. View of the active site with the solvent-accessible surface of the protein 
in grey. Water molecules are not shown for clarity, the ligand is visualized by Fo-Fc difference electron density 
(green) at 2σ. The blue sphere represents the zinc ion.   
 
 
Figure 3: Superposition of TLN-1, TLN-2, TLN-3, TLN-4, TLN-5, TLN-6, TLN-7 and TLN-8. Water molecules are 









Figure 4: Crystallographically determined binding mode of 3. The detailed interactions are illustrated next to the 
Cbz group (a), the phosphonamidate (b) and the P1’ side chain in the S1’pocket (c). Oxygen is coloured in red, 
nitrogen in blue, phosphorous in orange, carbon in white (protein) and in yellow (inhibitor). Distances in Å are 
depicted as dotted lines.  
a)             b) 




                                   
6.4.2 Analysis of the binding mode of the hydrophobic P2’ substituent in the S2’ pocket 
Major differences between the complexes are indicated with respect to the water network 
adjacent to the S2’ pocket. This network is perturbed and modulated by the size of the P2’ 
substituent. Unfortunately, not all complexes could be determined to the same resolution, the 
valyl 4 derivative even shows some disorder in this crucial region. For the related n-propylglycyl 




5 residual difference density indicates that some disorder of the side chain might be given, 
however we decided to describe the final density by one model. Local disorder makes the 
reliable detection of water molecules with increasing distance from the protein surface or from 
polar ligand functional groups difficult; particularly if chains of contiguously connected water 
molecules are analyzed. Therefore, the diffraction properties of the crucial water molecules 
have been thoroughly inspected by difference electron density maps (Fo-Fc) to examine the 
accuracy and reliability of the hydration properties of the S2’ pocket. Particularly, the B-factors 
and occupancies which are highly correlated have been regarded with care. These limitations 
complicate a straight-forward comparison of absolute numbers of water molecules across the 
ligand series, especially considering the relative inventory of released or picked-up water 
molecules. The distances along the water network vary and may even correlate with the 
strength of formed hydrogen bonds. However, the determined spatial accuracy of individual 
water positions can be affected by, e.g. residual mobility, disorder or partial occupancy which 
limits positional accuracy. Therefore, we refrained from any detailed analysis of H-bond length 
variations. 
 
6.4.3 Water network patterns  
Virtually the same solvation pattern is observed for all complexes next to the Cbz carbonyl and 
negatively charged terminal carboxylate group (Figure 5, upper part). A network of at least 
seven mutually connected water molecules mediates interactions between the latter two 
ligand functional groups and Asp226, Asn227 and Asn112. In two complexes water molecules 
corresponding to the second solvation shell are indicated (TLN-4, TLN-5).  
A more complex pattern is observed next to the area of the S2’ pocket where the growing P2’ 
side chain extends and perturbs the water network (Figure 5, lower part). In a previous study 
the crystal structures of TLN-1 and TLN-2 have been compared.(25) The glycine derivative 1 
shows two water molecules hydrogen-bonded to the backbone carbonyl group of Asn111 
which are repelled from the TLN-2 complex (Figure 6 a, encircled in cyan) due to the steric 
conflicts of the attached methyl group in the alanyl derivative 2. In contrast, the latter recruits 
two additional water molecules (Figure 6 b, encircled in yellow and green) which are picked-up 
and find favorable van-der-Waals contacts with the terminal methyl group. In TLN-2 the water 




network establishes a contiguously connected water chain from the ligand’s carboxylate group 
to Asn111(C=O), whereas in TLN-1 the water network is ruptured. 
Figure 5: Binding modes of the ligands 1-8 next to the S2’ pocket. All eight ligands (color coding, cf. Fig. 6) are 
superimposed and the corresponding solvation shells are shown as colored spheres. In the upper part a virtually 
identical water network pattern is indicated, differences in the number of water molecules assigned to the density 
are most likely attributed to differences in the resolution of the individual structure determinations (1.28 – 1.66 Å). 
In the lower part next to the varied P2’ substituent of the ligand pronounced differences in the water network 
pattern can be detected.  
 
Figure 6: Binding modes of the ligands 1-8 (a-h) next to the S2’ pocket. Each complex is shown with a different 
color, heteroatoms in atom-type color coding, water molecules as spheres with the same color as the parent 
structure. The same colors are used in Fig. 5. In TLN-1 two water molecules (encircled in cyan) are present that are 
replaced in the other complexes due to steric requirement of the growing P2’ substituent. TLN-1 shows a break in a 
contiguously connected water network (red arrow) which is closed in TLN-2 and TLN-3 by the pick-up of an 
additional water molecule (encircled in yellow) which is stabilized by favorable van der Waals contacts with the P2’-
methyl or ethyl group in 2 or 3. Similar favorable van der Waals interactions help to accommodate a water 
molecule at a position capping the ligand’s carboxylate group (encircled in green) in 2, 3, 4, and 5. In the 
complexes with 6, 7 and 8 this water molecule is repelled, whereas 8 picks up a water molecule (encircled in 
magenta) next to the benzyl moiety of the ligand’s P2’ substituent.  
             a)      b) 
                                  
             




            c)                  d) 
                                 
             e)      f) 
                                 
             g)      h) 
                                 
                           
A comparison of the water networks in TLN-2 and TLN-3 (Figure 6 b, c) suggests nearly identical 
patterns, whereas those in TLN-4 and TLN-5 (Figure 6 d, e) seem to deviate and they are 
disconnected at the lower left rim of the pocket, nonetheless the valyl 4 and n-propyl 5 
derivatives display very similar water network patterns. In TLN-4, the propyl side chain is 
scattered over at least two conformations. This partial disorder is translated to the neighboring 




Leu202 residue as its iso-butyl side chain adopts two conformations which refine to 55 % and 
45 % occupancy, respectively (Fig. 7). Both conformations occur in correlated manner due to 
mutual steric interference. Considering the water molecules picked up by TLN-2 and 3 
compared to TLN-1, the complexes with 4 and 5 show the water molecule capping the position 
of the carboxylate group (Figure 6 d, e, encircled in green). 
 
Figure 7: (a) Crystallographically determined binding modes of TNL-4 (yellow) and TLN-5 (orange), heteroatoms 
type-coded, water molecules indicated as spheres with the same color as used for the respective crystal structure. 
The side chain of the P2’ substituent is observed with disorder over at least two conformations. (b) In case of the 
valyl derivative 4 the difference density suggests that also the side chain of the adjacent Leu202 residue adopts 
two conformations. Most likely conformation A corresponds for steric reason to the conformer A of the ligand, 
whereas conformation B aligns with ligand conformer B of the P2’ substituent. Selected distances in Å are depicted 
as dotted lines.  












The complex of the Ile derivative 6 (Figure 6 f) makes again a contiguously connected water 
network evident which wraps around the terminal hydrophobic group as also seen in TLN-2 and 
TLN-3. The network takes a more extended detour around the butyl group compared to TLN-2. 
TLN-7, reported in a previous study (PDB code 3FWD(6)), was re-refined in the present study to 
apply exactly the same refinement protocol and program suite. Even though the indicated 
network is not as complete as for TLN-6, a related pattern is indicated for TLN-7 (Figure 6 g).  
Remarkably, for both complexes the water molecule at the position capping the carboxylate 
group is no longer present for steric reasons, the site occupied in all complexes with 2, 3, 4, and 
5 (Figure 6 b - e, encircled in green) would sterically interfere with the more bulky butyl side 




chains in TLN-6 and TLN-7. Finally, TLN-8 with a terminal benzyl moiety shows the least amount 
of ordered water molecules next to the S2’ pocket. Is seems that nearly all water molecules 
observed in other complexes close to the lower rim of the S2’ pocket are either repelled or not 
sufficiently well ordered. Most likely this correlates with increasing steric requirements of the 
benzyl group which fills the S2’ pocket quite significantly. Remarkably, however, one water 
molecule returns back into the complex next to the ligand binding site that is also found in TLN-
2 and TLN-3 (Figure 6 h, encircled in magenta) and occupies a site very close to the ligand. This 
site is clearly not accommodated in TLN-6 and TLN-7. At this site in TLN-8 a water molecule 
finds stabilizing interactions (3.2 Å) with the π-system of the ligand’s neighboring phenyl ring 
(Fig. 8). Interestingly enough, the water molecule at the position capping the ligand’s 
carboxylate group is missing in TLN-8, apparently again due to steric interference with the 
ligand’s terminal P2’ substituent.  
 
Figure 8: (a) Crystallographically determined binding modes of TLN-2 (light green) and TLN-6 (white), and TLN-8 
(beige), heteroatoms type-coded, water molecules indicated as spheres with the same color as used for the 
respective crystal structure. In TLN-2 and TLN-6, a contiguously connected chain of water molecules is indicated 
that wraps around the protruding P2’ substituent. With the larger Ile residue the network takes a larger detour. 
Only TLN-2 with the small P2’ substituent allows accommodation of a water molecule capping the position of the 
ligand’s carboxylate group (encircled in red). In the Phe complex TLN-8 a similarly connected network is not 
indicated, however this complex picks up a water molecule in close neighborhood of the ligand (encircled in blue). 
It almost matches with the position of a water molecule found in TLN-2. (b) This water molecule in TLN-8 is 
stabilized through interactions with the aromatic system of the P2’-Phe substituent in 8 (encircled in blue). 
Furthermore the Phe substituent penetrates deeply into the S2’ pocket and pushes the backbone carbonyl group of 
Asn111 out of space. This adopts two alternative conformations A and B, both are most likely energetically 
destabilized as indicated by unfavorable geometric distortions.  
a)                    b) 
 
 




The bulky benzyl group in TLN-8 takes impact on the neighboring protein molecule. It interfers 
with the carbonyl group of Asn111 which is pushed to a different position giving rise to two 
split conformations (Fig. 8). This perturbance seems to parallel a partial loss of planarity of the 
peptide bond between Asn111 and Asn112 which is not observed in the other complexes of the 
series (ω angle deviates from planarity by 10.4° and -17.3°, more details Table 2). Apparently, 
the carbonyl oxygen evades in two directions to create enough space for the large benzyl side 
chain of 8. The φ angle in conformation B is - 3.7° indicating the amide nitrogen to adopt nearly 
planar geometry. The φ values in the other complexes range between 51-55°. The ψ angles of 
conformation A (- 158.9°) and B (- 125.0°) also show remarkable differences from the other 
complexes where ψ ranges between 166-168°. Despite the efforts on the protein side to 
generate the required space for 8, conformer A is still in very close distance to one of the ring 
carbons of 8 (2.3 Å). The pronounced deviation from planarity of the peptide bond in B, even 
avoiding a steric clash with the ligand’s phenyl moiety, is supposed to be quite unfavorable 
because it disturbs the electronic conjugation across the amide bond. A closer inspection of the 
B-factors in the terminal part of the phenyl ring indicates that this part of the ring is scattered 
over more than one orientation which corresponds to the evasion of the carbonyl group in two 
directions. Despite these slight perturbances, the phenyl ring of 8 achieves pronounced π-
stacking with the carbamide group of Asn112 (3.7 Å) and extended van-der-Waals contacts to 
the phenyl side chain of Phe130 (3.3 Å) through mutual parallel packing. 
 
Table 2: Torsion angles of the peptide bond Asn111-Asn112 are listed in the respective structure.  
 Ω (°) Ψ (°) Φ (°) 
TLN-1 179.9 51.4 - 166.3 
TLN-2 178.7 53.1 - 167.8 
TLN-3 179.2 54.0 - 167.8 
TLN-4 178.6 54.3 - 167.2 
TLN-5 177.5 54.9  - 166.8 
TLN-6 177.3 55.3 - 167.8 
TLN-7 176.7 55.5 - 167.4 




TLN-8 (Conf. A) 169.6 53.7 - 158.9 
TLN-8 (Conf. B) - 162.7 - 3.7 - 125.0 
 
6.4.4 Thermodynamic binding data 
The thermodynamic binding properties of each inhibitor have been determined by ITC. 
Unfortunately, no absolute values could be recorded as the experiments are superimposed by 
the displacement of the cleavage product Val-Lys produced by autoprotolyses at high TLN 
concentrations. In this respect, all measured thermodynamic values are associated with a 
constant contribution resulting from the displacement of Val-Lys upon inhibitor binding. Since 
we focus on relative differences within the ligand series, replacement of the dipeptides cancels 
out. To obtain an independent confirmation of the binding data we recorded the enzyme 
kinetic inhibition data of all inhibitors 1-8, despite a constant offset they show very similar 
increments among the compounds (Table 1).  
Furthermore, a buffer dependence of our recorded ITC data is given which shows that all 
complexes pick-up one proton per mol formed ligand-protein complex. It could be shown that 
Glu143 next to the catalytic zinc ion changes its protonation state upon inhibitor binding. 
Englert et al.(29) reported on a buffer dependence of the enthalpy term in a series of 
phosponamidates. Similarly also in our phosphonamidate series a protonation step is 
superimposed to the binding process. The origin, however of the protonation change remained 
unclear. In 1987 Holden et al.(30) stated that the decrease of bond angles at the 
phosphonamidate nitrogen and the concurrent increase in P-N bond length in the complex is an 
indication for a cationic state of nitrogen. Later Copié et al.(31) could not confirm this hypothesis 
by NMR measurements. In order to provide additional evidence for the assumed protonation 
step, we studied two ligands supposedly capable to trace the ligand functional group 
responsible for proton uptake. In the phosphonester 9 the amidate nitrogen is replaced by an 
oxygen and the phosphonamidate analog 10 which lacks the terminal carboxylate group (Figure 
9). 9 records possible protonation of the amidate nitrogen (i.e. -NH2
+-) and 10 elucidates 
whether the carboxylate group is involved in the protonation reaction (i.e. -COOH). ITC 
measurements of 9 and 10 in three different buffers revealed similar buffer dependencies in all 
cases (Figure 10). Thus for all ligands (1, 2, 9, 10 displayed), in molar ratio one proton is taken 




up per mol formed ligand-protein complex, suggesting that the protein and not the ligand 
changes protonation state.  
 
Figure 9: Depiction of the strategy to elucidate whether the ligand is involved in the protonation reaction. 
 
 
Figure 10: The observed enthalpy Hobs for binding of 1, 2, 9 and 10 to thermolysin as a function of the 
deprotonation enthalpy Hion of the three applied buffers Tris, Hepes and Aces at pH 7.5. The slope of the linear 
regression yields the molar ratio of protons captured during the binding reaction. For all investigated ligands the 
same amount of protons is picked-up by the complex (0.9-1.3 mol). 
 
 
To further trace where protonation might occur, a reliable structure without the Val-Lys 
dipeptide would be required. As all trials failed to remove the dipeptide, e.g. by dialysis, we 
attempted to stop TLN self-digestion by removal of zinc, soaking crystals with the chelator 1,10-
phenanthroline since the zinc-free protein has been reported as inactive.(32) Refinement of 




diffraction data collected with thus treated crystals indicates that 50 % of the zinc ions were still 
present in the active site. Fortunately, the partial zinc removal was sufficient to obtain crystals 
free of the protolysis product Val-Lys. Instead, a DMSO molecule accommodates the S1’ pocket 
picked up from the crystallization buffer and an acetate ion coordinates the zinc ion (Figure 11 
a). This structure shows Glu143 in proximal geometry to the zinc ion (Figure 11 b). This suggests 
the glutamate to be deprotonated in the apo structure as it allows forming a charge-assisted 
interaction of its carboxylate with the positively charged zinc ion. In contrast, in the complexes 
with bound phosphonamidates Glu143 is pushed away by 2.6 Å from the zinc ion to interact 
with the oxygen of the phosphonamidate moiety. This geometry is also observed in the zinc 
free protein (PDB code 3FB0).(33) Considering the uncomplexed and complexed TLN, Glu143 
switches its interaction partner from a positively charged to partially negatively charged 
species, which most likely requires a change in protonation state of the latter residue, 
otherwise formation of a hydrogen bond between its carboxylate group and the 
phosphonamidate oxygen appears impossible.  
 
Figure 11: a) Crystal structure of dipeptide free TLN but in complex with DMSO and an acetate ion in the active 
site is shown. The Fo-Fc difference electron density is shown in green at 2σ. The solvent accessible surface of TLN 
is depicted in grey. Water molecules are displayed as red spheres. b) Superposition of different TLN structures:  in 
white complexed with 3, in green a zinc free TLN (3FB0), in cyan complexed with ruthenium-III (3FXS), in 
magenta complexed with copper-II (3FBO) and in blue complexed with DMSO (our apo structure).  
 
 
As our apo structure exhibits only partial population of the zinc ion, we consulted the 
catalytically inactive TLN iso forms where the zinc ion has been exchanged by either copper-II 




(PDB code 3FBO(33)) or ruthenium-III (PDB code 3FXS(33)) (Figure 11 b). Also in these structures, 
Glu143 is in a geometry directly coordinating to the central metal ion which also suggests 
deprotonated state. Interestingly, these observations are in agreement with the proposed 
catalytic mechanism of TLN which involves displacement of a zinc-bound water molecule 
towards the deprotonated Glu143 by the incoming substrate.(34,35) A negatively charged 
glutamate enhances in this step the nucleophilicity of the water molecule and transfers a 
proton to the leaving amine. As this residue is not directly involved in ligand binding of the P2’ 
portion, the thermodynamic data will be affected for all complexes in the same way, thus in a 
relative comparison also this contribution cancels out.  
Figure 12 illustrates that, apart from TLN-1, binding becomes increasingly more entropic with 
growing size of the attached hydrophobic P2’ substituent, nevertheless, also significant 
enthalpy-entropy compensation is observed. Across the series, the absolute changes in 
enthalpy and entropy are much larger than those of the free energy due to mutual 
compensating effects.   
A remarkable gain in potency (ΔΔG1/2 = - 5.7 kJ/mol) is obtained for 2, compared to 1 which is 
mainly due to an increase in enthalpy (ΔΔH1/2 = - 13.4 kJ/mol). This effect is partly compensated 
by the lower entropic signal of 2 relative to 1 (- TΔΔS1/2 = 7.7 kJ/mol) (Table 3). Across the 
remaining series the Gibbs free energy seem to improve continuously from 1 to 5, the 
remaining ligands 6, 7 and 8 loose slightly in affinity (Figure 12). 
 
Table 3: Binding data ΔG0, ΔH0 and - TΔS0 (kJ/mol) of ligands determined by ITC. 
Ligand name ΔG0 (kJ/mol) ΔH0 (kJ/mol) -TΔS0 (kJ/mol) 
1 - 32.8 ± 0.1 - 19.0 ± 0.5 - 13.8 ± 0.4 
2 - 38.5 ± 0.3 - 32.4 ± 0.3 - 6.1 ± 0.1 
3 - 40.7 ± 0.2 - 33.6 ± 0.7 - 7.1 ± 0.9 
4 - 40.6 ± 0.1 - 31.0 ± 0.2 - 9.6 ± 0.1 
5 - 40.6 ± 0.4 - 30.4 ± 0.2 - 10.2 ± 0.3 
6 - 38.7 ± 0.2 - 22.7 ± 0.9 - 16.0 ± 0.7 
7 - 39.4 ± 0.8 - 21.8 ± 0.1 - 17.6 ± 0.7 
8 - 36.5 ± 0.1 - 18.3 ± 0.4 - 18.2 ± 0.5 
 




Figure 12: a) The diagram shows the thermodynamic results for G (blue), H (green) and -T S as obtained by ITC. 
The experiments were performed in Hepes buffer and not corrected for superimposed protonation steps and 
replacement of the autocleavage product Val-Lys. b) To show the relative differences, mutual enthalpy-entropy 
compensation leading to minor free energy changes and stepwise changes in terms of related pairs the 







Considering closely related ligand pairs some systematics seem to be given in the series. The 
pairs 2/3 (ΔΔH2/3 = - 1.2 kJ/mol, - TΔΔS2/3 = - 1.0 kJ/mol), 4/5 (ΔΔH4/5 = - 0.6 kJ/mol, - TΔΔS4/5 = 
0.6 kJ/mol) and 6/7 (ΔΔH6/7 = 0.9 kJ/mol, - TΔΔS6/7 = - 1.6 kJ/mol) exhibit very similar properties 




to each other, whereas the steps from 3 to 4 (ΔΔH3/4 = 2.6 kJ/mol, - TΔΔS3/4 = - 2.5 kJ/mol) and 
5 to 6 (ΔΔH5/6 = 7.7 kJ/mol and - TΔΔS5/6 = - 5.8 kJ/mol) involve larger changes. The 
phenylalanine derivative shows again an altered thermodynamic signature with balanced 
enthalpic and entropic portions.  
 
6.5 Discussion 
In the studied series of peptide-like transition state analog inhibitors the terminal hydrophobic 
substituent is gradually grown into the S2’ pocket of thermolysin. This pocket opens as a flat 
and widely opened crevice towards the bulk solvent. Apparently, it can host substituents up to 
the size of a benzyl moiety. This group fills the pocket quite substantially. It pushes to the limits: 
the carbonyl group of an adjacent backbone peptide group has to move out of space for steric 
reasons. It evades in two directions, so that two alternative geometries are produced, both 
likely to be strained and energetically disfavored. 
Even though, the hydrophobic surface grows from hydrogen in the Gly to phenyl in the Phe 
derivative (1 - 8) by approximately 160 Å2, overall the Gibbs free energy improves only by -3.7 
kJ/mol. This is a minor contribution considering as a rough estimate about - 2 to - 3 kJ/mol per 
methyl group that becomes buried upon protein binding.(36) In total we would expect a much 
larger value as hydrophobic effect for this change. Interestingly enough, the affinity shows an 
optimum with an ethyl (3), iso-propyl (4) or n-propyl (5) substituent, even though in terms of 
size these groups do not yet fill the S2’ pocket optimally. More remarkable is the trend in 
enthalpy/entropy partitioning (Fig. 12). The absolute difference is largest with the most potent 
inhibitors and changes are observed not constantly across the series but systematically distinct 
pairs are indicated: 2/3, 4/5 and 6/7 exhibit closely similar thermodynamic profiles (Figure 12). 
This suggests similarities in the structural properties. 
Analyzing the binding modes of 1 - 8, the parent scaffold remains virtually unchanged across 
the entire series. Also the interaction pattern next to the ligand’s Cbz group and terminal 
carboxylate groups which involves at least seven conserved water molecules and mediates a 
complex network between ligand and protein functional groups is highly conserved (Fig. 5 
upper part) and no changes are visible for the contact to the glycerol and DMSO molecules 
picked up from the cryo buffer. Thus, the only differences occur next to the hydrophobic P2’ 




substituent of increasing size (Figure 5 lower part). Here, the network of adjacent water 
molecules is highly perturbed.  
A huge change in the thermodynamic profile is experienced by adding a methyl group to the 
glycine derivative 1 to feature an alanine substituent 2. One difference is clearly given by the 
fact that the Gly derivative has in solution, prior to protein binding, access to a larger 
conformational space than the Ala analog. In consequence, TLN-2 will experience a smaller loss 
in entropy than TLN-1. However, additional effects are in operation. As already shown in 
previous studies(25) also involving the non-carboxylated analogs of 1 and 2, this effect can be 
explained by the rupture of the contiguously connected water network which wraps around the 
terminal methyl group in 2 (Figure 6 a, b). Obviously, this methyl group provides favorable 
interaction sites for two additional water molecules which stabilize their binding positions 
through van-der-Waals contacts. Vice versa, two water molecules H-bonded in TLN-1 to 
Asn111(C=O) are repelled from the complex due to steric conflicts with the attached methyl 
group in 2. The rupture of the contiguously connected H-bonding network disfavors exothermic 
binding of 1 whereas binding of 2 is entropically less favorable due to a stronger fixation of the 
water network. Accordingly, the step from 1 to the more hydrophobic 2 is enthalpy-driven and 
we would have to classify this change as “non-classical hydrophobic effect”.  
The ethyl derivative 3 shows nearly an identical thermodynamic signature as 2. As either 
enthalpy and entropy increases, ΔΔG improves by - 2.2 kJ/mol; a value found in the typical 
range for favorably placed methyl groups. Structurally, TLN-3 is nearly identical with TLN-2. The 
iso-propyl and n-propyl derivatives 4 and 5 share again very similar thermodynamic properties, 
but they are found with different enthalpy/entropy values compared to the former pair 2/3. In 
TLN-4 the substituent is scattered over two conformations and also a slightly disordered side-
chain of Leu202 is detected. In TLN-5 some disorder of the P2’ substituent might be given, but it 
is less evident. Side-chain disorder translates into an entropic advantage of a formed complex. 
Next to the far end of the pocket two water molecules mediating the water network in TLN-2 
and TLN-3 cannot be detected and the network appears incomplete in TLN-4 and TLN-5. This 
should result, as seen for TLN-1, in an enthalpic loss and an entropic advantage. Both aspects, 
disorder and water release, will support the entropic advantage of TLN-4 and -5, however with 
respect to the free energy, the latter advantage is nearly canceled out. Nonetheless it is 
remarkable, that 4 and 5 share not only similar thermodynamic signature but their detailed 
water networks resembles significantly and some similarity with respect a side-chain disorder 




seems to be given. The hydrophobic effect related to the change from 2/3 to 4/5 must be 
classified as “classical entropy-driven”. 
All four complexes TLN-2, TLN-3, TLN-4 and TLN-5 host one water molecule at a position 
capping the ligand’s carboxylate group. This position should be energetically favored for 
electrostatic reasons. Frequent occupancy of such carboxylate-water contacts has been 
highlighted by Pauline et al.(37) in protein structures and a clear preference for this geometry 
can be found in the compilation of water-carboxylate contacts as compiled in IsoStar.(38)  
 TLN-6 and TLN-7 place in ordered fashion a sec-butyl or isobutyl group into the S2’ pocket. 
Again both complexes experience a very similar enthalpy/entropy profile with strong enthalpic 
loss and entropic gain over the pair 4/5. With respect to their water solvation pattern, quite 
similar networks are observed that wrap around the terminal hydrophobic substituent and 
orient along the rim of the S2’ pocket. Compared to TLN-2 and TLN-3, in TLN-6 two water 
molecules are shifted in space to more remote positions to create an expanded network. 
Remarkably, the capping water above the carboxylate group is no longer seen due to steric 
conflicts with the size-increased butyl substituent. Obviously, the release of this special water is 
one determinant for the observed enthalpy loss and entropy gain which we would relate to the 
“classical hydrophobic effect”.  
Finally, the benzyl derivative 8 looses 2.9 kJ/mol in ΔΔG with respect to 7. This price is paid by 
enthalpy in agreement with the steric clash provoked with the backbone carbonyl group of 
Asn111. Furthermore, also in this complex the capping water is repelled from the site above the 
carboxylate group. The solvation structure at the far end of the S2’ pocket appears to be 
thinned out, however, one water site close to the ligand is newly populated that has already 
been accommodated in TLN-2 and -3. A water molecule is most likely stabilized at this pivotal 
position perpendicular to the terminal aromatic benzyl moiety.  
All described structural features next to the S2’ pocket are additionally modulated by further 
contributions arising from desolvation differences of the ligands of increasing size.(39,40) 
Furthermore, slight differences will also relate to the deviating conformational properties of the 
P2’ substituents which exhibit different numbers of rotatable bonds. These contributions are 
overlaid to the perturbances of the water network and as a sum they describe quantitatively 
the observed thermodynamic profiles. As thermolysin is a very rigid protein influences resulting 
from changes of the residual mobility of protein residues or induced-fit adaptations, apart of 
TLN-8, will be of minor importance. Even so our discussion only intends a qualitative 




correlation, it is remarkable that complexes with side chains of comparable size and number of 
rotatable bonds show very similar thermodynamic signature.    
    
6.6 Conclusion  
The present series allows tracing details how the first solvation layer around a binding pocket 
takes impact on binding affinity of ligands. It also shows that water networks can take 
significant influence modulating structure-activity relationships. Growing hydrophobicity of 
ligand functional groups placed into hydrophobic binding pockets is usually discussed in terms 
of the hydrophobic effect. This effect has been related to enthalpic or entropic 
signature(6,7,11,12), however, most important it relates to changes in the local water 
structure.(6,8,9) The present series of closely related complexes shows that both, enthalpy and 
entropy are involved and many detailed structural phenomena determine the final signature. If 
a contiguously connected water network ruptures, an enthalpic loss and entropic gain are 
experienced.(25) This results from a loss of hydrogen bonds which allows the system to activate 
and distribute energy over more degrees of freedom. The displacement of ordered water 
molecules can result in an overall entropic signal, but the release of largely disordered waters 
can also reveal a predominately enthalpic signal.(6-9) However, particularly if ligand portions are 
accommodated in pockets opening to the bulk solvent and parts of the placed ligand are 
exposed to the water phase, also new binding sites for water molecules can be generated, e.g. 
in our study the position capping the carboxylate group or the site found on top of the benzyl 
ring. The capping water seems to provide a significant contribution. The three complexes TLN-6, 
-7 and -8 lack this water molecule due to steric conflicts and they lose in Gibbs free energy 
predominantly for enthalpic reasons. This is partly compensated by entropy as these complexes 
do not capture the water molecule, a process which is entropically unfavorable. All these 
phenomena contribute on the molecular level to the finally determined hydrophobic effect. In 
summary, there are no arguments why the hydrophobic effect should be predominantly 
“entropic” or “enthalpic”; small structural changes in the binding features of water molecules 
on the molecular level determine whether hydrophobic binding to hydrophobic pockets results 
in a more enthalpy or entropy-driven signature.    
Admittedly, the present study goes towards the limits of experimental accuracy, 
accomplishable in contemporary protein-ligand structural work. Assignment of water molecules 




to the difference electron density is crucial and depends on resolution and local ordering 
phenomena. However, in the present series eight crystal structures indicate similar and 
internally consistent solvation pattern which gives confidence about the necessary reliability to 
underscore its relevance. Our structural data originate from crystal environment taken from 
flash-cooled crystals which should capture a frozen-in image of the properties at ambient.(41) 
The thermodynamic data were recorded in solution. Nevertheless, a very consistent picture is 
received. Surprising pairwise systematics in the thermodynamic data are experienced for 
complexes of related ligands and they are convincingly well reflected by the structural 
properties. The present study unravels small but important details. Computational methods 
simulate molecular properties at atomic level and usually they are determined by the 
summation of many small details.(42) However, details as the ones observed in the present 
study are at present hardly regarded as relevant, simply because we are not really aware about 
their importance for protein-ligand binding, structure-activity relationships or rational drug 
design in general. Taking them into account will make our simulations not necessarily simpler, 
however, hopefully the present examples give the necessary evidence what is required to 
improve simulation models. 
 
6.7 Materials & Methods 
6.7.1  Crystallization and soaking  
Native thermolysin (purchased from Calbiochem) was crystallized as described by Holmes and 
Matthews(43) applying slight modifications. Thermolysin was dissolved in 100 % DMSO at 8 mM. 
Subsequently, the DMSO solution was diluted with the buffer 1:1 (100 mM Tris/HCl, 5 M CsCl, 
pH 7.5). The suspension was then vortexed and centrifuged for two minutes. The so achieved 
supernatant was used in the crystallization trial. This final solution contained 50 % DMSO and 
2.5 M CsCl. The final protein concentration in the crystallization drop was 4.0 mM. Crystals 
were grown at 18 °C by the sitting drop vapor diffusion method using water as reservoir 
solution. Protein-ligand complex crystals were obtained by soaking crystals in a solution of 100 
mM Tris/HCl, 2 mM CaCl and 10 % DMSO. For soaking, ligand concentration varied between 1 
and 5 mM. When low solubility was given, saturated solutions were used. Crystals were soaked 
between one and two days before freezing. 
 




6.7.2 Data collection and processing  
Crystals were prepared for data collection at 110 K using a cryoprotectant solution of 20 % 
glycerol in a buffer containing 10 mM Tris/HCl, 10 mM Ca(CH3COO)2, 5 % DMSO at pH 7.3. The 
data sets for 3-6, 8 and the apo structure were collected with synchrotron radiation at BESSY 
beamline 14.2 (Berlin, Germany) on a Rayonix MX 225 CCD detector. Data processing and 
scaling were performed using the HKL2000 package(44).  
 
6.7.3 Structure determination of the complex structures and refinement 
The complex structures were determined by molecular replacement. The coordinates of TLN 
(PDB code 8TLN)(45) were used for initial rigid body refinement of the protein molecules 
followed by repeated cycles of maximum likelihood energy minimization, simulated annealing 
and B-factor refinement using the CNS program package(46). All structures were then refined 
with PHENIX.(47) The temperature factors for structures 3, 4, 6 and 8 were anisotropically 
refined whereas for structures 5 TLS refinement was applied. The TLN-7 complex (3FWD) was 
re-refined with PHENIX to ensure a comparable refinement protocol and to reduce potential 
bias caused by the refinement program. The resulting structure remained virtually unchanged, 
however, now a total of 331 water molecules were refined. Also TLS refinement was applied. 
For the newly refined structure, the R-value could be improved to 15.2% with Rfree being 17.0%.  
The definition of the TLS groups was done with the TLSMD server(48,49). A randomly chosen 5 % 
of all data were used for the calculation of Rfree and were not used in the refinement. Amino 
acid side chains were fitted into σ-weighted 2Fo – Fc and Fo – Fc electron density maps using 
Coot(50). After the first refinement cycle, water molecules and subsequently ions and ligands 
were located in the electron density and added to the model. Restraints were applied to bond 
lengths and angles, planarity of aromatic rings and van-der-Waals contacts. Multiple side chain 
conformations were built in case an appropriate electron density was observed and maintained 
during the refinement, and if the minor populated side chain showed at least 20 % occupancy. 
The final models were validated using PHENIX own validation options or MolProbity(51). The 
Ramachandran plots were calculated with PROCHECK(52). Thr26 of TLN lies in a forbidden region 
of the Ramachandran plot, but this is frequently observed for residues located at the tip of a γ-
like turn.(53) Data collection, unit cell parameters and refinement statistics are given in Table 4. 
Analysis of temperature factors was done with Moleman(54) and fconv(55).  




6.7.4 Isothermal titration calorimetry (ITC) 
ITC experiments were performed using an ITC200™ system from MicroCal (now part of GE 
Healthcare, Northhampton, MA, USA). Thermolysin from Calbiochem was freshly prepared for 
each experiment in the buffer applied in the measurements. The comparison of the 
thermodynamic data of the dialysed and undialysed protein solution revealed no significant 
difference. Therefore, the undialysed protein solution was used in this study. The inhibitor 
solution was freshly prepared in the experimental buffer to the required concentration. The ITC 
experiments were done at 25 °C in a buffer composed of 20 mM Hepes, 500 mM NaSCN, 2 mM 
CaCl2 at pH 7.5. Inhibitor solutions (1-1.5 mM) were titrated into the sample cell containing the 
TLN solution (45.0 μM) after a stable baseline was achieved. ITC experiments comprised an 
initial ligand injection of 0.3 μl followed by 15 injections of 1-2 μl with a 300 s interval between 
each injection. The ITC cell volume was 200 μl. Raw data were collected and the area under 
each peak was integrated, followed by correction for heats of dilution and mixing by 
subtracting the final baseline consisting of small peaks of the same size to zero. The initial data 
point was deleted from the integrated data because this injection usually reflects an erroneous 
amount of heat due to the possible exchange of liquids between syringe and cell when inserting 
the syringe into the calorimetric cell and the backlash error in the motorized screw mechanism 
in the injector.(56) Data were analysed using ORIGIN Software (Microcal Inc.), by fitting a single-
site-binding isotherm(57) that yields ΔH0 (enthalpy of binding) and KD (dissociation constant). 
Measurements were performed at least in duplicate. The absolute values for ΔG, ΔH and –TΔS 
together with the estimated errors are listed in Table 3, the relative differences ΔΔG, ΔΔH and –
TΔΔs are given in Figure 12.   
 
6.7.5 Data deposition 
Coordinates and structure factors have been deposited in the Protein Data Bank with the 
following accession codes: TLN-3 complex 3T87; TLN-4 complex 3T8H; TLN-5 complex 3T8C; 
TLN-6 complex 3T8D; TLN-8 complex 4D9W, TLN-1 and TLN-2 were previously reported as 3T8G 
and 3T74, respectively. TLN-7 (3FWD) has been newly refined and deposited replacing the 
former refinement results. 
 




Table 4: Data collection and refinement statistics for the six TLN complex structures. 
 










Apo TLN     
(4D91) 
A. Data collection and processing       
No. Crystals used 1 1 1 1 1 1 
Wavelength (Å) 0.91841 0.91841 0.91841 0.91841 0.91841 1.9 
Space group P6122 P6122 P6122 P6122 P6122 P6122 
Unit cell parameters       
    a, b (Å) 92.7 92.8 92.6 92.8 93.1 93.4 
    c (Å) 131.1 130.1 130.4 130.1 130.9 129.9 
Matthews coefficient (Å3/Da) 2.4 2.4 2.4 2.4 2.4 2.4 
Solvent content (%) 48 48 48 48 48 48 
       
B. Diffraction dataa       
Resolution range (Å) 50 – 1.28 50 – 1.45 50 – 1.66 50 – 1.41 50 – 1.38 50 – 1.90 
 (1.30 – 1.28) (1.48 – 1.45) (1.69 – 1.66) (1.43 – 1.41) (1.40 – 1.38) (1.93 – 1.90) 
Unique reflections 83,248 58,688 39,580 64,097 68,072 49,334 
R(I)sym (%) 6.5 (37.8) 5.3 (36.3) 5.4 (22.0) 6.2 (49.4) 6.7 (50.0) 5.6 (33.3) 
Completeness (%) 97.0 (99.1) 99.5 (99.1) 99.7 (99.7) 99.8 (100.0) 98.6 (99.9) 98.3 (95.9) 
Redundancy 10.7 (9.0) 5.8 (5.7) 5.5 (5.4) 4.7 (4.6) 5.8 (5.9) 30.6 (27.5) 
I/σ(I) 30.6 (5.2) 30.0 (4.6) 28.8 (7.6) 23.3 (3.0) 23.4 (3.4) 82.5 (11.3) 
       
C. Refinement       
Resolution range (Å) 34.2 – 1.28 40.2 – 1.45 43.6 – 1.45 31.7 – 1.41 22.3 – 1.38 34.3 – 1.90 
Reflections used in refinement 80,710 / 4,106 56,621 / 2,860 38,705 / 1,949 60,892 / 3,082 64,916 / 3,315 48,848 / 2,393 
    (work/free)       
Final R values for all reflections 10.5 /12.7 12.3 /15.3 13.9 /16.6 12.6 / 15.3 10.9 / 14.0 15.0 / 18.4 
    (work/free) (%)       
Protein residues  316 316 316 316 316 316 




Calcium /zinc ions 4 / 1 4 / 1 4 / 1 4 / 1 4 / 1 4 / 1 
Inhibitor atoms 30b / 34c 31b / 41c 31 32b / 36c 35b / 39c - 
Water molecules 481 446 432 450 474 368 
RMSD from ideality       
    Bond lengths (Å) 0.014 0.011 0.011 0.012 0.014 0.017 
    Bond angles (°) 1.353 1.047 1.030 1.050 1.275 0.979 
Ramachandran plot        
    Residues in most favoured regions 
(%)  
87.8 88.1 87.8 88.5 87.8 88.5 
    Residues in additionally allowed           11.1 11.1 11.5 10.7 11.5 10.4 
        regions (%)       
    Residues in generously allowed 0.7 0.4 0.4 0.4 0.4 0.7 
        regions (%)       
    Residues in disallowed regions (%) 0.4 0.4 0.4 0.4 0.4 0.4 
Mean B-factor (Å2)       
    Protein  9.9 11.8 11.0 11.4 11.2 17.1 
    Binding sited 6.9 9.1 8.2 8.9 9.6 - 
    Inhibitor 9.8e 11.7e 11.2 11.4e 14.7e - 
    Water molecules 26.5 30.6 28.0 29.6 29.6 32.5 
a Numbers in parenthesis are for the highest resolution shell. 
b The inhibitor atoms from the additional disordered part were not considered 
c All inhibitor atoms which were included in the refinement model  
d Definition of the binding site: all amino acids which are within 4 Å from inhibitor. 
e Average B value for the ordered and fully occupied inhibitor portion, the disordered portions were not considered 




6.7.6 Phase determination and model building of apo structure of TLN 
Structure determination utilized the graphical interface of hkl2map (version 0.2)
58
, which 
connects several programs from the SHELX-suite
59
 to guide the user from analysis of scaled 
diffraction data (SHELXC), via substructure determination (SHELXD), to phasing 
(SHELXE). In addition to conventional SHELXE, we were able to use the new beta-test 
version (kindly provided by Prof. George Sheldrick), which includes auto-tracing of the 
protein backbone via a polyalanine model. Six sites were found which correspond to four 
calcium, one zinc and one sulfur atom from a DMSO molecule. 20 cycles of density 
modification were done resulting in a pseudo-free correlation coefficient of 54.5 % (see Table 
5 and 6 for further statistics). The initial phases achieved with hkl2map were submitted to the 
automatic model-building program ARP/wARP (version 7.0.1) included the program suite of 
CCP4. The TLN structure was built on the basis of the poly-Ala trace obtained from 
SHELXE_beta. After 200 building cycles, 311 residues were found in four chains with a 
connectivity index of 0.965. After loop building the structure contained 314 residues out of 
316. 
 
Table 5: Phasing statistics. 
 TLN apo structure 
Resolution range in Å 50 – 1.9 
D’’/sig(d’’) (SHELXC) max/min 3.72 – 0.96 
Resolution cut off (SHELXD) in Å 2.5 
CCmax (SHELXD) in % 52.6 
Number of sites 6 
Mean FOM (SHELXE_beta) 0.561 
CC in % (SHELXE_beta) 59.3 
CC in % (SHELXE_beta) for best cycle 7 44.2 
Connecitivity index  (SHELXE_beta) for best cycle 7 0.764 
Contrast (SHELX_beta) for best cycle 7 0.438 
Residues (SHELX_beta) for best cycle 7 310 in 11 chains 
 




Table 6: Data collection and refinement statistics for apo structure. 
Structure (PDB entry) Apo TLN (4D91) 
A. Data collection and processing  
No. Crystals used 1 
Wavelength (Å) 1.9 
Space group P6122 
Unit cell parameters  
    a, b (Å) 93.4 
    c (Å) 129.9 
Matthews coefficient (Å3/Da) 2.4 
Solvent content (%) 48 
  
B. Diffraction data  
Resolution range (Å) 50 – 1.90 
 (1.93 – 1.90) 
Unique reflections 49,334 
R(I)sym (%) 5.6 (33.3) 
Completeness (%) 98.3 (95.9) 
Redundancy 30.6 (27.5) 
I/σ(I) 82.5 (11.3) 
  
C. Refinement  
Resolution range (Å) 34.3 – 1.90 
Reflections used in refinement 48,848 / 2,393 
    (work/free)  
Final R values for all reflections 15.0 / 18.4 
    (work/free) (%)  
Protein residues  316 
Calcium /zinc ions 4 / 1 
Inhibitor atoms - 
Water molecules 368 
RMSD from ideality  
    Bond lengths (Å) 0.017 
    Bond angles (°) 0.979 
Ramachandran plot   
    Residues in most favoured regions 
(%)  
88.5 
    Residues in additionally allowed           10.4 
        regions (%)  
    Residues in generously allowed 0.7 
        regions (%)  
    Residues in disallowed regions (%) 0.4 
Mean B-factor (Å2)  
    Protein  17.1 
    Binding site - 
    Inhibitor - 
    Water molecules 32.5 
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7 Untersuchung der Kooperativität zwischen einer Wasserstoff-





7.1 Einleitende Bemerkungen/Introductory Remarks 
Diese Arbeit wurde in Kooperation mit der Arbeitsgruppe von Prof. Dr. Hangauer (University 
of Buffalo, USA) durchgeführt. Das Manuskript für die Veröffentlichung wird wie mit 
unserem Kooperationspartner vereinbart von Nader Nasief als Erstautor in englischer 
Sprache angefertigt. Der vorliegende Text wird daher in keiner Zeitschrift sondern nur in 
dieser Dissertation erscheinen. Ein herzlicher Dank geht an Nader Nasief, der an der 
Synthese der Verbindungen und der Interpretation der Daten beteiligt war, und an Prof. Dr. 
Engels, der die quantenmechanischen Rechnungen durchgeführt hat. 
 
7.2 Einleitung/Introduction 
Im Bereich des computergestützten Designs (Docking) ist die größte Herausforderung die 
richtige Vorhersage der Bindungsaffinität für einen gegebenen Liganden. Nur wenn dies 
gelingt können aufwendige und kostspielige experimentelle Suchverfahren (HTS, FBDD) 
durch die materialschonenden Computermethoden in Teilen ersetzt werden. Für den Erfolg 
der richtigen Beurteilung der Bindungsaffinität im Docking spielen Scoring-Funktionen (z.B. 
DrugScore(1), GoldScore(2)) die entscheidende Rolle. Wenn die Scoring-Funktion alle Facetten 
des Bindungsprozesses berücksichtigen würde, wäre eine optimale Vorhersage möglich. 
Leider existieren innerhalb des Bindungsvorgangs zwischen Protein und Ligand etliche 
Phänomene (Wassereffekte(3), Enthalpie-Entropie-Kompensation(4), Kooperativität(5)) für die 
es zur Zeit keine endgültige Erklärung gibt. Eine Einbeziehung dieser Effekte in Scoring-
Funktionen ist daher nicht zu rechtfertigen, da die Datenlage an experimentell im Detail 
untersuchten Protein-Ligand Komplexen einfach zu gering ist, um diese Prozesse 





der Bindungsaffinität im Docking solange noch Utopie bleibt bis der Bindungsvorgang in allen 
seinen kleinen Details verstanden ist.  
Gerade kooperative Effekte sind zwar lange bekannt, aber weit davon entfernt theoretisch 
quantifiziert zu werden. Im Grunde besagt die Kooperativität, dass zwei miteinander 
verbundene Liganden eine andere Freie Energie (ΔGL1-L2) liefern als die Summe der zwei 
einzelnen Bestandteile (ΔGL1 + ΔGL2).  Vor der Entdeckung der Kooperativität ist man von 
einem rein additiven Konzept ausgegangen in dem alle positiven und negativen 
Bindungsbeiträge im Komplex aufsummiert wurden ohne zu berücksichtigen, dass die Größe 
der Beiträge teils stark von einander abhängen. Aus theoretischen Gründen ist dies nicht 
weiter verwunderlich, es wurde bereits mehrfach darauf hingewiesen, dass vor allem bei 
entropischen Bindungsbeiträgen eine Additivität nicht erfüllt sein kann. Baum et al.(6) 
konnten z.B. zeigen, dass die Stärke der hydrophoben Wechselwirkung zur S3/4 Tasche von 
Thrombin stark davon abhängt, ob eine Wasserstoffbrücke zu Gly216 vorhanden war oder 
nicht. Bei Vorhandensein der Wasserstoffbrücke zu Gly216 war die hydrophobe Optimierung 
zur S3/4 Tasche signifikant besser (- 0,127 kJmol-1Å-2 Affinitätsbeitrag bezogen auf 
Oberflächen-beiträge) als bei Nichtvorhandensein dieser Wasserstoffbrücke (- 0,077 kJmol-
1Å-2). Das heißt mit anderen Worten, dass die Stärke der van-der-Waals Wechselwirkung von 
der Ausbildung einer anderen Wechselwirkung im Komplex abhängt. Würde man von einem 
additiven Konzept ausgehen, müsste der Gewinn an Bindungsaffinität pro Å2 vergrabener 
hydrophober Oberfläche vergleichbar sein. Die zusätzliche Wasserstoffbrücke in Thrombin 
sorgt aber für einen um 65 % effizienteren Weg einen Inhibitor hydrophob zu optimieren. 
Wenn man sich diesen Unterschied vor Augen führt, wirkt es nahezu naiv zu versuchen, den 
Beitrag zu bestimmen, den eine Wasserstoffbrücke(7) oder ein van-der-Waals Kontakt(8) zur 
Bindung beiträgt. Dieses Unterfangen muss im Detail als unmöglich gelten, da alle Kontakte 
miteinander zusammenhängen und jede Interaktion praktisch nicht isoliert betrachtet 
werden kann. 
Aufbauend auf der Hypothese, dass die hydrophobe Optimierung zur S3/4 Tasche von 
Thrombin vom Vorhandensein einer Wasserstoffbrücke abhängt, haben wir fünf neue Serien 
entworfen und synthetisiert, in denen versucht wird, die Stärke dieser Wasserstoffbrücke zu 
modifizieren (Abbildung 1). Unmittelbar neben der NH-Funktionalität des Liganden sind 
verschiedene Reste eingefügt, die alle in unterschiedlichem Ausmaß einen Einfluss auf die 





systematisch variiert, um schrittweise eine immer größere hydrophobe Kontaktoberfläche 
zur S3/4 Tasche zu generieren. Kinetische Untersuchung der Ligandserien soll nun zeigen, ob 
die hydrophobe Interaktion nicht nur vom Vorhandensein einer Wasserstoffbrücke abhängt, 
sondern ob das Ausmaß der hydrophoben Wechselwirkung auch mit der Stärke der 
Wasserstoffbrücke korreliert.     
 
Abbildung 1: Schematische Darstellung der Bindetasche von Thrombin im Komplex mit dem 




7.3 Ergebnisse & Diskussion/Results & Discussion 
7.3.1 Inhibitionskonstanten und die Korrelation mit den hydrophoben 
Kontaktoberflächen 
Tabelle 1 zeigt die untersuchten Serien mit den jeweiligen hydrophoben Modifizierungen 
und den Inhibitionskonstanten. In jeder Serie konnte die Bindungsaffinität schrittweise durch 
immer größer werdende hydrophobe Reste verbessert werden. Der Gewinn an 
Bindungsaffinität pro Å2 vergrabener hydrophober Oberfläche (Berechnung siehe Material & 
Methoden, Abschnitt 6.6.2) ist jedoch eindeutig abhängig von der Substitution an der 
terminalen Aminogruppe. Abbildung 2 zeigt die Auftragung der Freien Energie (ΔG) gegen 
die jeweilige berechnete hydrophobe Kontaktoberfläche (Å2). Die Korrelationskoeffizienten 
(R2) variieren zwischen 0,8179 - 0,950, was auf einen zuverlässigen linearen Zusammenhang 
hindeutet. Die Steigungen sind der Größe nach in Tabelle 2 zusammengefasst. In der Serie 1 
ist, wie erwartet, die schwächste Kooperativität erkennbar (- 0,077 kJmol-1Å-2). Die Serie 3 





während die Serie 4 mit der Formyl-Gruppe eine signifikante Verbesserung um 29,9 % (- 
0,100 kJmol-1Å-2) im Vergleich zu Serie 1 erzielt. Die Trifluoracetylgruppe in Serie 5 hat sogar 
einen um 48,1 % verbesserten Gewinn pro vergrabenener hydrophober Oberfläche (- 0,114 
kJmol-1Å-2). Die Methylsulfonierung der Aminogruppe führt zu einer weiteren Steigerung des 
kooperativen Effekts. In der methylsulfonierten Serie 6 (-NHSO2CH3) konnte eine Steigerung 
um 61,0 % auf - 0,124 kJmol-1Å-2 und in Serie 7 (-NHSO2NH2) um 76,6 % auf - 0,136 kJmol
-1Å-2 
erzielt werden. Damit war die Serie 7 diejenige mit dem größten kooperativen Effekt. Die 
Serie 2 mit der freien Aminogruppe liegt dagegen zwischen den sulfonierten Liganden mit 
einer Verbesserung von 64,9 %. Es ist verwunderlich, dass die sulfonierten Serien eine 
ähnliche Kooperativität zeigen wie die Serie mit der freien Aminogruppe, die 
höchstwahrscheinlich protoniert vorliegt. Somit ergibt sich eine starke ladungsunterstützte 
Wasserstoffbrücke zu Gly216. Obwohl deutliche Unterschiede in den kooperativen Effekten 
erkennbar sind, steht die Frage noch aus, ob die Substitutionen an der freien Aminogruppe 
auch wirklich die Stärke der Wasserstoffbrücke modifizieren. Um dies zu überprüfen, haben 
wir pKa Werte aus der Literatur für die jeweiligen Substitutionen herausgesucht (Abbildung 
3). Die gefundenen pKa Werte korrelieren dabei eindeutig mit den Werten für die Stärke der 






Tabelle 1: Chemische Strukturen der untersuchten Liganden mit den Inhibitionskonstanten in μM in schwarz, UBTHR-ID in grün, Freie Energien ΔG (kJ/mol) aus Ki in 
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634,7 ± 138,9 
87 
- 18,3 / 299 
330,9 
88 
- 19,9 / 312 
 
180,6 ± 53,4 
195 
- 21,4 / 342 
88,5 ± 36,0 
89 
- 23,1 / 368 
 
24,2 ± 5,3 
90 
- 26,4 / 370 
88,8 ± 7,2 
156 
- 23,1 / 387 
8,7 ± 1.0 
91 
- 28,9 / 409 
4    
 
308,7 ± 59,9 
200 
- 20,1 / 313 
248,9 ± 46.0 
201 
- 20,6 / 337 
74,7 ± 18,5 
202 
- 23,6 / 343 
25,1 ± 6,2 
203 
- 26,3 / 366 
  
32,6 ± 10,1 
169 
- 25,6 / 388 
5,7 ± 2,7 
204 
- 30,1 / 409 
5  
 
636,8 ± 86,4 
144 
- 18,2 / 312 
349,3 ± 36,7 
198 
- 19,7 / 334 
105,1 ± 20,4 
199 
- 22,7 / 342 
58,6 ± 32,0 
145 
- 24,2 / 369 
12,1 ± 1,4 
147 
- 28,1 / 378 
 
24,2 ± 14,0 
155  
- 26,4 / 386 
9,3 ± 2,3 
148 
-28,7 / 409 
6     
133,2 ± 10,0 
117 
- 22,1 / 299 
65,6 ± 4,4 
149 
- 23,9 / 312 
34,4 ± 8,2 
196 
- 25,5 / 333 
10,7 ± 1,2 
197 
- 28,4 / 343 
2,5 ± 1,3 
150 
- 31,9 / 368 
0,624 ± 0,101 
151 
- 35,4 / 376 
 
6,0 ± 2,9 
154 
- 29,8 / 387 
0,524 ± 0,064 
152 
- 35,8 / 409 
7  
154,4 ± 18,7 
162 
- 21,8 / 299 
50,5 ± 17,9 
205 
- 24,6 / 314 
17,6 ± 5,4 
206 
- 27,2 / 334 
4,9 ± 0,5 
207 
- 30,3 / 343 
2,6 ± 1,1 
208 
- 32,1 / 370 
0,524 ± 0,016 
209 
- 35,9 / 378 
 
1,3 ± 0,5 
160 
- 33,7 / 387 
0,386 ± 0,028 
210 





Abbildung 2: Graphische Auftragung der Freien Energien gegen die hydrophoben Kontaktoberflächen. Serie 1 und 
2 in a, 3 in b, 4 in c, 5 in d, 6 in e und 7 in f. 
a)       b) 
 
c)       d) 
 








Tabelle 2: Die ermittelten Steigungen der Kurven bei den sieben Serien und die prozentuale 
Veränderung der Steigung im Vergleich zur Serie 1.  
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Abbildung 3: Darstellung der Substituenten nach der Höhe der pKa-Werte in DMSO. Für Serie 2 liegt 
kein Wert in DMSO vor, jedoch kann er abgeschätzt werden, da der pKa Wert in Wasser bekannt ist 
(8.0). Grundsätzlich sind die Werte für DMSO 8-10 Einheiten größer wie die Wasserwerte.   
 
 
7.3.2 Die Stärke der Wasserstoffbrücke zu Gly216 
Um die Hypothese weiter zu untermauern, wurde auf einem reduzierten Gerüst die Stärke 
der Wasserstoffbrücke mittels quantenchemischer Rechnungen abgeschätzt (siehe Material 
& Methoden für Details zur Berechnung). Diese Rechnungen wurden freundlicherweise in 
der Arbeitsgruppe von Prof. Dr. Engels (Julius-Maximilians-Universität Würzburg) 
durchgeführt. Das Gerüst bestand aus dem Pyrrolidin-Ring des Prolins und aus einem Alanin 
(Tabelle 3). Die Abschätzung der Energien der Wasserstoffbrücke in Abhängigkeit von den 
jeweiligen Substituenten wurde im Vakuum durchgeführt. Die Ergebnisse aus diesen 
Rechnungen liefern kein eindeutiges Bild. Die niedrigste Energie zeigt, wie erwartet, 
diejenige Serie, die keine Wasserstoffbrücke zu Gly216 aufweist (- 23 kJ/mol für Serie 1). Die 
Energie steigt sprunghaft an, wenn eine zusätzliche Wasserstoffbrücke ausgebildet wird (- 31 
kJ/mol für die unprotonierte Serie 2). Die Protonierung der Amino-Gruppe zeigt dagegen den 
höchsten Wert aller berechneten Energien. Dies ist verständlich, da ladungsunterstützte 
Wasserstoffbrücken stets stärker sind als die neutralen Analoga. Der Rest der Werte zeigt 
jedoch keine eindeutige Korrelation weder zu den beschriebenen pKa-Werten noch zu den 
Werten aus Tabelle 2. Die sulfonierte Serie 6 zeigt sogar eine kleinere Energie (- 42 kJ/mol) 
als die acetylierte (- 45 kJ/mol) und die trifluoracetylierte Serie (- 46 kJ/mol). Dieses ist nicht 
in Einklang zu bringen mit den Überlegungen aus dem vorherigen Kapitel. Bei näherer 
Betrachtung lassen sich viele Gründe anführen, wieso man sich nicht auf diese Werte alleine 
stützen kann. Erstens, die Werte wurden berechnet anhand eines stark reduzierten Systems, 
das bedingt vergleichbar ist mit dem experimentell untersuchten Fall. Zweitens, wurde 
wegen der rechenintensiven Abschätzung aus jeder Serie nur die Energie für das jeweilige 
Alanin-Derivat untersucht. Eine zuverlässige Analyse müsste alle untersuchten P3-Reste 





Einfluss auf die Energie der Wasserstoffbrücke ausübt. Drittens, gehen die Berechnungen bei 
den sulfonierten Serien davon aus, dass die Sulfonylgruppen keine Interaktion mit dem 
Protein eingehen. Eine in dieser Arbeit untersuchte Serie mit ähnlichen 
Benzylsulfonylderivaten zeigt aber eindeutig eine zweite Wasserstoffbrücke zu Gly219.(10) 
Gerade dieser dritte Aspekt könnte der Hauptgrund dafür sein, wieso die berechnete Stärke 
der Wasserstoffbrücke nicht mit der beobachteten Kooperativität korreliert. Auch würde die 
zweite Wasserstoffbrücke bei den sulfonierten Serien die Hypothese um die Stärke der 
Wasserstoffbrücke weiter stützen. Anfangs war schon kritisch angemerkt, dass die 
Kooperativität bei den Serien 6 und 7 mit der ladungsunterstützten Wasserstoffbrücke in 
Serie 2 vergleichbar ist. Die zweite Wasserstoffbrücke in Serie 6 und 7 würde den Bereich um 
Gly216 noch stärker fixieren als eine einzelne Wasserstoffbrücke, auch wenn diese durch 
eine Ladung verstärkt wird. Zusätzlich ist aber auch noch zu berücksichtigen, dass die 
einzelnen Liganden mit abweichendem Desolvatationsbeitrag für die Bindung an das Protein 
freigesetzt werden müssen. Vor allem für die geladene Aminogruppe ist hier ein deutlich 
stärkerer Beitrag zu erwarten.  
 
Tabelle 3: Die Energien aus den quantenchemischen Rechnungen für die Stärke der Wasserstoff-
brücke zu Gly216. 
 
























In dieser Arbeit wurde untersucht, in welchem Ausmaß eine Kooperativität zwischen der 
hydrophoben Wechselwirkung und der Wasserstoffbrücke zu Gly216 besteht. Die 
vorliegenden Daten zeigen eindrucksvoll, dass kooperative Effekte in Abhängigkeit von der 
Substitution am terminalen Amin vorliegen. Die quantenmechanischen Berechnungen 
anhand eines reduzierten Systems zeigen jedoch nicht den erwarteten Einfluss der 
Substitution auf die untersuchte Wasserstoffbrücke zu Gly216. Erste Hinweise aus 
verwandten Bindungsmodi lassen den Verdacht zu, dass die sulfonierten Serien eine zweite 
Wasserstoffbrücke zum Protein ausbilden. Daher besteht hier die Notwendigkeit, jeweils 
eine Kristallstruktur aus den Serien 6 und 7 zu bestimmen, um sicher zu stellen, ob 





vorliegt, muss dieses Faktum natürlich in den Rechnungen zur Stärke der Wasserstoffbrücke 
berücksichtigt werden. Die Hypothese, den Ursprung der Kooperativität auf die Stärke der 
Wasserstoffbrücke zurückzuführen, bleibt somit noch bestehen, jedoch wird man 
untersuchen müssen, ob auch die Anzahl der ausgebildeten Wasserstoffbrücken bei den 
beobachteten kooperativen Effekten eine Rolle spielt.    
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7.6 Material & Methoden/Materials & Methods 
7.6.1 Bioassay 
Der Inhibitionskonstanten (Ki) wurden mit einen photometrischen Assay bei 405 nm 
gemessen. Der Assay wurde unter Verwendung des chromogenen Substrats Pefachrom tPa 
(LoxoGmbH, Dossenheim, Germany) wie beschrieben(11) bei folgenden Bedingungen 
durchgeführt:  50 mM Tris–HCl, pH 7,4, 154 mM NaCl, 5 % DMSO, 0,1 % PEG8000 bei 25°C 
und verschiedenen Substrat- und Inhibitorkonzentrationen. Ki-Werte (n ≥ 3) wurden wie 
beschrieben(12) nach Dixon berechnet. 
 
7.6.2 Berechnung der hydrophoben Kontaktoberflächen 
Die Liganden wurden gedockt und energieminimiert mit dem Tripos-Kraftfeld. Die molcad-
Oberfläche für das Protein wurde generiert. Auf diese Oberfläche wurde nun das 
entsprechende lipophile Potential abgebildet. Für die Analyse wurden nur die hydrophoben 
Oberflächenanteile berücksichtigt. Als erstes wurde der Schwerpunkt für den lipophilen 
Potentialbereich für das Protein berechnet und das Minimum des lipophilen 
Oberflächenpotentials ausgewählt. Im Folgenden wurde die molcad-Oberfläche ein zweites 
Mal auf die Oberfläche projiziert, diesmal entsprechend der Distanz zwischen Ligand und 
Protein. Danach ist eine neue Oberfläche mit dem lipophilen Potential entsprechend dem 





kein Wassermolekül sich zwischen den Oberflächen aufhalten kann. Nachdem diese neue 
Oberfläche kreiert wurde, konnte man die gewünschten Oberflächenanteile berechnen. 
 
7.6.3 Berechnung der Stärke der Wasserstoffbrücke zu Gly216 
Die Geometrie des Komplexes wurde im Vakuum mit BLYP/TZVP optimiert und dann an 
Hand einer  Einzelpunktberechnung mit CCSD(T)/aVDZ die Energie berechnet. Die 
Rechengenauigkeit dieser Messungen liegt bei ca. 2-4 kJ/mol. 
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8 Preorganisierende Effekte während der Protein-Ligand Inter-




8.1 Kristallographische und thermodynamische Untersuchung von MI001 
und MI002 
In diesem Kapitel wurden zwei Thrombin-Inhibitoren in Kooperation mit der Arbeitsgruppe 
von Prof. Dr. Steinmetzer thermodynamisch und kristallographisch charakterisiert. Die 
beiden Inhibitoren sind mit dem Grundgerüst der Inhibitoren aus dem Kapitel 4 vergleichbar. 
In diesem Fall wurde jedoch in P3 keine hydrophobe Aminosäure sondern das polare D-
Arginin eingebaut. Ein AMBA- und ein ACB-Anker wurden, wie im Kapitel 4,  ausgesucht, um 
die S1 Tasche zu adressieren (Abbildung 1).  
Die Komplexstruktur von MI001 wurde bei einer Auflösung von 1,45 Å bestimmt (Abbildung 
2). Der Bindungsmodus zeigt, wie erwartet, den S1 Anker in der S1 Tasche und das 
Benzylsulfonylamid in der Nähe einer Disulfidbrücke. Dieser U-förmige Bindungsmodus 
wurde bisher bei allen Derivaten beobachtet, die in der P3 Position eine chirale Aminosäure 
enthielten (siehe Kapitel 4). Interessanterweise wird die polare Seitenkette des D-Arg nicht in 
die S3/4 Tasche platziert. Die Guanidin-Gruppe des D-Arg interagiert nur mit dem Glu217 
(2.9 Å) in der Bindetasche. Dieses Glutamat ist durch die Interaktion mit dem Inhibitor in 
einem starken Netzwerk aus Wasserstoffbrücken fixiert. Es interagiert zusätzlich mit dem 
Lys224 (2.6 Å) und dem Thr172 (2.6 Å). Neben der Interaktion zu dem Glutamat verbrückt 
ein Wassermolekül eine Interaktion zwischen dem Inhibitor und der NH-Gruppe des Arg173. 
Interessanterweise ist auffällig, dass die Guanidingruppe stark solvatisiert ist. Insgesamt 
wurden fünf Wassermoleküle in unmittelbarer Nachbarschaft zur Guanidingruppe (2,9 – 3,5 
Å) gefunden. Die S3/4 Tasche behält in diesem Komplex den Solvatationszustand der 
Apostruktur bei, da kein einziges Wassermolekül durch MI001 verdrängt wurde. Der 
Inhibitor MI002 (PDB-Code 3EQ0) wurde bereits in der Doktorarbeit von Dr. Baum(1) 
kristallographisch untersucht. Die Überlagerung beider Strukturen ist in Abbildung 3 zu 
sehen. Das Benzylsulfonylamid ist abhängig vom S1 Anker in einer unterschiedlichen 




Position. Der Inhibitor mit dem ACB Anker hat im Komplex nicht die Möglichkeit einen U-
förmigen Bindungsmodus einzunehmen, da die Aminomethylengruppe sterisch diese 
Geometrie verhindert. Das Kapitel 4 behandelt diese Problematik bereits im Detail. Die D-Arg 
Reste zeigen jedoch ebenfalls unterschiedliche Bindungsmodi. Während in MI001 eindeutig 
nur eine Konformation zu sehen ist, werden in der Struktur MI002 zwei Konformationen 
beobachtet. Die zweite Konformation in MI002 ist nur zu 30 % besetzt und zeigt eine 
ähnliche Position wie das D-Arg in MI001. Neben der problematisch niedrigen Besetzung 
bestehen zusätzlich zwei weitere Punkte, die diese zweite Konformation in Frage stellen.  
 
















Abbildung 2: Bindungsmodus des Inhibitors MI001 im Komplex mit Thrombin. Besonders im Fokus 
stehen die strukturellen Details in der Region nahe der D-Arg Seitenkette. Die Fo-Fc Differenz-
elektronendichte ist bei 2σ in grün gezeigt. Günstige Interaktionen mit den jeweiligen Distanzen in Å 
sind mit gestrichelten Linien angedeutet. Wassermoleküle sind als Kugeln dargestellt. Rote 
Wassermoleküle interagieren mit dem D-Arg und die hellblauen mit der S3/4 Tasche.  
 
 
Abbildung 3: Überlagerung der Komplexstrukturen von MI001 und MI002 (PDB-Code 3EQ0). 
Besonders im Fokus stehen die strukturellen Details in der Region nahe des D-Arg. Ungünstige 
Interaktionen mit den jeweiligen Distanzen in Å sind mit gestrichelten Linien in rot angedeutet. 
Stickstoff ist in blau, Sauerstoff in rot, Kohlenstoff in gelb (MI001) und in hellblau (MI002) dargestellt. 
Wassermoleküle sind entweder als rote (MI001) oder als schwarze (MI002) Kugeln dargestellt. 
 
 




Das D-Arg ist in einer ungewöhnlich kurzen Distanz nahe dem Benzyl-Rest des eigenen 
Inhibitors. Darüberhinaus zeigt die 2Fo-Fc Elektronendichte auch bei 0,7σ keine 
überzeugenden Hinweise für eine zweite Konformation (Abbildung 4). Vieles spricht daher in 
dieser Kristallstruktur für ein zweites Wassermolekül in der Nähe der Guanidin-Gruppe von 
MI002.     
Die thermodynamische Charakterisierung (Tabelle 1) zeigt dieselben Trends, die schon im 
Kapitel 4 zwischen den zwei S1 Ankern eindeutig zu erkennen waren. Die Enthalpie der 
Interaktion ist einerseits pufferabhängig (Abbildung 5), was auf die Deprotonierung des 
His57 zurückzuführen ist. Andererseits bestätigen die thermodynamischen Daten, dass die 
Interaktion mit dem ACB Anker wesentlich enthalpischer (ΔHKorr.= - 46,5 kJ/mol für MI002) 
abläuft als die Interaktion mit dem korrespondierenden AMBA (ΔHKorr.= - 16,4 kJ/mol für 
MI001). Das ACB-Derivat ist darüberhinaus stärker (ΔG = - 53,3 ± 0,3 kJ/mol für MI002) als 
das analoge AMBA (ΔG = - 46,5 ± 0,1 kJ/mol für MI001). Dies bestätigt die Ergebnisse aus 
dem Kapitel 4 im Hinblick auf die Unterschiede in der Bindungsaffinität zwischen ACB- und 
AMBA-Anker.  
 
Abbildung 4: Darstellung des Inhibitors MI002 (PDB-Code 3EQ0) im Komplex mit Thrombin. Die 2Fo-
Fc Elektronendichte ist in cyan bei 0,7σ gezeigt. Stickstoff ist in blau, Sauerstoff in rot und Kohlenstoff 










Tabelle 1: Bindungsterme ΔG0, ΔH0 und - TΔS0 (kJ/mol) der untersuchten Liganden aus Kapitel 7.1 und 
























MI001 - 46,5 ± 0,1 - 33,6 ± 3,2 - 28,8 - 23,6 - 16,4 - 32,3 0,36 
MI002 - 53,3 ± 0,3 - 67,3 ± 3,2  - 64,7 - 54,1 - 46,5 - 6,8 0,46 
MI034 - 59,0 ± 0,9 - 63,2 ± 3,1 - 54,6 - 50,5 - 40,2 - 18,8 0,47 
MI330 - 50,7 ± 0,3 - 44,6 ± 0,2 - 37,9 - 31,2 - 21,3 - 29,4 0,49 
Die thermodynamischen Daten wurden mithilfe einer ITC-Verdrängungstitration gemessen. Kapitel 4 
beschreibt die Vorgehensweise im Detail. 
 
Abbildung 5: Im Diagramm sind die beobachteten Enthalpien (ΔHobs) gegen die 
Ionisierungsenthalpien (ΔHIon) des jeweiligen Puffers aufgetragen. 
 




8.2 Kristallographische und thermodynamische Untersuchung von MI034 
und MI330 
Diese Studie wurde ebenfalls in Kooperation mit der Arbeitsgruppe von Prof. Dr. Steinmetzer 
durchgeführt. Das Grundgerüst ist in diesem Fall nicht mehr vergleichbar mit dem aus dem 
vorangegangenen Kapitel. Es wurde ein an zwei Stellen substituiertes Phenylsulfonylamid 
neben der P3 Position eingebaut (Abbildung 6). Außerdem ist in P3 eine L-Aminosäure (L-
Asparagin) eingeführt. Alle anderen in dieser Dissertation untersuchten Thrombin-
Inhibitoren waren in P3 mit einer D-Aminosäure ausgestattet. Das Asn ist zudem N-
substituiert mit einem 4-Cyanophenylrest. Vergleichbar mit den anderen Studien zur 
Thrombin-Inhibition ist auch hier der direkte Vergleich der S1 Anker AMBA und ACB 
wesentlicher Bestandteil dieses Kapitels.   
 











Die kristallographische Untersuchung von MI330 im Komplex mit Thrombin zeigt, dass der S1 
Anker die S1 Tasche und das Prolin in P2 die S2 Tasche ausfüllt (Abbildung 7). Der Chlor-
substituierte Phenylsulfonylrest besetzt die hydrophobe S3/4 Tasche besetzt. Das 4-
Cyanobenzyl-substituierte L-Asn liegt trotz P3 Position gegenüber der S3/4 Tasche. Die 
falsche Konfiguration am α-Kohlenstoffatom und die voluminöse Substitution schließen eine 
Adressierung der S3/4 Tasche durch den P3 Rest aus.  
Der Aminomethylen-Anker zeigt eine intramolekulare Wasserstoffbrücke (2.8 Å) mit dem 
Carbonylsauerstoff des substituierten L-Asn (Abbildung 8a). Diese Interaktion ist zudem 
durch ein Wassermolekül unterstützt. Der 4-Cyanophenylrest ist in einer Region, die 
ausschließlich von polaren Aminosäuren (Glu146, Arg221A, Lys224, Glu217) ausgebildet wird 
(Abbildung 8b). Jedoch kann die Cyanogruppe keine dieser Reste adressieren. In der 
Kristallstruktur konnten für die Cyanogruppe weder Interaktionen zum Protein noch zum 
umgebenden Wasser festgestellt werden. Die kleinste Distanz weist 3.9 Å zum Glu217 auf. 
Das Interaktionsmuster in der S3/4 Tasche ist durch van-der-Waals Kontakte und Halogen-π-
Wechselwirkungen charakterisiert (Abbildung 8c). Das m-ständige Chloratom zeigt dabei auf 
das Zentrum des Benzolringes des Indols des Trp215 (3.6 Å). Zudem ist das Chloratom in 
unmittelbarer Nachbarschaft zum Carbonylsauerstoff des Asn98 (3.3 Å).  




Abbildung 7: Bindungsmodus des Inhibitors MI330 im Komplex mit Thrombin. Die Fo-Fc 
Differenzelektronendichte ist bei 2σ in grün gezeigt. Wassermoleküle sind wegen einer besseren 
Darstellung ausgeblendet. In dieser Darstellung ist die Oberfläche des Proteins gezeigt.  
 
 
Abbildung 8: MI330 im Komplex mit Thrombin. a) Besonders im Fokus stehen die strukturellen 
Details in der Region nahe des Aminomethylen-Ankers. b) Interaktionsmuster zum 4-Cyanophenyl-
sulfonylamid. c) Bindungsmodus des Inhibitors in der S3/4 Tasche. d) Überlagerung von MI034(1) und 
MI330. Stickstoff ist in blau, Sauerstoff in rot, Kohlenstoff in gelb (MI330) und in hellblau (MI034) 
dargestellt.  
a)             b) 
   
 
 




c)            d) 
  
 
Der Sauerstoff des Methylethers ist jedoch in einer ungünstigen Position, da er nur 3.3 Å 
vom Carbonylsauerstoff des Glu97A entfernt ist. Daher ergibt sich eine abstoßende 
Interaktion zwischen einem sp2 und einem sp3 Sauerstoff. Die Methylgruppe hingegen liegt 
in einer Position, die es erlaubt mit den benachbarten Carbonylsauerstoffen van-der-Waals 
Kontakte auszubilden (3,4 Å, 4,4 Å). Der strukturelle Vergleich zum AMBA zeigt überwiegend 
einen vergleichbaren Bindungsmodus. Der einzige Unterschied zeigt sich in der 
Konformation des L-Asn (Abbildung 8d). Das ACB-Derivat offenbart wie oben beschrieben 
eine intramolekulare Wechselwirkung zwischen dem Carbonylsauerstoff des L-Asn und dem 
Aminomethylen-Anker. Diese Wechselwirkung fehlt in der AMBA-Struktur. Dort dreht sich 
die Amidgruppe um 180° und der Carbonylsauerstoff steht zum Wasser hin.  
Das neuartige Grundgerüst führt auch zu einem thermodynamischen Profil (Tabelle 1), das 
nicht vergleichbar ist mit den Benzylsulfonylamiden aus vorangegangenen Studien. In 
diesem Fall ist das AMBA (ΔG = - 59,0 ± 0,9 kJ/mol für MI034) weitaus stärker als das ACB-
Derivat (ΔG = - 50,7 ± 0,3 kJ/mol für MI330). Bei allen bisher untersuchten Benzyl-
sulfonylamiden wurde für den ACB-Anker stets eine stärkere Bindungsaffinität beobachtet 
als bei den korrespondierenden AMBA-Liganden. Ebenfalls interessant sind die 
enthalpischen Beiträge für MI034 und MI330. Während der ACB-Anker bei den 
Benzylsulfonylamiden immer einen höheren enthalpischen Beitrag aufwies als das AMBA, 
wurde hier das Gegenteil beobachtet. Nun zeigt das thermodynamische Profil für das AMBA 




einen höheren enthalpischen Term (ΔHKorr.= - 40,2 kJ/mol für MI034) als das analoge ACB-
Derivat (ΔHKorr.= - 21,3 kJ/mol für MI330).  
Die Kristallstruktur von MI034 offenbart, dass die preorganisierenden Effekte nicht so 
ausgeprägt sind wie bei den Benzylsulfonylamiden. MI330 zeigt mit seinem Aminomethylen-
Anker nur schwache intramolekulare preorganisierende Interaktionen. Diese Interaktion ist 
höchstwahrscheinlich auch nicht sehr entscheidend, da B-Werte der P3-Seitenkette 
eindeutig zeigen, dass dieser Rest durch eine hohe Unordnung charakterisiert ist. Dieses 
widerspricht einer starken intramolekularen Interaktion. Der Einbruch in der 
Bindungsaffinität von MI330 ist daher wahrscheinlich durch das Fehlen von 
preorganisierenden Effekten zu erklären. Die Anzahl der übertragenden Protonen war 
vergleichbar mit allen anderen bisher untersuchten Thrombin-Inhibitoren (0,47 mol für 
MI034 und 0,49 mol für MI330, Abbildung 9).  
 
Abbildung 9: Im Diagramm sind die beobachteten Enthalpien (ΔHobs) gegen die 




1 Baum B. (2010) The well-tempered Thrombin: A systematic crystallographic and 








Tabelle 2: Datensammlung und Verfeinerungsstatistik für die Liganden aus den Kapiteln 7.1 und 7.2. 




A. Data collection and processing   
No. Crystals used 1 1 
Wavelength (Å) 0.91841 1.00 
Space group C2 C2 
Unit cell parameters   
    a, b, c (Å) 70.3, 71.5, 72.2 69.9, 71.2, 72.6 
    β (°) 100.4 100.1 
Matthews coefficient (Å3/Da) 2.5 2.5 
Solvent content (%) 51 51 
   
B. Diffraction dataa   
Resolution range (Å) 50 – 1.45 50 – 1.58 
 (1.48 – 1.45) (1.61 – 1.58) 
Unique reflections 59.463 (3.072) 46.917 (2.328) 
R(I)sym (%) 5.9 (45.3) 3.7 (47.1) 
Completeness (%) 95.2 (97.9) 97.6 (95.6) 
Redundancy 3.0 (2.9) 3.0 (2.8) 
I/σ(I) 17.4 (2.6) 28.8 (2.4) 
   
C. Refinement   
Resolution range (Å) 22.6 – 1.45 35.7 – 1.58 
Reflections used in refinement 56.456 / 2.856 44.933 / 2.233 
    (work/free)   
Final R values for all reflections 16.4 / 18.7 16.4 / 19.6 
    (work/free) (%)   
Protein residues (L chain/H chain) 28 / 251 28 / 251 
Sodium ions 2 2 
Inhibitor atoms 39  
Water molecules 344 253 
RMSD from ideality   
    Bond lengths (Å) 0.008 0.008 
    Bond angles (°) 1.117 1.087 
Ramachandran plot    
    Residues in most favoured regions (%)  84.1 85.0 
    Residues in additionally allowed             
        regions (%) 15.9 15.0 
    Residues in generously allowed   
        regions (%) - - 
Mean B-factor (Å2)   
    Protein (L + H chain) 19.7 24.7 
    Binding siteb 15.7 21.0 
    Inhibitor 19.9 25.0 
    Water molecules 34.2 35.1 
a Numbers in parenthesis are for the highest resolution shell. 
b
 Definition of the binding site: all amino acids which are 4 Å within the inhibitor. 
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9 Zusammenfassung & Perspektiven/Summary & Perspektives 
 
 
9.1 Deutsche Version 
Der zentrale Focus dieser Arbeit liegt auf der kristallographischen und thermodynamischen 
Untersuchung der Rolle von Wassermolekülen bei der Protein-Ligand-Wechselwirkung.  
Da die meisten untersuchten Liganden einen zu starken (Ki ≤ 1 nM) bzw. zu schwachen (Ki ≥ 1 
μM) Affinitätsbereich abdecken, ist die direkte ITC-Titration für die thermodynamische 
Charakterisierung nicht in Frage gekommen. Es ist schließlich ein Verdrängungsansatz 
ausgewählt worden, um eine zuverlässige thermodynamische Analyse in diesen 
Affinitätsbereichen zu garantieren. Der erste Teil dieser Arbeit (Kapitel 2) widmet sich daher 
der Etablierung und Validierung der Verdrängungstitration für die Charakterisierung von 
schwach und stark affinen Liganden. Es ist gezeigt worden, dass die Dissoziationskonstanten 
(Kd) aus der Verdrängungs-ITC sehr gut mit den kinetisch bestimmten Inhibitionskonstanten 
(Ki) korrelieren. Diese Methode kann auch angewandt werden um Fragmente, die für ihre 
überaus schwache Bindungsaffinität bekannt sind, thermodynamisch zu charakterisieren. 
Gerade bei Fragmenten wird in kinetischen Assays offensichtlich, dass ein großer Nachteil 
darin besteht eine korrekte Bindungsaffinität zu erhalten. Die kinetischen Assays sind nicht 
sensitiv genug oder entsprechende Assayprotokolle fehlen um eine zuverlässige 
Abschätzung im mikro- bzw. millimolaren Bereich zu liefern. Die korrekte Bestimmung der 
Bindungsaffinität ist jedoch im frühen FBDD (Fragment-based drug discovery) von 
entscheidender Bedeutung, da nur dann eine sinnvolle Aussage getroffen werden kann, 
welche Fragmente in die weitere Optimierung einbezogen werden können. Die 
Verdrängungs-ITC stellt hier eine zuverlässige Alternative dar, wie aus der guten Korrelation 
der Bindungsaffinitäten von verschiedenen Methoden ersichtlich ist. Neben der 
Bindungsaffinität kann die Verdrängungs-ITC auch den enthalpischen Parameter mit hoher 
Zuverlässigkeit bestimmen. Dieses stellt ebenfalls ein wichtiges Kriterium dar, um zu 
entscheiden, welche Fragmente in die nähere Auswahl für die Optimierung fallen. Auch ist es 
bei der Verdrängungs-ITC möglich die Proteinkonzentration zu reduzieren, wenn Liganden 
mit einem niedrigen enthalpischen Beitrag untersucht werden. Der oft in der ITC kritisierte 




Proteinverbrauch kann um das dreifache reduziert werden. Außerdem ist theoretisch 
abgeleitet worden, wie die Konzentration eines schwach affinen Liganden sein muss um 
einen gewissen Grad an Inhibition zu gewährleisten. Die aus diesen Überlegungen 
resultierende Gleichung ist in ein Excel-Sheet übertragen worden, wo in Abhängigkeit von 
der erwarteten Affinität und der Proteinkonzentration der Grad der Inhibition bei einer 
gegebenen Ligandkonzentration berechnet werden kann. 
Die nächste Studie befasst sich (Kapitel 3) mit der S1 Tasche von Thrombin. Am Boden dieser 
Tasche befindet sich das deprotonierte Asp189. Dieses ist in der Apostruktur von Thrombin 
sehr gut solvatisiert. Ziel war es nun zu untersuchen, wie sich eine Änderung der Aspartat-
Solvatisierung durch eine Pyridin-basierte Ligandenserie auf die Bindungsaffinität und das 
thermodynamische Profil auswirkt. Methodisch basiert die thermodynamische 
Untersuchung dieser mikromolaren Pyridininhibitoren auf der Validierung der Verdrängungs-
ITC. Diese Serie zeigt ein tieferes Verständnis über die Folgen von Desolvationseffekten, die 
in der Proteinbindetasche und im Liganden auftreten. Die Apoform von Thrombin zeigt ein 
fest gebundenes und geordnetes Wassermolekül am negativ geladenen Asp189 in der S1 
Tasche. Die beobachteten Effekte bei der Adressierung der Solvatationsschicht der S1 Tasche 
mit Pyridin- und den analogen Methylpyridinium-Derivaten zeigen deutlich die Gründe für 
die nur mikromolare Aktivität. In allen Pyridin-Derivaten werden Wassermoleküle entdeckt, 
die in unterschiedlicher Art so gut es geht den ursprünglichen Solvatationszustand zu 
konservieren versuchen. Die damit verbundenen entropischen Verluste sind immens. In zwei 
Ligandkomplexen finden sich sogar ungeordnete Ligandbestandteile in der S1 Tasche als 
Folge von Desolvatationseffekten. Der Preis für die Desolvatation einer geladenen 
Aminosäure ist einfach zu groß, um in diesem Fall eine komplette Verdrängung des 
Wassermoleküls zu gewährleisten. So resultiert ein Kompromiss, wo 50 % der Wasser 
verdrängt werden und 50 % der Wasser am Asp189 verbleiben. Eine zu hohe 
Desolvatationsenergie kann daher zu ungeordneten Systemen führen, nur um den Preis der 
Desolvatation so gering wie möglich zu halten. Auch wird deutlich, dass fast alle positiv 
geladenen Methylpyridinium-Derivate schwächer sind als die neutralen Pyridin-Analoga. Die 
quantenchemische Berechnung der Solvatationsenergien der Liganden zeigen deutliche 
Unterschiede zwischen den neutralen und geladenen Derivaten. Die geladenen 
Verbindungen benötigen eine Größenordnung mehr Energie um desolvatisiert zu werden als 
die neutralen Liganden. Die aufgeklärten Komplexstrukturen zeigen zudem, dass die 




geladenen Methylpyridinium-Derivate nicht optimal das am Boden lokalisierte negativ 
geladene Asp189 adressieren können. Entweder lässt sich aus sterischen Gründen kein 
kurzer Abstand erreichen oder die Methylgruppe bietet einen zu guten Schutz, um über eine 
kurze Entfernung mit dem negativen Asp189 zu interagieren, beispielsweise wie es in den 
Benzamidinen-Liganden zu realisieren ist. Daher kann die Energie für die Desolvatation nicht 
durch die freiwerdende Energie aus der Interaktion zwischen dem Methylpyridinium und 
dem Asp189 aufgebracht werden. Ein Verlust der Bindungsaffinität ist die Folge. So ist 
ebenfalls gezeigt worden, dass je näher die positive Ladung des Methylpyridiniums am 
Asp189 platziert ist desto geringer fällt der enthalpische Nachteil aus. Ein anderes Pyridin ist 
zudem fähig die Solvatationsschicht der S1 Tasche komplett in einen ungeordeneten Zustand 
zu transferieren. Der Vergleich zur Apostruktur und dem analogen Methylpyridinium 
enthüllt einen günstigen entropischen Term, der auf die ungeordnete Wasserhülle 
zurückzuführen ist.       
Der vierte, fünfte und sechste Teil befasst sich mit Wassereffekten bei der hydrophoben 
Wechselwirkung. Eine vorherige Arbeit über die Bindung von hydrophoben Liganden zu der 
stark hydrophoben S1‘ Tasche von Thermolysin zeigt einen enthalpisch getriebenen 
hydrophoben Effekt. Dies wird auf die unzureichende Desolvatation der S1‘ Tasche 
zurückgeführt, was durch eine verwandte Arbeit von Homans et al. bestätigt wird. Basierend 
auf der Hypothese, dass das Bindungsprofil einer hydrophoben Wechselwirkung abhängig ist 
vom Solvatationsgrad der untersuchten Bindetasche, sind zwei Serien zum einen für die S3/4 
Tasche von Thrombin, zum anderen für die S2‘ Tasche von Thermolysin konzipiert worden. 
Beide adressierten Bindetaschen sind durch ausgeprägte Solvatisierung aber 
unterschiedliche Form gekennzeichnet.  
Die S3/4 Bindetasche hat die Form eines Halbkreises und ist leicht zugänglich für 
Wassermoleküle. Zwei Serien mit unterschiedlichem S1-Anker sind dann in P3 Position 
hydrophob modifiziert worden. Die thermodynamische Charakterisierung zeigt einen 
hydrophoben Effekt, der eindeutig entropisch getrieben ist. In dieser Studie ist die S3/4 
Tasche mithilfe der immer größer werdenden hydrophoben Modifizierungen schrittweise 
desolvatisiert worden. In beiden Serien verbessert sich die Bindungsaffinität um das 40-
fache. Ausgehend von einer nanomolaren Aktivität ist die Bindungsaffinität in den niedrigen 
pikomolaren Bereich hydrophob optimiert worden. Die Benzamidin-Derivate sind sogar 
durch einen Bindungsmodus mit zwei gebundenen Liganden gekennzeichnet. Der zweite 




gebundene Ligand ist zwar nur zu 50 % populiert, aber man erkennt deutlich die 
Differenzelektronendichte. Überraschenderweise zeigt dieser Bindungsmodus eine 
bemerkenswerte Ähnlichkeit mit dem Bindungsmodus von Fibrinopeptid A, das ein 
Spaltprodukt des natürlichen Thrombin-Substrats (Fibrinogen) darstellt.  
Trotz der berechtigten Kritik bei der Verfeinerung von nur partiell populierten 
Wassermolekülen sind auch in dieser Arbeit Wassermoleküle entdeckt worden, die nicht 
komplett besetzt sind. Die komplette Desolvatation reiche auch hier nicht aus, da der 
enthalpische Preis für die Verdrängung aus dieser Proteinbindetasche nicht durch neue 
Interaktionen zum Protein vollständig kompensiert werden kann.   
Die im fünften und sechsten Kapitel untersuchte S2‘ Tasche von Thermolysin ist dagegen 
weniger gut geformt, aber dafür wegen ihrer Lage auf der Oberfläche optimal solvatisiert.  
Im fünften Kapitel unterschieden sich die untersuchten Thermolysin-Liganden nur durch eine terminale 
Carboxyat- und/oder eine Methylgruppe. Eine überraschende Nicht-Additivität 
von Beiträgen einer Carboxylat- und/oder Methylgruppe ist festgestellt worden. Das Hinzufügen einer 
Methylgruppe bewirkte eine relativ kleine Zunahme in der Freien Energie mit kleinen 
Änderungen in der Enthalpie/Entropie, während das im nächsten Schritt carboxylierte 
Derivat mit einem starken Affinitätssprung und großen Änderungen in der Enthalpie/Entropie 
begleitet war. Wurde das Carboxylat jedoch zuerst und dann erst die Methylgruppe eingefügt, wurden 
umgekehrte Effekte beobachtet: jetzt war die saure Gruppe von geringfügigen Effekten begleitet, während 
die zusätzliche Methylgruppe enorme Veränderungen verursachte. Die Carboxylat-Gruppe stört in beiden 
Komplexen das lokale Wassernetzwerk. Die zusätzliche Methylgruppe bietet dagegen günstige 
Wechselwirkungen für zusätzliche Wassermoleküle an. In allen Komplexen, abgesehen von einem Beispiel, 
wird ein zusammenhängendes Wassernetzwerk zwischen den funktionellen Gruppen des Proteins und des 
Liganden beobachtet. Bei der Komplexstruktur mit dem carboxylierten Liganden fehlt die endständige 
Methylgruppe und dadurch bricht das Wassernetzwerk zusammen. Dieser Zusammenbruch der 
Wasserkette ergibt die überraschende thermodynamische Signatur mit nur geringen Affinitätsunterschieden 
bei dem carboxylierten Liganden, dem die Methylgruppe fehlt. Eine zusätzliche Methylgruppe dagegen hat 
günstige Interaktionsstellen für Wassermoleküle geschaffen und das Netzwerk wurde wieder hergestellt, 
begleitet von starken Affinitätsänderungen und einer enormen Änderung in der Enthalpie/Entropie. 
Im sechsten Kapitel wurde die hydrophobe Bindung zur S2‘ Tasche mit verschiedenen 
hydrophoben Liganden untersucht. Es hat sich gezeigt, dass kleine Reste eindeutig bevorzugt 
werden. Große und sperrige Substituenten haben auf der Proteinseite zu ungünstigen 




Konformationen geführt. Ein Benzyl-Rest, zum Beispiel, hat zwar in dieser Position eine 
Verdrängung von Wassermolekülen bewirkt, aber dieser entropische Gewinn wurde in 
Teilen zunichte gemacht durch den Verlust der Planarität einer benachbarten Peptid-
Bindung. So gingen große Reste mit einem deutlichen Verlust in der Bindungsaffinität einher 
aufgrund von Konformationsänderungen.  
Die Adressierung der S2‘ Tasche zeigt, wie in den beiden Serien aus der vierten Studie, 
ebenfalls ein entropisch dominiertes Signal, welches dem klassischen hydrophoben Effekt 
entspricht. Die vorliegende Reihe von eng verwandten Liganden zeigt, dass beide 
thermodynamischen Parameter betroffen sind und dass viele kleine strukturelle Änderungen 
das thermodynamische Profil bestimmen. Wenn ein zusammenhängendes Wassernetzwerk 
zusammenbricht, zeigen sich deutliche Verluste in der Enthalpie, während die Entropie stark 
zunimmt. Insbesondere bei der Bindung von Liganden in offene hydrophobe Taschen, die 
leichten Zugang zu Wasser haben, können sich neue Bindestellen für Wassermoleküle 
ergeben, wenn Ligandenbereiche zur Wasserphase ausgerichtet sind. In unserer Studie 
wurde zum Beispiel ein zusätzliches Wassermolekül über dem Carboxylat (capping position) 
und an der Seite des Benzolrings entdeckt. Auch solche Phänomene tragen natürlich auf der 
molekularen Ebene zum hydrophoben Effekt bei. Abschließend kann man feststellen, dass 
die hydrophobe Interaktion weder als überwiegend "entropisch" noch "enthalpisch" 
beschrieben werden kann.  Kleine strukturelle Veränderungen auf molekularer Ebene 
bestimmen schließlich darüber, welche treibenden Kräfte hinter der Bindung von 
hydrophoben Bindungspartnern stehen. 
In dieser Serie hat sich zudem ein weiteres Mal gezeigt, dass wenn eine strukturell 
wohldefinierte Solvatation auf der Proteinseite vorhanden ist, der klassische hydrophobe 
Effekt sichtbar wird. Alles spricht also dafür, dass das Bindungsprofil eines hydrophoben 
Liganden stark von den Solvatationseigenschaften der adressierten Proteinbindetasche 
abhängt. Andererseits zeigt sich, dass die Qualität der Solvatation einer Proteinbindetasche 
höchstwahrscheinlich von der Form und Lokalisierung der Bindetasche mitgestaltet wird. Die 
S1‘ Tasche hat zum Beispiel eine klar definierte Gestalt in der Form eines abgeschnittenen 
Kegels. Bisher konnte der tatsächliche Solvatationszustand jedoch nicht beschrieben 
werden, da die Apostruktur bisher durch die Anwesenheit des Verdauungsprodukts Val-Lys 
nicht zugänglich ist. Alle Untersuchungen in dieser Arbeit und die Ergebnisse aus der 
Literatur deuten jedoch darauf hin, dass kristallographisch keine Wassermoleküle in der S1‘ 




Bindetasche vorhanden sind. Ein an diese Arbeit anschließendes Projekt versucht dieses 
Geheimnis zu lüften indem eine Thermolysinmutante produziert wird, die sich nicht mehr 
selbst verdauen kann, da das problematische Valin am C-Terminus zum Glycin mutiert wird. 
Nun wird die Kristallstruktur dieser Mutante zeigen, ob in der Tasche tatsächlich 
Wassermoleküle zu detektieren sind. Auch wenn in der Kristallstruktur dieser 
Thermolysinmutante ebenfalls keine S1‘ Wasser gefunden werden, bleibt immer noch eine 
gewisse Unsicherheit vorhanden, da man letztendlich nicht feststellen kann, ob die 
Wassermoleküle wirklich fehlen oder einfach in einem ungeordneten Zustand vorliegen, der 
naturgemäß in der Kristallographie schwer zugänglich ist. Nun muss hier deutlich betont 
werden, dass einige in dieser Arbeit gefundene Wasserpositionen trotz offensichtlicher 
Unordnung (insgesamt 6 Strukturen) sichtbar sind, wenn die Strukturen ausreichend hoch 
aufgelöst werden. In gewissem Maße würde diese Beobachtung für einen S1‘ 
Solvatationszustand sprechen, in der Wassermoleküle keine höhere Population als 50 % 
aufweisen, da man sonst diese Art von Wasser höchstwahrscheinlich detektieren könnte, 
wie in dieser Arbeit gezeigt. Ein leerer Raum, gleich einem Vakuum, würde dagegen den 
Gesetzen der Physik folgend kollabieren. Daher wird man zwangsläufig andere Methoden 
anwenden müssen, die sich besser eignen eventuelle ungeordnete Wassermoleküle zu 
detektieren. Dazu gehören das NMR und die Neutronenstreuung. Letzteres hätte aber 
ebenfalls mit denselben Problemen zu kämpfen wie die Röntgenstreuung. Bis dahin stehen 
zwei Konzepte sich gegenüber: die eine Hypothese geht von einem leeren hydrophoben 
Raum aus und die andere von Wassermolekülen, die über viele Positionen im Raum 
verschmiert sind. 
Neben den Einblick in die hydrophobe Interaktion ist es gelungen Klarheit über den Ursprung 
der beobachteten Protonierung bei der Bindung von Phosphonamiden zu bringen. Alle 
bisher untersuchten Phophonamide zeigen eine Abhängigkeit der Enthalpie von dem 
untersuchten Puffersystem. Dies ist ein deutliches Zeichen für einen Bindungsprozess, der 
von einer Protonierungsreaktion überlagert ist. Die Untersuchung an verschiedenen 
Liganden hat schließlich ergeben, dass weder die NH-Gruppe des Phosphonamids noch die 
endständige Carboxylgruppe in die Protonierung involviert ist. Eine nähere Untersuchung 
der Aminosäuren in der gesamten Proteinbindetasche hat ergeben, dass Glu143 eine 
zentrale Rolle bei der Protonierungsreaktion spielt. In der Apoform ist dieses Glutamat 
deprotoniert und damit fähig mit dem Zink-Ion zu interagieren. Während der Bindung mit 




den phosphonhaltigen Liganden wird das Glutamat vom Zink-Ion weggedrängt und 
gleichzeitig protoniert, um mit dem Sauerstoff des Phosphonamids eine Wasserstoffbrücke 
aufzubauen. 
Der letzte Teil der Arbeit (Kapitel 7) befasst sich mit der Kooperativität zwischen der 
Wasserstoffbrücke zu Gly216 und hydrophoben Kontakten zur S3/4 Tasche von Thrombin. 
Unterschiedliche Substitutionen an der endständigen Aminogruppe, welche die 
Wasserstoffbrücke zu Gly216 aufbaut, zeigen tatsächlich deutliche Unterschiede im Ausmaß 
der Kooperativität. Diese kooperativen Effekte zeigen eine Korrelation mit den jeweiligen pKa 
Werten der Substituenten, was darauf schließen lässt, dass die Stärke der Wasserstoffbrücke 
beeinflusst wird. Eine quantenchemische Abschätzung der Energie dieser Wasserstoffbrücke 
zeigt kein einheitliches Bild. Hier ist jedoch anzumerken, dass die Rechnungen einige 
Schwächen aufweisen. Die Abschätzung erfolgt auf einem reduzierten Gerüst und nur für 
das jeweilige Alanin-Derivat in P3. Überdies deuten die Kristallstrukturen aus der vierten 
Arbeit darauf hin, dass einige untersuchte Substitutionen eine zusätzliche Wasserstoffbrücke 
zum Protein ausbilden, die nicht in der MD-Simulation berücksichtigt wurde. Eine 
zuverlässige Aussage über den Ursprung dieses Effekts ist leider zu diesem Zeitpunkt nicht 
möglich. Aus jeder Serie ist eine Kristallstruktur nötig um im Anschluss eine zuverlässige 
Berechnung der Stärke der Wasserstoffbrücke durchzuführen. Diese Abschätzung könnte 
somit alle bisher nicht einbezogenen Interaktionen berücksichtigen.  
 
9.2 English version 
The presented thesis focuses on the crystallographic and thermodynamic analysis of the role 
of water molecules in protein-ligand binding. 
Since most of the investigated ligands are found in an affinity range, which is too strong (K i ≤ 
1 nM) or too weak (Ki ≥ 1 μM) for direct ITC titration, this approach was not applicable for a 
thermodynamic characterization. Therefore, ITC displacement titrations were chosen to 
enable reliable thermodynamic analyses in these affinity ranges. The first part of this work 
(Chapter 2) is therefore devoted to the establishment and validation of the displacement 
titration for the characterization of low and high affinity ligands. It has been shown that the 
dissociation constants (Kd) of the displacement ITC correlate very well with kinetically 
determined inhibition constants (Ki). This displacement method can also be applied to 




fragments, which are known for their very weak binding affinity, in order to record accurate 
binding constants. The kinetic determination of binding constants for fragments is due to 
their unexceptionally weak binding not applicable. The latter kinetic assays are not sensitive 
enough or no appropriate assay protocols have been reported to provide reliable values in 
micro- to millimolar range. Nevertheless, the correct estimation of the binding affinity is in 
the early stage of FBDD (fragment-based drug discovery) of utmost importance, since only 
then a reliable decision can be made which fragments should be followed-up for further 
optimization. In such cases, the displacement ITC represents a suitable alternative. In 
addition to the binding affinity, the displacement ITC is also able to determine the enthalpic 
properties with high reliability. This value also represents an important indicator for the 
decision which fragments should be further optimized. Furthermore, it is also possible to 
reduce the protein concentration in an ITC displacement titration to save valuable material 
when working with ligands showing only tiny enthalpic signal. The often criticized protein 
consumption in ITC can be reduced at least threefold. A protocol is given to estimate 
theoretically, most appropriate concentration of the low-affinity ligand to achieve a certain 
degree of inhibition. The equation to estimate this concentration has been implemented 
into an Excel spreadsheet, to easily calculate the degree of inhibition as a function of the 
expected affinity and protein concentration for a given ligand concentration.  
The following study (Chapter 3) examined the positively charged Asp189 at the bottom of 
the S1 pocket of thrombin. It is well-hydrated in the apo structure of thrombin. The aim was 
now to investigate the impact of a change of the Asp189 solvation state by a series of 
pyridine-based ligands on the binding affinity and the thermodynamic profile. The 
thermodynamic study of these micromolar pyridine-based inhibitors is methodically realized 
by applying the displacement ITC presented in chapter 2. This series provides a deeper 
understanding of the consequences of desolvation effects performed on the protein as well 
as ligand side. The apo form of thrombin shows an ordered and tightly bound water 
molecule next to the negatively charged Asp189 in the S1 pocket. The effects observed for 
the perturbance of the solvation shell of the S1 pocket by pyridine and methylpyridinium 
analog inhibitors clearly explain why only micromolar activity is accomplished. In all complex 
structures with pyridine, it is evident that preserving the original solvation state of Asp189 is 
a crucial and a common feature upon binding of the pyridine inhibitors. However, the 
associated entropic losses are immense. In two ligand complexes even disordered ligand 




portions are found in the S1 pocket, which evade full desolvation of Asp189 compared with 
the apo form of thrombin. The price for the desolvation of a charged amino acid is simply 
too large to ensure in this case a complete displacement of all waters. The result is a 
compromise, where 50 % of the water is displaced and 50 % remains at Asp189. As a 
consequence, too high desolvation can lead to disordered systems just in order to keep the 
price of desolvation as low as possible. It has also been found that almost all positively 
charged methylpyridinium derivatives are weaker than the neutral pyridine analogues. The 
quantum-chemical calculation of the solvation of the ligands shows significant differences 
between the neutral and charged derivatives. The charged compounds require an order of 
magnitude more energy for desolvation than the neutral ones. The determined complex 
structures reveal that the charged methylpyridinium derivatives do not optimally address 
the negatively charged Asp189 at the bottom of the S1 pocket. A short distance to the 
deprotonated Asp189 cannot be achieved either due to steric reasons or the bulky methyl 
group provides a good protection to interact in a proper way with the negatively charged 
Asp189. The optimal interaction geometry to Asp189 as it is found in the benzamidine 
complexes cannot be realized in this series. Therefore, the energy released from the 
suboptimal interaction between methylpyridinium and Asp189 is not high enough to 
compensate for the large desolvation price required for the charged ligands. The inhibitors 
lose binding affinity as a result. The closer the positive charge of the methylpyridinium is 
placed to Asp189, the lower the enthalpic penalty turned out. Interestingly, the pyridine 
derivative with nitrogen in para position remains deprotonated and is capable of transferring 
the ordered solvation shell of the S1 pocket into a largely disordered state. The comparison 
to the apo structure and the analog methyl-pyridinium reveals a favorable entropic term, 
which is due to the disordered water shell in the complex structure with the p-pyridine 
derivative.  
The fourth, fifth and sixth part of this thesis deals with water effects in hydrophobic 
interactions. A previous study on the binding of hydrophobic ligands to the hydrophobic S1' 
pocket of thermolysin shows surprisingly an enthalpy-driven hydrophobic effect. This is likely 
attributed to the insufficient desolvation of the S1' pocket as evidenced by a related work of 
Homans et al. Based on the hypothesis that the binding signature of a hydrophobic 
interaction is dependent on the solvation of the investigated binding pocket, two 
hydrophobically modified series were designed: One for the S3/4 pocket of thrombin and 




the other for the S2' pocket of thermolysin. Both addressed binding sites are hydrophobic 
and marked by pronounced solvation but exhibiting different shape. 
The S3/4 binding pocket is shaped like a crescent, which is easily accessible to water 
molecules. Two series with different S1 anchor were hydrophobically modified in P3 
position. The thermodynamic characterization shows a hydrophobic effect which is clearly 
entropically driven. In the study, the S3/4 pocket has been gradually desolvated using 
increasing hydrophobic modifications in P3. In both series, the binding affinity improved by 
about 40-fold. The binding affinity has been optimized hydrophobically from nanomolar to 
low picomolar affinity. The benzamidine derivatives are even characterized by a binding 
mode showing two ligands to be bound simultaneously. The second bound ligand is only 
populated to 50 % but the difference electron density is well defined. Surprisingly, the 
additionally bound ligand traces remarkable well the recognition area that accommodates 
fibrinopeptide A, which is a cleavage product of the natural thrombin substrate (fibrinogen). 
Despite the substantiated criticism with respect to the refinement of partially populated 
water molecules in protein structures, also in the fourth study water molecules have been 
discovered which indicate no full occupancy. Exhaustive desolvation could not be achieved, 
since the enthalpic price for full water repulsion from these protein binding pockets cannot 
sufficiently be compensated by the new interactions formed between protein and ligand. 
The examined S2' pocket of thermolysin in the fifth and sixth study is less well shaped, but 
ideally solvated because of its exposure to the protein surface.  
The ligands differ only by a terminal carboxylate and/or methyl group in the fifth study. A 
surprising nonadditivity of functional group contributions for the carboxylate and/or methyl 
groups is detected. Adding first the methyl and then the carboxylate group results in a small 
Gibbs free energy increase and minor enthalpy/entropy partitioning for the first 
modification, whereas the second involves strong affinity increase combined with huge 
enthalpy/entropy changes. Adding however first the carboxylate and then the methyl group 
yields reverse effects: now the acidic group attachment causes minor effects whereas the 
added methyl group provokes huge changes. The added COO- groups perturb the local water 
network in both carboxylated complexes and the attached methyl groups provide favorable 
interaction sites for water molecules. In all complexes, apart one example, a contiguously 
connected water network between protein and ligand functional groups is observed. In the 
complex with the carboxylated ligand, still lacking the terminal methyl group, the water 




network is unfavorably ruptured. This results in the surprising thermodynamic signature 
showing only minor affinity increase upon COO- group attachment. Since the further added 
methyl group provides a favorable interaction site for water, the network can be re-
established and strong affinity increase with huge enthalpy/entropy signature is then 
detected. 
In the sixth study several hydrophobic S2’ occupants were investigated. Surprisingly, it has 
been found that small residues are clearly preferred. Large and bulky groups on the ligand 
side induce unfavorable conformations of protein residues. A benzyl group, for example, has 
resulted in the displacement of all water molecules, but this entropic gain is partially 
compensated by the loss of planarity of an adjacent peptide bond. Thus, large ligand 
portions are associated with a significant loss in binding affinity due to conformational 
changes on the protein side.  
Addressing the S2' pocket of thermolysin generates also an entropically dominated signal 
similarly to the series in the fourth chapter.  
The present series of closely related complexes shows that both thermodynamic properties 
are involved and many detailed structural phenomena determine the final signature. If a 
contiguously connected water network ruptures, an enthalpic loss and entropic gain is 
experienced. Particularly, in case of accommodation of ligand portions in pockets opening to 
the bulk solvent and exposing parts of the placed ligand to the water phase, new binding 
sites for water molecules can be generated, e.g. as in our study at the capping position 
above the carboxylate group or the site on top of the benzyl ring. Also such phenomena 
contribute on the molecular level to the finally determined hydrophobic effect. In summary, 
there are no arguments why the hydrophobic effect should be predominantly “entropic” or 
“enthalpic”; small structural changes on the molecular level determine whether hydrophobic 
binding to hydrophobic pockets results in a more enthalpy or entropy-driven signature.    
Additionally, it has been shown for the third time that the binding profile of hydrophobic 
ligands also strongly depends on the presence of a structurally well-defined solvation in the 
hydrophobic pocket of the apo form. On the other hand, the form and location of the 
binding pocket determines the properties of its solvation shell. The S1' pocket, for example, 
has a clearly defined shape in the form of a truncated cone. So far, the actual solvation 
pattern of the apo structure could not be described as the uncomplexed state is hardly 
accessible due to the presence of the digestion product Val-Lys in the active site. All studies 




in this work and the results from the literature indicate, however, that no crystallographic 
water molecules in the S1' binding pocket can be located. An on-going project tries to 
unravel the actual S1’ solvation state by creating a thermolysin mutant, which cannot digest 
itself because it lacks the crucial valine residue at the C-terminus. The crystal structure of 
this mutant will reveal whether there are localized water molecules detectable or not. If this 
thermolysin mutant also does not indicate any S1' waters, there are still some uncertainty in 
the water question since X-ray crystallography is here not able to differentiate whether the 
water molecules are really missing or just in a highly mobile state.  
It must be emphasized, that some water positions have been found although obvious 
disorder (total of 6 structures, 50 % occupancy) is indicated, provided that the structures are 
well enough resolved. To some extent this observation would speak for a S1' solvation state, 
where the water molecules are populated to less than 50 % occupancy since beyond this 
threshold water seems rather easily accessible by X-ray crystallography as shown in this 
work. In contrast, space without any water molecules (basically a vacuum) is likely to 
collapse according to the laws of physics. Hence, it will be inevitable to use other methods 
that are better suited to detect highly mobile water molecules. These methods include NMR 
and neutron scattering. The latter would have probably the same problems as the 
experiments with X-ray scattering because only coherent scattering will lead to a diffraction 
pattern. So far, there are two concepts how to explain the so-called non-classical 
hydrophobic effect: one hypothesis is based on an empty hydrophobic space and the other 
by water molecules, which are scattered over many positions in space. 
In addition to insights into the hydrophobic interaction, an unresolved question about the 
origin of the observed protonation effect in case of phosphonamidate binding to 
thermolysin could be clarified. All previously studied phophonamidates show a dependence 
of the binding enthalpy on the applied buffer system. This is a clear indication for a binding 
process, which is superimposed by a protonation reaction. The study of various ligands has 
finally revealed that neither the NH group of the phosphonamidate nor the ligand’s terminal 
carboxyl group are involved in the pick-up of a proton. A closer examination of the amino 
acids throughout the protein binding site has shown that Glu143 plays a central role in the 
protonation reaction. This glutamate is deprotonated in the apo form and thus able to 
interact with the zinc ion. Glu143 is pushed away upon phosphonamidate binding and 




simultaneously becomes protonated to build an H-bond with the oxygen of the 
phosphonamidate. 
The last part of the work deals with the cooperativity between a hydrogen bond to Gly216 
and hydrophobic contacts formed in S3/4 pocket of thrombin. Different substitutions at the 
terminal amino group, which builds up the hydrogen bond to Gly216, exhibit significant 
differences in the extent of cooperativity. These cooperative effects correlate well with the 
respective pKa values of the substituents, which suggest that the strength of the hydrogen 
bond is affected. A quantum-chemical estimation of the energy of this hydrogen bond 
reveals a mixed picture. However, it has to be noted that some limitations have to be 
regarded while interpreting these values. The calculations are performed only on a reduced 
scaffold and are limited to derivatives showing an alanine in P3. Moreover, the crystal 
structures from the fourth study suggest that for some of the considered substitutions the 
formation of an additional hydrogen bond to the protein has to be taken into account which 
is not regarded in the calculations. A consistent interpretation of the origin of the observed 
cooperative effect is unfortunately not yet possible. Crystal structures are necessary in each 
series to perform a reliable calculation of the connection strength of the hydrogen bond. A 










ABP L-arabinose binding protein 
ACB 2-(aminomethyl)-5-chlorobenzylamide 
ACE Angiotension-converting enzyme 




CSD Cambridge structural database 
DMSO Dimethyl sulfoxide 
DNA Deoxyribonucleic acid 
FBDD Fragment-based drug discovery 
FBLD Fragment-based lead discovery 
FPA Fibrinopeptide A 
Hepes 2-(4-(2-Hydroxyethyl)- 1-piperazinyl)-ethansulfonsäure 
HIV Human immunodeficiency virus 
HTS High-throughput screening 




MD Molecular dynamics 
MR Molecular replacement 
MUP Major urinary protein 
MW Molecular weight 
NMR Nuclear magnetic resonance 
PDB Protein data bank 
PEG Polyethylene glycol 
SAD Single-wavelength anomalous dispersion 
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